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Chapter 1 
 
Introduction 
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Magnetic Resonance Imaging (MRI) is one of the most successful and powerful non-invasive 
diagnostic methods among the several in vivo imaging techniques available in clinical 
diagnostic and biomedical research. MRI has severeal advantages as an imaging modality, 
which also explains its gain and very rapid development. These are: lack of ionizing radiation 
for image acquisition, noninvasiveness with a high patient acceptability, excellent delineation 
of anatomic systems that arises from a high level of inherent contrast, outstanding temporal 
and spatial resolution, ability of application to virtually every part of the body.
[1]
 The use of 
contrast agents (CA) has become really important in improving the low intrinsic sensitivity of 
this method.
[2]
 Traditionally, the imaging procedures have been combined with the use of 
dedicated contrast media, to further enhance the visualization of morphology and physiology. 
This combination of imaging hardware and contrast media was of high importance for the 
development of modern clinical radiology. MRI is no different in this respect, and the contrast 
media used are based largely on complexes of f-elements. The complexes need to be endowed 
with high stability to avoid the in vivo release of toxic free metal ions.  
Even though inherent contrast in MRI can be manipulated to a much greater extent than in 
other imaging techniques, certain diagnostic questions cannot be answered easily and require 
the application of CAs. The contrast in an MR image is the result of a complex interplay of 
several factors, including instrumental parameters, proton density and the relative T1 and T2 
relaxation times of the imaged tissues. Because it is nearly impossible to change the water 
content of tissues, CAs on the market or in clinical or pre-clinical trials focus upon T1,2 
changes. Generally, the purpose is to reduce T1 in order to obtain an intense signal in short 
times and a better signal-to-noise ratio. These paramagnetic probes are essentially complexes 
of Gd (or Mn) due to the combination of high magnetic moment and favourable properties in 
terms of electronic relaxation. Well over 200 million patients have been dosed so far and the 
world market is estimated to be of the order of 1.2 billion/y. The solid-state structure, in vitro 
and in vivo properties of a large number of Gd
3+
-complexes have been investigated 
intensively in the last 20-25 years. 
 
Timeline of MRI imaging: 
The history of MRI imaging can be dated back in the late 19
th
 century when Nikola Tesla 
discovered the Rotating Magnetic Field in Budapest, Hungary (1882). This was a radical 
discovery in physics. In 1946, two scientists in the United States, independently of each other, 
described a physico-chemical phenomenon, which was based upon the magnetic properties of 
certain nuclei in the periodic system. This was Nuclear Magnetic Resonance, for short NMR. 
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The two scientists, Edward M. Purcell and Felix Bloch, were awarded the Nobel Prize in 
Physics in 1952. 
In 1955, Erik Odeblad and Gunnar Lindström from Stockholm published their NMR studies, 
with relaxation time measurements of living cells and excised animal tissue. 
In 1971 Raymond Damadian, a physician and experimenter working at Brooklyn's Downstate 
Medical Center reported that discovered that tumors and normal tissue can be distinguished in 
vivo by nuclear magnetic resonance because of the differences in the relaxation times. One of 
the greatest pioneers in the history of NMR is Paul Lauterbur. In March 1973, he published 
the first images of two tubes of water in Nature. 
In 1977-78, Raymond Damadian built the first MRI scanner, assisted by his two post-doctoral 
students, Michael Goldsmith and Larry Minkoff, at New York’s Downstate Medical Center. 
He recorded the first MRI scan of a healthy human body in 1977 and of a human body with 
cancer in 1978. 
In 1987, real time MR imaging of heart becomes its development. In 1991, Filler and 
colleagues describe imaging of axonal transport of superparamagnetic metal oxide particles, a 
technique that later becomes important in imaging of neural tracts. In 1993, functional MRI of 
the brain is introduced. In 1994, the first intraoperative MR unit developed by GE and 
Harvard is installed at the Brigham and Women's Hospital in Boston. In the 1990's, in 
addition to research centers and large hospitals, small distant hospitals and imaging centers 
started to exploit MRI principally for neuroimaging and locomotor system imaging. 
The use of contrast agents also started in the early 1980’s. Paul C. Lauterbur described the 
concept of using paramagnetic metal ions to enhance the contrast (and reduce acquisition 
times) of structures, in 1978. After injecting a manganese salt solution as contrast agent, he 
imaged five dogs with myocardial infarctions and was able to highlight them. 
In October 1983, Lauterbur's group published a major overview of paramagnetic contrast 
agents in MRI, addressing problems and questions involved in the development of CAs. 
The patent application for Gd-DTPA dimeglumine was submitted in July 1981. In 1984, 
Dennis H. Carr and Wolfgang Schörner reported the first images in men. In 1988, Gd-DTPA 
(Magnevist) became commercially available, followed shortly afterwards in 1989 by the 
macrocyclic Gd-DOTA (Dotarem) from Guerbet (France). A number of other agents entered 
the marketplace during the 1990s.
[3,4] 
Over the last decades, more than 800 potential MR contrast agents have been described in the 
literature or have been patented, but only a dozen are available on the market for clinical use. 
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Nowadays there are more than 60 million experiments are carried out in every year, and MRI 
is still the most rapidly developing diagnostic method. 
 
Classes of Contrast Agents: 
MRI contrast agents can be conveniently classified into five different classes:  
T1 agents, T2/T2 * agents, CEST agents, 
19
F-based agents and hyperpolarized probes. 
 
T1 agents: 
T1 agents are mainly represented by complexes of paramagnetic metal ions [Gd(III) or Mn(II)] 
that enhance the MR water signal intensity. These are also called positive CAs because they 
provide brighter images in T1w scans. The main benefits using T1 agents arise from the high 
versatility of this contrast mechanism that is affected by a large number of factors related to 
either structural and dynamic characteristics of the agent and biological aspects like the intra-
voxel distribution of the probe (e.g., intra/extra-vascular, intra/extra-cellular).
[5,6,7]
 All Gd-
based CAs have a low molecular mass of about 500 Da, are extremely hydrophilic complexes 
and are excreted unmetabolised in the urine. They have similar pharmacokinetic properties 
with similar plasma half-lives, and, due to their small size, extracellular Gd-based CAs are 
excreted almost exclusively by passive glomerular filtration through the kidneys with neither 
secretion nor reabsorption. However, protein binding GBCAs are also excreted to varying 
degrees by the hepatobiliary route. 
 
T2/T2* agents: 
T2/T2* agents are chemicals, mostly superparamagnetic nanoparticles made of iron oxides, 
capable to shorten the T2/T2* of water protons much more than T1. These complexes can be 
identified by the following molecular formula: Fe2
III
O3M
II
O, where M
II 
can be: Fe
2+
, Mn
2+
, 
Ni
2+
, Co
2+
, Mg
2+
. In solution, these complexes are assumed to be spherically symmetric 
solvated superparamagnetic iron-oxides (SPIO) nanoparticles. They can be classified into four 
groups based on their diameter. Oral-SPIO: 300 nm; Standard SPIO (SSPIO): 60-150 nm; 
Ultrasmall-SPIO (USPIO): 5 to 30 nm; and monocrystalline iron-oxide nanoparticles 
(MION): smaller than 10 nm. They are also referred to as negative CA because they decrease 
signal intensity, which results in darker images. Such nanoparticles possess a higher 
sensitivity than T1 agents that justifies their widespread use in MR-molecular imaging 
methods, particularly for cellular imaging.
[8]
 An obvious disadvantage is that the signal loss is 
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not desirable, particularly when the target site has an intrinsically low signal (e.g., lungs, 
hemorrhages). 
 
CEST agents: 
The family of CEST agents is constantly growing; the peculiarities of these systems could 
open new and interesting future perspectives for MRI agents in pharmacology research. The 
diamagnetic metal-free systems can eliminate the risks associated with the use of metal-based 
contrast agents. The acronym CEST stands for Chemical Exchange Saturation Transfer and 
identifies those chemicals that generate a MRI contrast via the transfer, transmitted by 
chemical exchange, of saturated (i.e., after irradiation with a frequency specified RF pulse) 
protons from the donor pool (CEST agent) to the acceptor pool (bulk water). The most 
important advantage of using CEST agents is that the rate of the contrast is only dependent on 
the concentration of the contrast agent and their mobile protons exchange rate. A good CEST 
agent should be characterized by:  
- fast proton exchange in physiological pH and temperature 
- high chemical shift difference (Δω) among the mobile protons and the water protons 
- small toxicity, good solubility and small osmolality  
Endogenous metabolites with exchangeable protons including many endogenous proteins with 
amide protons, glycosaminoglycans, glycogen, myo-inositol, glutamate, creatine and several 
others have been identified as potential in vivo endogenous CEST agents. 
Paramagnetic lanthanide ions that induce large hyperfine shifted resonances in close protons 
are particularly useful for CEST contrast because high Δω values allow access to a wider 
variety of faster exchanging chemical systems. Lanthanide-based agents of this type are 
referred to as PARACEST agents.
[6] 
 
Heteronuclear agents: 
CEST agents share the frequency-encoded contrast property with those agents containing 
MRI detectable nuclei different from protons. Among them, two classes deserve to be 
mentioned here because they comprise compounds already approved for use in humans or in 
advanced clinical trials: 
19
F agents and hyperpolarized probes. 
 
19
F agents: 
19
F nuclei are the most sensitive nuclear spins after protons and hence can be detected by MRI 
without isotopic enrichment. The detection sensitivity is similar to CEST agents (few mM). 
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Consequently,
19
F agents are almost solely represented by nanosystems, where 
perfluorocarbon nanoparticles (PFCs) are by far the most commonly used.
[9] 
The important 
advantage of fluorinated agents over the other types of contrast media systems from the 
possibility to correlate straightly the MR signal to the agent concentration, thus enabling the 
quantification of selected biomarkers and/or drugs transported at the site of interest.
[10] 
 
Hyperpolarized probes: 
This class of MRI agents is by far the most sensitive one. These agents have some similarity 
with PET tracer, not only for the distinguished sensitivity, but also for the setback of the 
signal they generate (caused by the return back to the thermal polarization) that occurs on the 
timescale of the T1 of the polarized spin. Hence, one restriction in the use of hyperpolarized 
probes is the loss of the signal over time that requires fast injection and rapid accumulation at 
the target site.
[11] 
 
Design of new contrast agents: 
A contrast agent for MR must have the ability to change efficiently the T1 and/or T2 in tissues 
at low (μM to mM) concentrations with acceptable tolerance. The following points summarize 
the most important features of paramagnetic MRI contrast agents. 
 
High Relaxivity: 
The efficiency of the contrast agents is described by the parameter relaxivity (r1p), which is 
defined as the paramagnetic enhancement of the longitudinal relaxation rate (1/T1) of the 
water protons in 1mM aqueous CA solution. The value of the relaxivity is the combination of 
the inner, -second and the outer sphere contributions. The inner sphere contribution represents 
the transfer of the paramagnetic relaxation effect to the bulk via the exchange of directly 
coordinated water molecule(s) to the paramagnetic ion. The second sphere contribution arises 
from water molecules hydrating the complex (via hydrogen-bonding interactions) with a 
relatively long residency time, whereas the long-range interaction involving solvent molecules 
diffusing next to the complex represents the outer sphere term. 
Relaxivity is the most important property of contrast agents. Each agent’s fundamental ability 
to reduce T1 and/or T2 is referred to as its ‘‘relaxivity,’’ r1p and r2p. An agent with a higher 
relaxivity will lower the T1 and/or T2 more at equivalent concentrations than an agent with a 
lower relaxivity. Higher relaxivities are associated with larger molecular weight ligands, and 
higher relaxivity means that lower dose is enough to reach good resolution. 
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High Stability: 
Stability in this case means two different stabilities. One is thermodynamic stability and the 
other is kinetic inertia (commonly referred to as kinetic stability). Both of them are important 
to avoid toxicity problems. In general, thermodynamics describes the energy necessary to 
break the bonds between the metal ion and its chelating ligand and release the free metal ion 
(dissociation) independently from time. Kinetic stability refers to the rate at which 
dissociation occurs. Thermodynamic stability can be described quantitatively by the 
thermodynamic stability constant Ktherm (value given on a logarithmic scale, with larger values 
representing exponentially tighter binding) and the conditional thermodynamic stability 
constant Kcond. Ktherm is independent of pH, while Kcond is conditional, specifically reported in 
this context at physiologic pH. Kcond is therefore more useful than Ktherm to describe 
thermodynamic stability also in in vivo or ex vivo conditions.
[13]
 Kinetic stability is 
characterized by the dissociation rate constants of the Gd chelates, a measure of how rapidly 
equilibrium is reached or how fast the Gd ion is released from a Gd(III) chelate
 
when 
thermodynamic conditions are such that release can occur.
[14]
 In this case slower dissociation 
means higher kinetic inertness and more stable complex. 
 
Specific Biodistribution: 
Tissue specificity refers to the distribution of contrast agents to some organs or tissues with a 
higher concentration than to others, lowering the required contrast agent dose, and/or 
increasing the sensitivity of lesion detection. Currently, there are agents that use hepatobiliary, 
renal, or both routes of excretion.
[15] 
 
Rapid Clearance: 
MRI contrast agents should clear out rapidly and completely from the body after injection and 
subsequent imaging. This is necessary to prevent chronic toxicity due to the slow deposit of 
dissociated free metal ions in specific tissues or organs.  
 
Low Osmolality and Viscosity: 
Osmolality reflects the concentration of dissolved particles in a contrast agent's formulation. 
Most Gadolinium Based CAs are formulated at 0.5 M because of the need for rapid 
administration and therefore necessarily have some hyperosmolality relative to plasma. When 
used at clinical, approved doses, Gadolinium based CAs have a small total body osmotic load 
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(0.5–2 mOsm/L compared to blood osmolality of 300 mOsm/L), i.e., much lower than that of 
iodinated contrast media. There are preclinical data showing the deleterious effect of high 
osmolality in the case of Gadolinium based CAs and cases of extravasated Gadolinium based 
CAs have been described.
[16,17]
 Viscosity is a measure of the "thickness" and internal 
resistance to motion of a fluid. Formulations producing lower osmolality and viscosity may 
have improved dose tolerance and offer formulation flexibility, particularly for rapid bolus 
administration via a power injector. 
 
Low Toxicity: 
Contrast agents should have low acute toxicity, not producing side effects, such as allergic 
reactions and changes in normal serum parameters. Typically, ratios of >30 between rodent 
LD50 and human doses are sought. Problems in terms of chronic tolerance of agents should 
be nonexistent. Care regarding special patient populations such as those with renal 
impairment is of high importance. 
Nephrogenic systemic fibrosis (NSF) is a serious late adverse reaction associated with 
exposure to Gadolinium based CAs in patients with renal insufficiency or on dialysis.
[18,19]
 
NSF is a rare, progressive, usually fatal disease characterized by skin thickening, painful joint 
contractures, and fibrosis of multiple organs including the lungs, liver, muscles, and heart. 
Basically all cases that has been documented have occurred in patients with chronic severe 
renal insufficiency who have received gadolinium contrast.
[20]
 Therefore, researchers started 
to find an alternate solution for Gd. Complexes of Mn(II) can represent a possible solution. 
Manganese(II) shares several advantageous properties with gadolinium(III): high spin (five 
unpaired electrons), fast water exchange kinetics and slow electronic relaxation. Although 
Gadolinium has seven unpaired electrons and a larger magnetic moment, the water exchange 
rates on Mn
2+
 complexes are sufficiently fast not to limit relaxivity. Another advantage is that 
manganese is an essential metal ion and then the organism has developed a mechanism to 
remove the Mn(II) from the living system; a serum concentration of 0.5–1.2 μg/L[21] is 
essential for normal development and body function. Despite the important biological role of 
Mn
2+
, large doses of this metal ion are neurotoxic (LD50 = 0.22 mmol/kg for rat).
[22,23] 
Humans overexposed to Mn
2+
 can suffer from neurological disorders, which results in a form 
of Parkinsonism termed manganism,
[24]
 likely caused by the damage of basal ganglia.
[25] 
In comparison with Gd
3+
, Mn
2+
 is less paramagnetic and has a lower charge and lower ionic 
radius. These differences lead to synthesize different ligands with a structure suitable for 
stable Mn
2+
complexation. Depending on the denticity and rigidity of the ligand (open chain, 
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macrocycle, benzene ring included), Mn
2+
 has common coordination numbers of 6 or 7 in its 
complexes. In order to act as an efficient CA, a Mn
2+
 chelate has to allow direct coordination 
of water molecule(s) to the metal ion. The outer-sphere contribution to relaxivity is even 
lower than that for a Gd
3+
 complex with a higher spin. In fact, a problem with Mn-based 
contrast agents could be the lack of inner sphere water molecule, which is essential for use as 
MRI contrast agent. The relation between ligand geometry and coordination number is hardly 
predictable. Hexadentate ligands can form complexes with both coordination numbers 
{[Mn(NOTA)]
–
 CN = 6, [Mn(EDTA)(H2O)]
–
 CN = 7} and rigid pentadentate aza-crown-
ethers can form pentagonal-bipyramidal complexes with CN = 7.  
The complex needs to have also high thermodynamic stability and kinetic inertness. In 
general, the thermodynamic stability of Mn
2+ 
complexes is lower in comparison to that of 
Gd
3+
 analogues, because of the lower charge of the Mn
2+
 ion. Kinetic inertness is another 
important issue for safe in vivo application of CAs. In general most of the Mn(II) complexes 
of open-chain ligands were found to be kinetically too labile for in vivo use. Macrocyclic 
Mn(II) complexes have been reported to have reasonably high thermodynamic stability and 
kinetic inertness. 
 
Paramagnetic enhanced relaxation rate: 
In the presence of paramagnetic media, the theory of the solvent nuclear relaxation was 
developed by Solomon, Bloembergen, Morgan and others.
[26-31] 
The paramagnetic complexes 
are able to reduce both the T1 and T2 relaxation times of solvent nuclei in the region where 
they are present. The observed relaxation rate (1/Ti,obs) is the sum of the diamagnetic (1/Ti,d) 
and the paramagnetic relaxation rates (1/Ti,p): 
 
pidiobsi TTT ,,,
111
           i=1, 2                                         (1) 
 
The diamagnetic term (1/Ti,d) respects to the contribution of the diamagnetic environment 
(generally the water) to the observed relaxation rate in the absence of paramagnetic solute.  
The paramagnetic term (1/Ti,p) represents the “catalytic” effect of the paramagnetic substances 
on the relaxation rate of solvent nuclei. The 1/Ti,p values are directly proportional to the 
concentration of the paramagnetic complexes ([M]): 
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           i=1, 2                                      (2) 
The relaxivity is usually given in terms of the increase in the longitudinal relaxation rates of 
water protons. The specific chemical interactions are generally realized by the coordination of 
the water molecule(s) in the empty coordination site(s) of the metal ion (ri,p
is
 inner-sphere) 
and by the translation diffusion of the water molecules in the surrounding of the paramagnetic 
complexes (ri,p
os
 outer-sphere). The third type of interaction is linked to the approximately 
long residence time of the water molecules in the proximity of the paramagnetic centers due 
to the hydrogen bond formation with the strongly polarized functional groups (e.g. 
carboxylate or phosphonate) of ligands used for the complexation of metal ions. The 
contribution of these processes to the overall relaxation enhancement is called second-sphere 
relaxivity (ri,p
ss
). The observed paramagnetic relaxation rate (ri,p) of water protons may be 
considered as the sum of the inner- (ri,p
is
), outer- (ri,p
os
) and second-sphere (ri,p
ss
) contribution 
of the paramagnetic complexes:
 
 
ri,p = ri,p
is
  +  ri,p
os
  +  ri,p
ss
                     i=1,2                     (3) 
 
The inner-sphere relaxation mechanism is governed by the chemical exchange between the 
coordinated water protons and the bulk water. The longitudinal and transversal inner-sphere 
relaxation time of water protons are given by: 
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where q, M (corresponding to the inverse of water exchange rate 1/kex), 1/T1M, 1/T2M and M 
are the number of the inner-sphere water molecules, the lifetime of the water molecules in the 
inner coordination sphere of the paramagnetic metal ion, the longitudinal and transversal 
relaxation rate of the inner sphere water protons and the chemical shift difference between the 
inner-sphere and bulk water, respectively. According to the Solomon-Bloembergen theory 
developed for the simple paramagnetic aqua ions, the relaxation rate of the inner-sphere water 
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protons are originated from the sum of the dipole-dipole (DD) and scalar/contact (SC) terms. 
The dipole-dipole interaction is affected by the modulation of the proton spin – electron 
vector, whereas the scalar term is only influenced by the electron spin relaxation and the 
water exchange. The dipole-dipole and scalar relaxation rates of the inner-sphere water 
protons are given by the Eqn.(6) – (11): 
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where I, g, B, rMnH, S, A/ħ, I and S  are the nuclear gyromagnetic ratio of proton, the 
Landé-factor for the free electron (2.0023), the Bohr magneton, the distance between the 
proton and the metal ion, the electron spin quantum number (5/2 for Mn
2+
), the 
hyperfine/scalar coupling constant between the unpaired electrons of the paramagnetic ion 
and the protons of the inner-sphere water molecule, the Larmor frequencies of the proton and 
electron (S=658.21I), respectively. The correlation times (ci and ei) which characterize the 
relaxation of the inner-sphere water protons are expressed as follows: 
 
MieRci T 
1111
                      i=1, 2                     (12) 
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Mieei T 
111
                          i=1, 2                     (13) 
 
where R, T1e and T2e are the reorientation time of the metal – proton vector (rotational 
correlation time), the longitudinal and transversal  electronic relaxation times of the metal ion. 
Since the interaction between the Mn
2+
 ion and the donor atoms is predominantly ionic in 
nature, the scalar coupling between the protons of the inner-sphere water molecule and the 
electrons of the Mn
2+
 ion is very weak (to the best of our knowledge the value of the A/ħ 
value is unknown). On the other hand, the contribution of the e2/(1+S
2e2
2
) term can be 
neglected at higher frequencies (>10 MHz). By taking into account these considerations, the 
scalar contribution to the overall relaxation rate of the inner sphere water protons is very 
small.  
According to the Bloembergen-Morgan model,
[26]
 the magnetic field dependence of 
the electronic relaxation times (T1e and T2e) of the paramagnetic ions is interpreted by the 
variation of the transient zero-field splitting (ZFST) of the electronic spin states resulted in by 
the interaction of the ligand fields of the solvent molecules and the donor atoms participating 
in the coordination of the metal ion. The magnetic field dependence of the electronic 
relaxation times are given by the following equations: 
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where 2 and v are the mean-square ZFST energy and the correlation time for the modulation 
of the zero-field splitting interaction. The complete paramagnetic enhanced inner-sphere 
relaxation theory can be obtained by the combination of Eq. 4 and 5 with the Solomon-
Bloembergen (Eqs. 6 – 11) and Bloembergen-Morgan (Eqs. 14 and 15) models which are 
referred to as the Solomon-Bloembergen-Morgan (SBM) theory. According to the SBM 
theory, the various determinants of the inner-sphere proton relaxivity can be taken into 
account separately. Eqs. 4 – 15 clearly indicate that the relaxation enhancement of the inner-
sphere water protons is limited by the residence time of the inner-sphere water molecule 
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under the slow exchange conditions (M>>T1M) and by the relaxation rate of water protons 
directly coordinated to the paramagnetic center in the fast exchange condition (M<<T1M). 
Moreover the relaxation time of the water protons (T1M) is also influenced by the rate of the 
exchange between the coordinated and the bulk water molecules, the rotational correlation 
time (R) and the electronic relaxation time of the paramagnetic center (T1e, Eq. 14). The 
variation of the Mn – H distances (rMnH in Eqs. 7 and 10) and the hydration number (q in Eq. 
4 and 5) strongly affects the inner-sphere relaxivity. In order to obtain an easy overview of the 
effects of these parameters, the inner-sphere relaxivity have been calculated as a function of 
water exchange (1/M) and the rotational correlation rates (1/R) by using fixed v and 
2
 
values (Fig. 1A). These model calculations were also performed by the simulation of the 
inner-sphere relaxivities as a function of v and 
2
 at constant 1/M and 1/R values (Fig. 1B 
and C). The prediction of the inner-sphere relaxivity values were made at 0.47 and 1.41 T 
field strength. Figure 1 clearly shows that the exchange rate of the inner-sphere water 
molecule, the reorientation correlation time and the electron relaxation time strongly influence 
the value of the inner-sphere relaxivity, which decreases with the increase of the field 
strength. In order to obtain the maximum relaxivity value, the reorientation correlation time 
must be increased (R10
9
 s
-1
) whereas the exchange rate of the inner sphere water molecule 
(1/M) must be within the 3 - 3010
7
 s
-1
 range. The maximum of the inner-sphere relaxivity of 
the low molecular mass monohydrated Mn(II)-complexes is around 3.5 mM
-1
s
-1
 at 0.47 and 
1.41 T field strength (Fig. 1A). With the use of the M=10 ns and R=100 ps values, the 
maximum of the inner-sphere relaxivity (r1p
in
=3.5 mM
-1
s
-1
) can be obtained at 2<11019 s-2 
mean-square ZFST energy value (Fig. 1B). However, the elongation of the reorientation 
correlation time (R = 33 ns) results in the large variation of the maximum inner-sphere 
relaxivity as a function of v and 
2
 values at different field strength (Fig. 1C). At 0.47 T, the 
plateau of the relaxivity (r1p
in
=125 mM
-1
s
-1
) can be achieved at 2<41018 s-2 mean-square 
ZFST energy. However, the inner-sphere relaxation enhancement of the monohydrated 
Mn(II)-complex endowed with the slow reorientational correlation time (R = 33 ns) shows 
the maximum curve as a function of v and 
2
 values at 1.41 T field strength. The maximum 
of the r1p
in
 is about 46 mM
-1
s
-1
 which can be attained at 1.41 T in the 2=2 – 8 1019 s-2 and 
v=0.4 – 20 ps parameter range (Fig 1C). 
 
 
 
 
14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. r1p
is
 values as a function of log(1/M) and log(1/R) (A) and as a function of 
log(1/v) and log
for R=10 ps (B) and R=33 ns (C) (q=1; rMnH=2.75 Å) 
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Hydration number of Mn(II)-complexes: 
 The contribution of the paramagnetic metal ions to the inner-sphere relaxivity values is 
directly proportional to the number of the water molecules (q) directly coordinated to the 
metal ion (Eq. 4). The aqua complex of Mn
2+
 ion contains six inner-sphere water molecules, 
which results in a high enhancement of the relaxation rate due to the fast exchange between 
the inner-sphere and the bulk water molecules. By taking into account the known 
biochemistry
[32]
 and chemical properties of Mn
2+
-ion, the free Mn
2+
 can interact with 
enzymes
[32,33]
 and the Ca
2+
 or Mg
2+
 binding sites of proteins
[34,35]
 and nucleic acids
[36]
 which 
limit the in vivo application of the Mn(II)-salts (e.g. MnCl2 or MnSO4) in the MRI 
investigations, and as we mentioned before the free Mn
2+
 ion is neurotoxic. Therefore, the 
highly stable and kinetically inert polyamino-polycarboxylate complexes of Mn(II), which 
prevent the release of Mn
2+
 ion, are proposed to use in biological systems. 
Mn(II)-complexes are generally formed with the open-chain and macrocyclic polyamino-
polycarboxylate ligands (Scheme 1). The coordination number, the q values, the relaxivity, 
the water exchange rate and the reorientational correlation time of the Mn(II)-complexes are 
presented in Table 1. The open-chain chelating agents are generally the derivatives of EDTA 
and DTPA ligands. The detailed 
17
O-NMR, relaxometric and X-ray diffraction studies in 
solution and solid state indicate that the coordination number of the Mn
2+
-ion is 7 with one 
inner-sphere water molecule in the Mn(EDTA) and in the EDTA derivative complexes.
[2]
 
However, the relaxivity of the Mn(DEBPN) complex is double of  that of Mn(EDTA), which 
was explained by the coordination of two or three water molecules directly to the Mn
2+
-ion.
[37]
 
The DTPA ligand is octadentate which hinders the direct coordination of the water molecule 
to the Mn
2+
-ion.
[38]
 The relaxation enhancement observed for the Mn(DTPA)-derivatives is 
derived from the outer- and second-sphere contributions.
[38]
  
The coordination number of the Mn(II)-complexes formed with macrocyclic 
polyamino-polycarboxylate ligands is 6, 7 or 8, determined by the size of the macrocyclic ring 
and the nature of the donor atoms. The Mn(II)-ion is hexacoordinated with no inner-sphere 
water molecule in the complexes formed with the nine-membered NOTA and its derivative 
ligands.
[39,40]
 The coordination number of the Mn(II)-ion is 6 in the Mn(II)-complexes of the 
dimeric ENOTA
[41]
 and 9-aneN2O-2P ligands
[42]
 which contain one inner-sphere water 
molecule per Mn(II)-center. Interestingly, the relaxometric studies of the Mn(9-aneN2O-2A) 
complex indicate the hydration equilibrium between the 6 and 7 coordinatated Mn(II) with 
one and two inner-sphere water molecules. 
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The 12-membered macrocyclic ligands used for the complexation of Mn
2+
-ion are 
generally the DOTA and its derivative ligands furnished with the reduced number of donor 
atoms. The coordination number of the Mn(II)-ion is 6 with no inner-sphere water molecule in 
the Mn(DOTA),
[38],
 Mn(DO3A)
[43]
 and Mn(1,4-DO2A)
[44]
 and Mn(1,7-DO2A) complexes 
(80% of Mn(1,4-DO2A) is presented in monohydrated form in solution, so CN=7).
[45]
 The 
gradual replacement of the acetate pendant arms of DOTA with amide groups results in the 
formation of Mn(II)-complexes with seven (e.g. Mn(DO3AM), Mn(DO3AM-cyOH)) and 
eight coordinated (Mn(DOTAM) Mn(II)-ions with no water molecule directly coordinated to 
the metal center.
[38]
 Similarly to the DOTA derivatives, the coordination number of the 
Mn(II)-ion is 6 in the Mn(12-pyN4A) and Mn(12pyN4P) complexes with one inner-sphere 
water molecule.
[46]
 
The structure of the Mn(II)-complexes of aza- or aza-oxa crown ethers are generally 
pentagonal-bipyramidal (CN=7) with two inner-sphere water molecules in the axial 
positions.
[47]
 However, the nature of the donor atoms, the size and rigidity of the macrocyclic 
ring may influence the coordination number of the Mn(II)-ion. In the Mn(II)-complexes of 
15-aneN5, 17-pydienN5, 18-pydienN5 and 15-pyaneN5, the Mn(II) is six-coordinated with an 
inner-sphere water molecule, whereas the Mn(II)-ion is heptacoordinated with two inner-
sphere water molecules in the complexes of 15-pydienN5, 16-pydienN5, 16-pyaneN5 and 
(NH2Et)2-15-pydienN5.
[47]
 The Mn(II)-complexes of the 15-membered macrocyclic 15-
pyN3O2 and 15-pyN5 ligands are bis-hydrated with heptacoordinated Mn(II)-ion.
[48]
 Similar 
structural phenomena were identified in the Mn(II)-complexes of porphyrins.
[49,50] 
The heptadentate AAZTA ligand can be regarded as a combination of open-chain and 
macrocyclic ligands, which represent the formation of the relatively flexible coordination 
cage wrapping around Mn
2+
-ion.
[51]
 Because of the seven donor atoms, the coordination 
sphere of the Mn(II) is fully occupied in the Mn(AAZTA). The replacement of the acetate 
pendant arm with hydrogen or methyl group in the exocyclic imino-diacetate fragment of 
AAZTA results in the hexadentate AAZ3A, AAZ3AMA and MeAAZ3A ligands which can 
form Mn(II)-complexes in different hydration states. The hydration number of the 
Mn(AAZ3A)-derivative complexes are varied from 0.64, 0.32 and to 0.24 for the 
Mn(AAZ3A), Mn(MeAAZ3A) and Mn(AAZ3MA), which indicate that the coordination 
number of the Mn(II) are changed from mainly 7 to mainly 6 due to the different structural 
rigidity of the Mn(II)-complexes.
[51]
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Table 1. The relaxivity (r1p, 20 MHz),  the coordination number (CN), the number of the 
inner-sphere water molecules (q), the water exchange rate (kex
298
) and the reorientational 
correlation time (τR
298
) for the Mn(II)-complexes. 
 r1p (25/37C; 
mM
-1
s
-1
) 
CN q kex
298
 (10
7
 s
-1
) τR
298
 (ps) 
[Mn(H2O)6]
2+[44] 7.4/6.76 6 6 2.1 30 (308 K) 
Mn(NTA)
-[45] 
 6 2 150  
Mn(EDTA)
2-[45] 3.08
 
7 1 47.1 57 
Mn(CyDTA)
2-[47] 3.47
 
7 1 14  
Mn(PhDTA)
2-[46] 
 7 1 35  
Mn(TMDTA)
2-[48] 2.2
 
 7 1 13  
Mn(EDTA-BOM)
2-[49] 3.6 7 1 9.3 83.7 
Mn(EDTA-(BOM)2)
2-
[49] 
4.3 7 1 13 110.8 
Mn(diPHEDTA)
2-[50] 5.8 7 1 23  
Mn2(ENOTA)
[51] 3.39/2.71 6 1/Mn
2+ 
5.5 85 
Mn(1,4-DO2A)
[45] 2.1 7/6  0.87 113.4 46 
Mn(DO1A)
[45] 2.4 6 1 595.7 22 
Mn(9-aneN2O-2A)
[35] 2.83/2.30 6/7 1/2 119 22 
Mn(9-aneN2O-2P)
[52] 5.08/4.29 6 1 1.20 103 
Mn(12-pyN4A)
[53] 2.39/1.94 6 1 303 23 
Mn(12-pyN4P)
[53] 2.84/2.32 6 1 177 39 
Mn(15-pyN3O2)
2+[54] 4.48/3.61 7 2 0.38 40.3 
Mn(15-pyN5)
2+[54]
 3.56/3.13 7 2 6.9 28.3 
Mn(AAZ3A)
-[55] 2.49 6/7 0.64 4.7 50 
Mn(MeAAZ3A)
-[55] 2.01 6/7 0.32 12.6 50 
Mn(AAZ3MA)
-[55] 1.90 6/7 0.24 13.3 51 
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Mn
2+
 - H distance: 
 The effect of the Mn
2+
 - H distance (rMnH) on the relaxation rate of inner-sphere water protons 
governed by dipole-dipole interaction between the electron and nuclear spins are clearly 
indicated in Eqs. 7 and 10. In order to visualize the effects of the Mn
2+
 - H distance, the inner-
sphere relaxivity have been calculated as a function of rMn-H by using the fixed values of 
2
, 
M, R and v (Figure 2). 
 
 
 
 
 
 
 
 
 
 
Figure 2. The logarithmic inner-sphere relaxivity values (log r1p
is
) as a function of rMn-H at 20 
MHz (, ◊) and 60 MHz (■, □). (2=11019 s2; M=10 ns, R=100 ps (open symbols), R=33 
ns (filled symbols) and v=20 ps) 
 
As shown in Figure 2, the inner-sphere relaxivity increases by about 50% with the 0.2 
Å decrease of the rMn-H distance due to the dependence of the 1/Ti
DD
 on the sixth power of the 
rMn-H. The reduction of the rMn-H distance can be promoted by two ways: i) the increase of the 
tilt angle of the Mn
2+
  O-H bond; ii) the increase of the electron delocalisation towards of the 
ligand or the residual charge of the Mn(II)-ion. The first possibility could be achieved by the 
H-bond formation between the coordinated water molecule and the strongly polarised donor 
groups attached to the appropriate side of the ligand, which distorts the angle of Mn
2+
  O-H 
bond. The second variation might be controlled by the engage of the unsaturated C – C into 
the ligand backbone or the substitution of the charged donor groups with neutral donor atoms. 
In this order, there is an intense scrutiny to optimize the structural feature of the polyamino-
polycarboxylate ligands for the complexation of Mn
2+
.  
In spite of the important role of the Mn
2+
 - H distance, it is difficult to obtain the rMn-H 
values experimentally because the tilt angle of the Mn
2+
 – O-H bond is not well defined in 
1
10
100
1000
2.4E-08 2.6E-08 2.8E-08 3.0E-08 3.2E-08 3.4E-08 3.6E-08
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solution. The rMn-H values are generally deduced from the Mn
2+
 – OH2 distance that can be 
determined more easily. The Mn
2+
 – OH2 distances obtained from the solid-state X-ray 
structure are used to estimate the rMn-H value in solution. The average Mn
2+
 – OH2 and Mn
2+
 – 
OH2 distances of the [Mn(H2O)6]
2+
 and Mn(II)-complexes determined by X-ray diffraction 
studies in solid-state are presented in Table 2. 
 
Table 2. The rMn-O and rMn-H distances of the Mn(II)-complexes determined by X-ray 
diffraction studies in solid state. 
 rMn-O (Å) rMn-H (Å) Ref. 
[Mn(H2O)6]
2+
 2.17   2.68 53 
Mn(EDTA) 2.24 2.84 56 
Mn(CyDTA) 2.27 2.79 56 
Mn(PhDTA) 2.24 2.80 57 
Mn(DEBPN) 2.16 2.76 37 
Mn2(ENOTA) 2.14 2.75 41 
Mn(15-pyN3O2) 2.23; 2.29 2.76; 2.77; 2.79; 2.80 
48 
Mn(15-pyN5) 2.30; 2.27 2.77; 2.86; 2.74; 2.98 
Mn(15-pydieneN5) 2.22 2.75 
58 
 Mn(15-pyaneN5) 2.28; 2.24 2.78, 2.70 
 
The solid-state structure of the Mn(EDTA), Mn(CyDTA), Mn(PhDTA), Mn(15-
pyN3O2), Mn(15-pyN5), Mn(15-pydieneN5) and Mn(15-pyaneN5) complexes of 
heptacoordinated Mn(II) reveals that the rMn-O and rMn-H distances of the coordinated water 
molecules are 2.23 - 2.30 and 2.74 – 2.98 Å, respectively (Table 2). The X-ray analysis of the 
hexacoordinated Mn(II)-complexes ([Mn(H2O)6]
2+
 and Mn2(ENOTA)) indicate that the Mn
2+
 
– OH2 and Mn
2+
 – OH2 distances are 2.14 – 2.17 and 2.68 - 2.75 Å, respectively (Table 2). 
The comparison of the rMn-O and rMn-H values of heptacoordinated Mn(DEBPN) and 
Mn(EDTA) complexes (Mn(EDTA): rMn-O=2.24 Å, rMn-H=2.84 Å; Mn(DEBPN): rMn-O=2.16 
Å, rMn-H=2.76 Å) shows that the replacement of the charged carboxylates with non-charged 
ester and pyridine groups results in the decrease of the Mn
2+
 – OH2 and Mn
2+
 – OH2 distances 
due to the higher residual charge on the Mn(II)-ion. 
 
20 
References: 
 
1. P. Caravan Chem. Soc. Rev., 2006, 35, 512. 
2. B. Drahoš, I. Lukeš, É. Tóth, Eur. J. Inorg. Chem., 2012, 1975. 
3. E. R. Andrew, Brit Med Bull., 1984, 40, 115.  
4. D. M. Grant, R. K. Harris, Encyclopedia of Nuclear Magnetic Resonance, 1996. 3456. 
5. P. Caravan, C. T. Farrar, L. Frullano, R. Uppal, Contrast Media Mol Imaging, 2009, 4: 89. 
6. C. F. G. C Geraldes, S. Laurent, Contrast Media Mol Imaging, 2009, 4: 1. 
7. S. Aime, D. Delli Castelli, S. Geninatti Crich, E. Gianolio, E. Terreno, Acc. Chem. Res., 2009, 42 (7) 
822. 
8. A. K. Srivastava, D. K. Kadayakkara, A. Bar-Shir, A. A. Gilad, M. T. McMahon, J. W. Bulte, Dis. Model 
Mech., 2015, 8, 323. 
9. C. Jacoby, S. Temme, F. Mayenfels, N. Benoit, M. P. Krafft, R. Schubert, et al. NMR Biomed., 2013, 27, 
261. 
10. G. M. Lanza, X. Yu, P. M. Winter, D. R. Abendschein, K. K. Karukstis, M. J. Scott, L. K. Chinen, et al. 
Circulation, 2002 106, 2842.  
11. E. Terreno, S. Aime Front. Pharmacol., 2015, 6, 290. 
12. W. A. Gibby, K. A. Gibby, Invest Radiol., 2004, 39, 138. 
13. W. P. Cacheris, S. C. Quay, S. M. Rocklage, Magn. Reson. Imaging, 1990, 8, 467. 
14. T. Frenzel, P. Lengsfeld, H. Schirmer, J. Hutter, H. J. Weinmann, Invest Radiol., 2008, 43, 817. 
15. J. L. Major, T. J. Meade, Acc. Chem. Res., 2009, 42, 893. 
16. D. A. Carrier, J. J. Ford, L. A. Hayman, Am J Neuroradiol., 1993, 14, 363. 
17. V. M. Runge, K. M. Dickey, N. M. Williams, X. Peng, Invest Radiol., 2002, 37, 393. 
18. H. S. Thomsen, Eur Radiol., 2006, 16, 2619. 
19. T. R. Elmholdt, M. Pedersen, B. Jorgensen, et al. Br J Dermatol., 2011, 165, 828. 
20. S. P. Lin, J. J. Brown, J Magn Reson Imaging, 2007, 25, 884. 
21. J. Crossgrove, W. Zheng, NMR Biomed., 2004, 17, 544. 
22. M. Aschner, K. M. Erikson, D. C. Dorman, Crit. Rev. Toxicol., 2005, 35, 1. 
23. A. C. Silva, J. H. Lee, I. Aoki, A. P. Koretsky, NMR Biomed., 2004, 17, 532. 
24. M. G. Cersosimo, W. C. Koller, NeuroToxicology, 2006, 27, 340. 
25. N. A. Bock, A. C. Silva, Future Neurol., 2007, 2, 297. 
26. N. Bloembergen, E. M. Purcell, R. V. Pound, Phys. Rev., 1948 73, 679.  
27. I. Solomon, Phys. Rev., 1955, 99, 559. 
28. I. Solomon, N. Bloembergen, J. Chem. Phys., 1956, 25, 261. 
29. N. Bloembergen, J. Chem. Phys., 1957, 27, 572. 
30. N. Bloembergen, L. O. Morgan, J. Chem. Phys., 1961, 34, 842. 
31. R. E. Connick, D. Fiat, J. Chem. Phys., 1966, 44, 4103. 
32. D. W. Christianson, Prog. Biophys. Mol. Biol., 1997, 67, 217. 
33. F. C. Wedler, R. B. Denman, Curr. Top. Cell Regul., 1984, 24, 153. 
34. A. S. Mildvan, M. Cohn, Biochemistry, 1963, 2, 910. 
35. S. Aime, S. Canton, S. G. Crich, E. Terreno, Magn. Reson. Chem., 2002, 40, 41. 
36. J. Eisinger, F. Fawaz-Estrup, R. G. Shulman, J. Chem. Phys., 1965, 42, 43. 
37. Q. Zhang, J. D. Gorden, R. J. Beyers, C. R. Goldsmith, Inorg. Chem., 2011, 50, 9365. 
 
21 
38. J. S. Troughton, M. T. Greenfield, J. M. Greenwood, S. Dumas, A. J. Wiethoff, J. Wang, M. Spiller, T. J. 
McMurry, P. Caravan, Inorg. Chem., 2004, 43, 6313. 
39. C. F. G. C. Geraldes, A. D. Sherry, R. D. Brown III, S. H. Koenig, Magn. Reson. Med., 1986, 3, 242. 
40. M. Tan, Z. Ye, E.-K. Jeong, X. Wu, D. L. Parker, D.-R. Lu, Bioconjugate Chem., 2011, 22, 931. 
41. E. Balogh, Z. He, W. Hsieh, S. Liu, É. Tóth, Inorg. Chem., 2007, 46, 238. 
42. B. Drahos, M. Pniok, J. Havlícková, J. Kotek, I. Císarová, P. Hermann, I. Lukes, É. Tóth, Dalton Trans., 
2011, 40, 10131. 
43. S. Aime, P. L. Anelli, M. Botta, M. Brocchetta, S. Canton, F. Fedeli, E. Gianolio, E. Terreno, J. Biol. 
Inorg. Chem., 2002, 7, 58. 
44. A. Bianchi, L. Calabi, C. Giorgi, P. Losi, P. Mariani, D. Palano, P. Paoli, P. Rossi, B. Valtancoli, J. 
Chem. Soc., Dalton Trans., 2001, 917. 
45. G. A. Rolla, C. Platas-Iglesias, M. Botta, L. Tei, L. Helm, Inorg. Chem., 2013, 52, 3268. 
46. B. Drahos, J. Kotek, I. Císarová, P. Hermann, L. Helm, I. Lukes, É. Tóth, Inorg. Chem., 2011, 50, 
12785. 
47. S. C. Jackels, M. M. Durham, J. E. Newton, T. C. Henninger, Inorg. Chem., 1992, 31, 234. 
48. B. Drahos, J. Kotek, P. Hermann, I. Lukes, É. Tóth, Inorg. Chem., 2010, 49, 3224. 
49. D. Lieb, A. Zahl, T. E. Shubina, I. Ivanovic-Burmazovic, J. Am. Chem. Soc., 2010, 132, 7282. 
50. A. Budimir, J. Kalmár, I. Fábián, G. Lente, I. Bányai, I. Batinic- Haberle, M. Birus, Dalton Trans., 2010, 
39, 4405. 
51. L. Tei, G. Gugliotta, M. Fekete, F. K. Kálmán, M. Botta, Dalton Trans., 2011, 40, 2025. 
52. P. M. T. Piggot, L. A. Hall, A. J. P. White, D. J. Williams, L. K. Thompson, Inorg. Chem., 2004, 43, 1167. 
53. G. E. Kostakis, K. C. Mondal, C. E. Anson, A. K. Powell, Polyhedron, 2010, 29, 24. 
54. P. Wang, J. P. Ma, Y. B. Dong, R. Q. Huang, J. Am. Chem. Soc., 2007, 129, 10620. 
55. B. Wu, J. Liang, J. Yang, C. Jia, X. J. Yang, H. Zhang, N. Tang, C. Janiak, Chem. Commun., 2008, 
1762. 
56. X. F. Wang, J. Gao, J. Wang, Zh. H. Zhang, Y. F. Wang, L. J. Chen, W. Sun, X. D. Zhang Zh. Strukt. 
Khim. (Russ.) (J. Struct. Chem.) 2008, 49, 753. 
57. N. Nakasuka, S. Azuma, C. Katayama, M. Honda, J. Tanaka, M. Tanaka, Acta Crystallogr. Sect. C: 
Cryst. Struct. Commun., 1985, 41, 1176. 
58. O. Jiménez-Sandoval, D. Ramírez-Rosales, M. del Jesús Rosales-Hoz, M. E. Sosa-Torres, R. 
Zamorano-Ulloa, J. Chem. Soc., Dalton Trans., 1998, 1551. 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
Chapter 2 
 
Outline of the thesis 
 
The main goal of this thesis is the characterization in aqueous solutions of new Mn(II) 
complexes as MRI probes. Our investigation included thermodynamic, kinetic and detailed 
1
H 
and 
17
O NMR relaxometric measurements. We have taken into account Mn-complexes 
belonging to two different main types of structural units. 
One encompasses the Mn(II) complexes containing the pentadentate coordinating units 6,6-
((methylazanediyl)bis(methylene))dipicolinic acid. We considered several derivatives of the 
monomeric DPAMA ligand, including mono-, bi- and trinuclear bis-hydrated complexes 
(Chapter 4). In addition, we investigated a number of derivatives featuring different side arms 
and a couple of lipophilic derivatives (Chapter 5). All these complexes represent a fairly 
homogeneous series that has allowed us to obtain useful information on the relationship 
between the molecular structure, the thermodynamic stability and the relaxation parameters.  
The other class of complexes are those containing the macrocyclic unit cyclen and two 
coordinating pendant arms. These macrocyclic derivatives have been studied in detail, 
considering the chemical nature of the pendant arms, their relative position (cis/trans), the 
possible presence of isomers with different states of hydration, the kinetic and thermodynamic 
stability of the complexes and their relaxometric properties (Chapter 6). The synthesis of two 
novel derivatives bearing hydrophobic pendant groups enabled the investigation of the 
binding association with human serum albumin (Chapter 7). 
 
The global set of experimental results has allowed us to deepen our understanding of the 
chemistry of Mn(II) complexes as potential MRI probes. We are confident that the new 
information gained will help in the future design and development of more effective and safer 
MRI contrast enhancing agents. 
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Scheme 1. Ligands investigated in Chapters 4 and 5. 
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Scheme 1. Ligands investigated in Chapters 6 and 7. 
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Chapter 3 
 
Experimental techniques 
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Fast Field Cycling (FFC) NMR Relaxometry: 
Field-cycling NMR relaxometry is the preferred technique for obtaining the frequency (or 
magnetic field) dependence of relaxation times (or equivalently of relaxation rates). For this 
reason it is also known as nuclear magnetic relaxation dispersion (NMRD).The relaxation of a 
nuclear magnetic spin in general is a function of experimental parameters such as 
temperature, pressure, sample composition and magnetic field, B0. Changing thermodynamic 
parameters, like the temperature, influences the physical or chemical state of the sample under 
investigation. Change of the magnetic field, however, has typically no influence on the 
chemistry of the sample. It is therefore a useful tool for separation of different interaction 
mechanisms and dynamic processes influencing the relaxation behavior. Fast Field Cycling 
(FFC) NMR relaxometry is an important analytical tool for NMR research and material 
characterization in both industrial and academic environments and has been successfully used 
in a wide range of fields. For example in: pharmaceutical, food, oil, gas and petroleum 
industry. FFC NMR relaxometry is a non-destructive low-field magnetic resonance method, 
which is performed in the range of a few kHz up to around 100 MHz, depending on the 
instrument. The information obtained is connected to the molecular dynamics of a material or 
complex substance through the characterization of the nuclear spin-lattice constant 1/T1 over a 
large range of magnetic field strengths, which is carried out on the same instrument 
(relaxometer). The technique is excellent in revealing information on slow molecular 
dynamics, which can only be done at very low magnetic field strengths. Examples of 
important molecular dynamics information that can be obtained through FFC NMR 
relaxometry: 
 • Characterization of rotational dynamics 
• Identification of the presence of paramagnetic substances 
• Evaluation of MRI CAs (coordination number, kinetics of exchange, electronic 
relaxation, correlation times in the spectrum of re-orientation and diffusional dynamics 
of molecules) 
• Determination of aggregation states of complex biomolecules such as proteins 
 
The magnetic field dependence of 1/T1 of a substance or material is shown in the graphical 
form as a Nuclear Magnetic Resonance Dispersion (NMRD) profile (Figure 1). 
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Figure 1. NMRD profile of a Mn(II) complex at 25 (black) and 37 °C (red) 
 
The relaxation rate 1/T1 of a substance or material will tend to change when there is a 
variation in molecular dynamics, which may be caused by: 
• change of state (e.g. solid to liquid; complex systems phase change, such as liquid 
crystals) 
• concentration changes (e.g. effect on aggregation states of biomolecules) 
• temperature changes 
• viscosity changes 
• paramagnetic impurities 
FFC NMR relaxometry is a non-destructive method requiring a small amount of a solid or 
liquid sample (enough to fill a standard 10mm NMR tube to a volume of around 1cm
3
) with 
no other form of preparation required. 
 
The basic FFC NMR experiment consists of cycling the Zeeman field, B0, which is applied to 
the sample, through three different values. In the first instance, a high magnetic field, Bpol 
(polarization field), is applied to pre-polarize the sample in order to boost signal intensity. The 
sample is then allowed to relax in a second field, Brelax (relaxation field), which can be set to 
any desired value, including zero. Finally, the field is set to the detection field, Bacq 
(acquisition field), for signal acquisition.
[1] 
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Figure 2. Working of FFC NMR
[1] 
 
Changes in the relaxation rate, 1/T1, of a substance or material, are sometimes not evident at 
single magnetic field strengths, but when studied over a wide range of magnetic field 
strengths, as with FFC NMR relaxometry, changes are easier to identify as they are often 
more visible with the NMRD profile, especially at the lower magnetic field strengths. 
 
 
Figure 3. The SmarTracer FFC-NMR relaxometer. 
 
 
17
O NMR measurements: 
In the 
17
O NMR measurements we measure the temperature dependence of the 
17
O NMR 
longitudinal and transverse relaxation rates as well as the chemical shifts of aqueous solutions 
of the Mn(II) complexes. The observed acceleration of the relaxation rates and the observed 
shift of the resonance frequencies can be described by the formulas developed by Swift and 
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Connick 
[2] 
for 1/T2 and Δω, the chemical shift difference, and by Zimmermann and Brittin
[3] 
for 1/T1. 
The detailed equations are in Chapter 4. 
 
 
Figure 4. The superconductive magnet of the 500 MHz NMR spectrometer 
 
pH-potentiometric titrations: 
There are several ways to determine stability and protonation constants. In this work, we used 
direct pH-potentiometric titrations. The pH-potentiometry with a suitable ion-selective 
electrode can be a possibility to determine components (metal ion, ligand) equilibrium 
activity. A pH-potentiometric titration is one of the most common way to determine stability 
constants. The ligands are usually weak bases, so in the lack of metal ion the ligand is in a 
protonated form in a quite range pH-region. During the forming of the metal complexes a 
proton is removed from the coordinated group. Thanks to that with an indirect pH effect, we 
can use pH-potentiometry. The system is showing the difference in the pH during the 
measurement. In a pH-potentiometric titration, a generally used glass-electrode can be used 
between pH 1.7 and 11.8. The complexes stability constants can be calculated from the fit of 
the titration curves. For the calculation, it is necessary to know the ligand protonation 
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constants, and every other type of side effect that can have an influence of the complex’s 
formation. For example, we can calculate the stability constant with a general equation (Eq 1). 
 
;rqp HLMrHqLpM                                   rqp
rqp
HLM
HLM
pqr ][][][
][
                     
 
 
 
 
 
 
Figure 5. Titration curves of the well-known H3DO3A (1), and H4DOTA (2) ligands. 
 
 
Figure 6. The automatic pH-potentiometric titrator. 
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Chapter 4 
 
Bis-Hydrated Mn
2+
 
Complexes with the 
picolinate binding unit 
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Introduction: 
Earlier we already mentioned that the application of Mn
2+
 complexes as MRI CAs was 
envisaged in the early times of MRI, in the late 1970s.
[1,2]
 As a result of these pioneering 
studies a Mn
2+
-based CA, mangafodipir trisodium (Mndpdp, TESLASCAN, Scheme 1) was 
approved for clinical use. More recently, a mixture of MnCl2, alanine and vitamin D3, 
denoted as CMC-001, has been proposed as a CA for visualization of liver and bile, and it is 
currently undergoing phase III clinical trials.
[3]
 Furthermore, preclinical safety assessment of 
Mndpdp serendipitously revealed superoxide dismutase activity, a useful property that can be 
potentially exploited for the treatment of several pathological conditions characterized by 
oxidative stress (i. e. cancer treatment, acute myocardial infarction…).[4] An important 
advantage of Mn
2+
 CAs over the traditional Gd
3+
 counterparts is the lower toxicity of free 
Mn
2+
, which is highlighted by the formulation of CMC-001. On the other hand, the lower 
effective magnetic moment of Mn
2+
 complexes with respect to Gd
3+
 analogues generally 
results in lower relaxivities of the Mn
2+
 complexes.
[5]
 An obvious strategy to increase 
relaxivity is to increase the number of water molecules coordinated to the paramagnetic ion 
(q), as the inner-sphere contribution to relaxivity is directly proportional to q. This approach 
has been successfully used to increase the relaxivities of Gd
3+
 complexes, although generally 
reducing the denticity of the ligand to increase the hydration number results in lower 
thermodynamic stabilities of the complexes.
[6]
 Some attempts have also been made to obtain 
bis-hydrated Mn
2+
 complexes as potential MRI contrast agents, but the expected relaxivity 
gain was not observed due to a low exchange rate of the coordinated water molecule with the 
bulk water.
[7]
 A second advantage of Mn-based contrast agents is that, in principle, they can 
be used as redox-sensitive MRI probes, providing that a suitable ligand stabilizes both Mn
2+
 
and Mn
3+
.
[8,9] 
 
 
33 
 
Scheme 1. Ligands mentioned in the chapter. 
 
We decided to explore these issues and thus we have undertaken a study of the complexes 
based on a well-defined structural unit, the potentially pentadentate ligand dpama. So, we 
investigated the potential of the Mn
2+
 complex of H2dpama, mX(H2dpama)2 and 
mX(H2dpama)3. These ligand form, mono- bi- and trinuclear Mn
2+
 complexes potentially 
containing two water molecules coordinated to each metal center. These complexes are 
expected to display enhanced relaxivities, as well as relatively high affinities towards human 
serum albumin (HSA). In this chapter, we describe a detailed characterization of the Mn
2+
 
complexes with these three ligands using 
1
H relaxometry and 
17
O NMR measurements. 
Furthermore, the ligand protonation constants and stability constants of the metal complexes 
were determined using potentiometric measurements. Cyclic voltammetry experiments were 
also carried out to investigate the relative stability of the Mn
2+
 and Mn
3+
 complexes. The 
hexadentate ligand H2bcpe was reported
 
earlier.
[10]
 It forms rather stable complexes with 
different divalent and trivalent metal ions.
[11,12]
 Given the ability of Mn
2+
 complexes to form 
both six- and seven-coordinate complexes in aqueous solution, we have also checked whether 
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the [Mn(bcpe)] complex contains a coordinated water molecule or not by using 
1
H 
relaxometric measurements and X-ray diffraction studies. 
 
Synthesis: 
Prof. Carlos-Platas Iglesias, at the Departamento de Química Fundamental, Universidade da 
Coruña, performed the syntheses of the ligands. The H2dpama was synthesized in two steps. 
First step was a reaction of 6-chloromethylpyridine-2-carboxylic acid ethyl ester (1)
 
with 
methylamine chlorohydrate in the presence of K2CO3,
[13] 
 followed by hydrolysis of the ethyl 
ester groups in 6 M HCl (Scheme 2). The desired ligand was isolated as the chlorohydrate salt 
with a yield of 66% over the two steps. This represents a 2.6-fold increase with respect to the 
yield reported previously for the analogous ligand derived from ethylamine.
[14] 
Ligand 
mX(H2dpama)2 was prepared in 76% yield following a similar procedure by reaction of 1 
with 1,3 phenylenedimethanamine (3) followed by acid hydrolysis of the ester groups. 
Reaction of H2dpama and mX(H2dpama)2 with Mn(ClO4)2·6H2O in the presence of 
triethylamine resulted in the formation of the charge neutral complexes 
[Mn(dpama)(H2O)2]·2H2O and [mX(Mn(dpama)(H2O)2)2]·6H2O, respectively, which were 
isolated in 65% yield. The synthesis of mX(H2dpama)3 (Scheme 3) was achieved in two steps 
by reaction of benzene-1,3,5-triyltrimethanamine (1b) and 6-chloromethylpyridine-2-
carboxylic acid ethyl esther (2b) in the presence of K2CO3, and subsequent hydrolysis of the 
ethyl ester groups in 6M HCl. Reaction of the ligand with MnCl2·4H2O in the presence of 
trimethylamine produced the desired charge neutral complex. The synthesis of H2bcpe was 
achieved by following the previously reported procedure.
[10]
 Reaction of H2bcpe with 
Mn(ClO4)2·6H2O in the presence of trimethylamine provided the charge neutral [Mn(bcpe)] 
complex, which was isolated in 60% yield The high-resolution mass spectra (ESI
+
) and 
analytical data confirm the formation of the desired neutral complexes (Figure 1-4). 
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Scheme 2. Synthesis of H2dpama and mX(H2dpama)2 
 
 
 
 
 
Scheme 3. Synthesis of mX(H2dpama)3. 
 
 
 
36 
 
 
Figure 1. Observed (left) and calculated (right) mass spectral isotopic distribution for the 
fragment [Mn(dpama)+H]
+
 obtained from a solution of the complex in a 
H2O:CH3CN:MeOH mixture. 
 
 
 
 
Figure 2. Observed (left) and calculated (right) mass spectral isotopic distribution for the 
fragment [(mX(Mndpama)2+Na]
+
 obtained from a solution of the complex in a 
H2O:CH3CN:MeOH mixture. 
 
 
 
 
Figure 3. Observed (left) and calculated (right) mass spectral isotopic distribution for the 
fragment [Na2mX(Mndpama)3]
2+
 obtained from a solution of the complex in a H2O:MeOH 
1:1 mixture. 
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Figure 4. Observed (left) and calculated (right) mass spectral isotopic distribution for the 
fragment [Mn(Hbcpe)]
+
 obtained from a solution of the complex in a H2O:MeOH 1:1 
mixture. 
 
 
Aiming to obtain information on the solution structure of the [Mn(dpama)(H2O)2] complex 
we turned our attention to theory.  Prof. Carlos-Platas Iglesias carried out the DFT 
calculations and X-ray diffraction analyses. I report a representative figure of the optimized 
geometry and X-ray diffraction analyses of the Mn(II) complexes.  
  
Figure 5. Optimized geometry of the [Mn(dpama)(H2O)2]·4H2O complex obtained with DFT 
calculations performed in aqueous solution at the TPSSh/SVP level. (left) Average bond 
distances (Å) of the MnII coordination environment: Mn-Owater 2.205(1); Mn-OCOO 2.335(64); 
Mn-Namine 2.569; Mn-NPY 2.287(9). Optimized geometry of the 
[mX(Mn(dpama)(H2O)2)3]·12H2O complex obtained with DFT calculations performed in 
aqueous solution at the TPSSh/SVP level.(right) Average bond distances (Å) of the Mn2+ 
coordination environment: Mn-Owater 2.213(19); Mn-OCOO 2.315(58); Mn-Namine 2.620(6); 
Mn-NPY 2.280(14). Hydrogen atoms, except those of water molecules, have been omitted for 
simplicity. 
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Figure 6. View of the X-ray structure of the [Mn(bcpe)] complex. Water molecules and 
hydrogen atoms are omitted for simplicity. The ORTEP plot is at the 30% probability level. 
Bond distances: Mn(1)-O(1), 2.1771(12); Mn(1)-O(3), 2.1783(12); Mn(1)-N(1), 2.1919(15); 
Mn(1)-N(4), 2.1948(15); Mn(1)-N(2), 2.3046(14); Mn(1)-N(3), 2.3217(14) Å. 
 
Ligand protonation constants and stability constants of the metal complexes:  
The protonation constants (logKi
H
) of the previously mentioned ligands investigated in this 
chapter have been determined by pH-potentiometry in 0.15 M NaCl. The values of the 
constants and standard deviations are listed in Table 1. The protonation constants are defined 
by eq 1: 
 
 Hi-1L  +   H
+
     HiL 
]L][Η[Η
L][Η
Κ
1i
iΗ
i 

           i=1, 2,…, 8.                                         (1) 
 
Table 1. Protonation constants of ligands bcpe
2-
, dpama
2-
, mX(dpama)2
4-
, mX(dpama)3
6-
 and 
picolinate (0.15 M NaCl, 298 K) 
 dpama
2- 
mX(dpama)2
4- 
mX(dpama)3
6- 
bcpe
2- 
Picolinate
a 
logK1
H 
7.82(1) 7.77(1) 7.73(1) 8.83(2) 5.25 
logK2
H 
3.71(2) 6.49(1) 6.82(1) 6.22(3) 0.92 
logK3
H 
2.61(2) 4.24(2) 6.06(1) 3.27(3) - 
logK4
H
 - 3.45(2) 4.31(1) 2.03(3) - 
logK5
H
 - 2.93(2) 3.70(1)  - 
logK6
H
 - 2.24(2) 3.30(1)  - 
logK7
H
 - - 2.79(1)  - 
logK8
H
 - - 2.36(1)  - 
   1.01(3)   
∑logKi
H 
14.14 27.13 38.09 20.36 6.17  
 
a 
Taken from ref. 15. 
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By taking into account the protonation constants and protonation scheme of picolinic 
acid,
[15]
 we can presume that the first and second protonation constants of dpama
2-
 correspond 
to the amine nitrogen and the carboxyl groups of the picolinate fragments, respectively. The 
first and second protonation constants of mX(dpama)2
4-
 are related to the protonation of the 
amine nitrogen atoms, whereas subsequent protonations of the ligand take place at the 
carboxylate groups. Also in the case of mX(dpama)3
6-
, the logK1
H
, logK2
H
 and logK3
H
 values 
are also attributed to the protonation of the amine nitrogen atoms, while subsequent 
protonation processes take place at the carboxylate groups of the picolinate residues. 
The difference between successive protonation constants of identical and independent 
coordination sites are expected to follow the statistical factor,
[16]
 which predicts a difference 
between two successive identical protonation sites of logKH= logK1
H
- logK2
H
 = 0.6. In the 
case of three independent protonation sites this factor reduces to logKH= 0.5. The second 
protonation constant of mX(dpama)2
4-
 is ca. 1.3 logK units lower than logK1
H
. This difference 
is larger than that expected for the statistical factor, which is explained by the repulsive 
electrostatic interaction between the protonated amine nitrogen atoms in the bis-protonated 
species. Similarly to the mX(dpama)2
4-
 ligand, the differences between logK1
H
, logK2
H
 and 
logK3
H
 of mX(dpama)3
6-
 are larger than expected according to the statistical factor. However, 
the protonation of the carboxylate groups of mX(dpama)2
4-
 characterized by logKH =logK3
H
 
– logK4
H
 = 0.8, as well as those of mX(dpama)3
6-
 given by logKH =logK4
H
 – logK5
H
 = 0.6, 
approach the behavior expected according to the statistical factor. This is likely related to the 
longer distances between the involved protonation sites in comparison to the amine nitrogen 
atoms. Comparison of the ∑logKi
H
 of dpama
2-
 (14.14), ∑logKi
H
/2 of dimeric 
mX(dpama)2
4-
 (13.56) and ∑logKi
H
/3 of trimeric mX(dpama)3
6-
 (12.36) indicates that the total 
basicity of dpama
2-
 is higher than that of the average basicity of the dpama
2-
 units in 
mX(dpama)2
4-
 and mX(dpama)3
6-
. 
The protonation constants determined for bcpe
2-
 in 0.15 M NaCl are almost identical to 
those determined previously using a 0.1 M (Me4N)(NO3) ionic strength.
[10]
  
The first and second protonation processes occur at the amine nitrogen atoms of the ligand, 
while the third and fourth protonation constants are assigned to the protonation of the 
carboxylate groups of the picolinate part. 
The stability and protonation constants of Mn
2+
 complexes formed with bcpe
2-
, dpama
2-
, 
mX(dpama)2
4-
 and mX(dpama)3
6-
 were determined by pH-potentiometric titration. Moreover, 
we have also determined the stability and protonation constants of the Zn
2+
 and Cu
2+
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complexes with dpama
2-
. The metal-to-ligand concentration ratios were 1:1, as well as 2:1 and 
3:1 in the case of mX(dpama)2
4-
 and mX(dpama)3
6-
. The stability and protonation constants of 
the metal complexes are defined by eq 2: 
 
pM
2+
   +   qH
+
   +   rL
n-
      [MpHqLr]
n-(q+2p)-  
                               
rqp2
rqp
pqr
]L[]H[]M[
]LHM[

                    (2) 
  
Table 2. Stability and protonation constants of Mn
2+
 complexes formed with bcpe
2-
, dpama
2-
, 
mX(dpama)2
4-
 and mX(dpama)3
6-
 ligands (0.15 M NaCl and 298 K). 
 bcpe
2- 
dpama
2- 
mX(dpama)2
4- 
mX(dpama)3
6- 
logK101 (MnL) 10.63(2) 10.13(2) 11.60(6) 10.99(9) 
logK111 (MnHL) 3.42(7) 2.57(4) 6.50(4) 7.23(9) 
logK121 (MnH2L)   3.61(2) 6.11(7) 
logK131 (MnH3L)   2.56(1) 4.07(6) 
logK141 (MnH4L)    3.29(3) 
logK151 (MnH5L) 
logK201 (Mn2L) 
logK211 (Mn2HL) 
logK301(Mn3L) 
logK311(Mn3HL) 
   
8.43(2) 
 
 
 
2.73(4) 
9.17(9) 
6.00(9) 
8.51(4) 
2.54(3) 
logK1-11(MnH-1L)  11.09(4) 10.41(8)  
 
 
 
Table 3. Stability and protonation constants of Zn
2+
 and Cu
2+
 complexes formed with the 
bcpe
2-
 and dpama
2-
 ligands (0.15 M NaCl, 298 K). 
 Zn
2+
:dpama
2-
 Cu
2+
:dpama
2-
 Zn
2+
:bcpe
2-
 Cu
2+
:bcpe
2-
 
log101 (ML)
 11.75(1) 13.32(4)
a 
17.53(2) 19.846(9)
a 
logK111 (MHL)
 
1.51(2)
 
3.60(4) 2.07(2) 1.45(3) 
logK121 (MH2L)  1.40(4)   
logK1-11(MH-1L) 9.18(6) 9.53(4)   
logK1-21(MH-2L) 11.16(7) 11.60(6)   
a
 Determined by spectrophotometry. 
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The stability constants and protonation constants of the metal complexes are reported in 
Tables 2 and 3. The logK101 values determined for the four Mn
2+
 complexes are really similar. 
Which shows that the pentadentate dpama
2-
 ligand and the di- and tri-nucleating 
mX(dpama)2
4-
 and mX(dpama)3
6-
 ligands provide metal complexes with stabilities that are 
very similar to that of the complex with the hexadentate ligand bcpe
2-
, with log101 values in 
the range 10.1 – 11.6. 
The stability of the Mn
2+
 complex of the pentadentate ligand dpama
2-
 is very similar to that 
of the complex with the hexadentate ligand bcpe
2-
. The stability constants of the mononuclear 
Mn(dpama), mX(Mndpama)2 and mX(Mndpama)3 complexes are analogous, indicating that 
in all cases the Mn
2+
 ion is coordinated by a dpama
2-
 unit characterized by similar metal ion 
affinity. Since the mononuclear mXMn(dpama)2 and (mX(dpama)3Mn) complexes have one 
and two non-coordinated dpama
2-
 units, the free donor atoms can be protonated with the 
formation of several protonated MnHiL species (mX(dpama)2: i=1 – 3; mX(dpama)3: i=1 – 5). 
The protonation constants of mononuclear mXMn(dpama)2 and mXMn (dpama)3 complexes 
(Table 2) are comparable to the corresponding logKi
H
 values of the free ligands (Table 1). 
The stability constants of the dinuclear (mX(Mndpama)2), (mXMn2(dpama)3) and 
trinuclear mX(Mndpama)3 complexes are very similar and somewhat lower than the logK101 
values of the mononuclear mXMn(dpama)2 and mXMn(dpama)3 entities (Table 2). A recent 
study has reported virtually identical stability constants for the mono- and bi-nuclear Mn
2+
 
complexes of ditopic do3a-based ligands containing a long spacer separating the two metal 
binding units.
[17]
 Thus, the slightly lower stability constants of the dinuclear and trinuclear 
Mn
2+
 complexes of mX(dpama)2 and mX(dpama)3 might be explained by the electron 
withdrawing effect caused by the coordination of Mn
2+
 to a dpama
2-
 unit on the non-
coordinated amine nitrogen atom of the neighbor dpama
2-
 moiety. If we study the  logK101 
value of Mn(dpama) (10.13) with the log201/2 value of dinuclear Mn2(mX(dpama)2) (10.01) 
and log301/3 value of trinuclear Mn3(mX(dpama)3) (9.56), we can assume that the average 
Mn
2+
 affinities of the dpama
2-
 units in the mono-, bi- and trimeric ligands decrease in the 
following order: dpama
2-
>mX(dpama)2
4-
> mX(dpama)3
6-
. 
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Figure 7. Species distribution diagrams of the Mn
2+
- dpama ([Mn
2+
]=[dpama]=1.0 mM)  
system (0.15 M NaCl, 298 K). 
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Figure 8. Species distribution diagram of the Mn
2+
- mX(dpama)2 system at metal-to-ligand 
ratio of 1:1 ([mX(dpama2)]=1.0 mM, 0.15 M NaCl, 298 K) (A), and Mn
2+
-mX(dpama)2 
([Mn
2+
]= 2 mM, [mX(dpama)2]=1.0 mM) (B). 
 
(B) 
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Figure 9. Species distribution diagrams of the Mn
2+
-mX(dpama)3 systems at metal-to-ligand 
ratio of 1:1 (A), 2:1 (B) and 3:1 (C) ([mX(dpama3)]=1.0 mM, 0.15 M NaCl, 298 K). 
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Figure 10. Species distribution diagram of the Mn
2+
 - bcpe system at metal-to-ligand ratio 1:1 
([bcpe]=1.0 mM, 0.15 M NaCl, 298 K) 
 
The stabilities of the Mn
2+
, Cu
2+
 and Zn
2+
 complexes are following the Irving-Williams order 
(Mn
2+
 < Cu
2+
 > Zn
2+
).
[18]
 However, the stability of the [Cu(bcpe)] complex is 9 orders of 
magnitude higher than that of [Mn(bcpe)], while the Zn
2+
 complex is about 7 orders of 
magnitude more stable than the Mn
2+
 one. In the case of the dpama
2-
 complexes the stabilities 
of the Zn
2+
 and Cu
2+
 complexes are only 1.6 and 3.2 logK units higher than that of the Mn
2+
 
analogue. These results show that the pentadentate dpama
2-
 ligand is suprisingly well 
preorganized to provide a seven-coordinate Mn
2+
 complex with pentagonal bipyramidal 
coordination. Pentagonal bipyramidal coordination is much more less favorable for Cu
2+
 and 
Zn
2+
 complexes,
[19]
 which likely results in a modest increase of complex stability of the latter 
complexes with respect to Mn
2+
. 
The species distribution of the Mn
2+
 - dpama, Mn
2+
 - mX(dpama)2 and Mn
2+
 - mX(dpama)3 
systems have been calculated by taking into account the equilibrium constants of Tables 1 and 
2 (Figure 7-10). The dissociation of [Mn(dpama)] occurs below pH ~ 5, while it represents the 
major species in solution up to pH ~ 11. However, at pH>8.5 deprotonation of the complex 
takes place with the formation of a MnH-1L species, likely as a result of the coordination of a 
OH
- 
anion to the Mn
2+
-ion. The [mX(Mndpama)2] and [mX(Mndpama)3] complexes 
dissociate below pH ~ 4, which results in the formation of complex species with reduced 
nuclearity. No evidence for the formation of hydroxo complexes was found in any of these 
cases. 
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Relaxometric studies: 
The efficiency of a paramagnetic complex as a CA in vitro is often and conveniently 
evaluated by its proton relaxivity, r1p, which is defined as the relaxation enhancement of water 
protons normalized to a 1 mM concentration of the paramagnetic metal ion. The r1p values 
determined for [Mn(bcpe)] and [Mn(dpama)] in the pH range ~10.0-5.0 (20 MHz, 25 ºC) are 
fairly constant (Figure 11). Below pH 5.0 relaxivity progressively increases due to the 
dissociation of the complex and formation of [Mn(H2O)6]
2+
,
[20]
 in agreement with the 
speciation diagrams obtained from equilibrium data. The relaxivity measured for [Mn(bcpe)] 
is rather low (1.4 mM
-1
 s
-1
 at 25 ºC, 20 MHz, pH 7.47), and compares well to those measured 
for [Mn(do3a)]
-
, [Mn(dtpa)]
3-
 and [Mn(1,7-do2a)], which lack inner-sphere water molecules 
(1.3 – 1.5 mM-1 s-1 at 25 ºC and 20 MHz).[21] Thus, the relaxivity observed for [Mn(bcpe)] can 
be attributed to the outer-sphere mechanism, in full agreement with the X-ray structure of the 
complex described above. The relaxivity (r1p) measured for [Mn(dpama)] at 20 MHz and 298 
K (pH = 7.3) amounts to 5.32 mM
-1
 s
-1
. This value is ca. 60% higher than those measured 
under the same conditions for small Mn
2+
 complexes containing one coordinated water 
molecule (i. e. r1p = 3.3 mM
-1
 s
-1
 for [Mn(edta)]
2-
, Figure 12, Table 4).
[21]
 Interestingly, the 
relaxivity measured for [Mn(dpama)] is also higher than those determined for bis(aquated) 
seven-coordinate Mn
2+
 complexes with neutral pentadentate macrocyclic ligands (r1p = 3.5-
4.5 mM
-1
 s
-1, 20 MHz, 25 ºC),[22] or most commercially available Gd3+-based contrast agents 
(r1p = 4-5 mM
-1
 s
-1, 20 MHz, 25 ºC).[23] A further improvement of the relaxivity is observed 
for [(mX(Mndpama)2], which presents a r1p value (8.63 mM
-1
 s
-1, 20 MHz, 25 ºC) higher than 
those usually observed for small Gd
3+
 bisaqua complexes for example Gd(do3a) and 
Gd(aazta)
-
.
[6d]
 The high relaxivity values determined for [Mn(dpama)] and [(mX(Mndpama)2] 
can only be explained by the presence of two water molecules in the inner coordination sphere 
of the metal ion. 
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Figure 11. Plot of the relaxivity (20 MHz; 25 ºC) of the [Mn(bcpe)] and [Mn(dpama)] 
complexes as a function of pH. 
 
 
 
Figure 12. Plot of the relaxivity, r1p, for selected Gd
3+
 and Mn
2+
 complexes at 20 MHz and 
298 K. 
 
To gain more insight into the physicochemical parameters that govern the relaxivities 
observed for [Mn(bcpe)] and [Mn(dpama)] we recorded 
1
H nuclear magnetic relaxation 
dispersion (
1
H NMRD) profiles of aqueous solutions of these complexes in the proton Larmor 
frequency range 0.01−70 MHz, corresponding to magnetic field strengths varying between 
2.34310-4 and 1.645 T (Figure 13). The relaxivity of [Mn(dpama)] decreases with increasing 
temperature, this behavior  is typical for small chelates in which fast rotation of the complex 
in solution limits proton relaxivity. Furthermore, the 
1
H NMRD profiles of [Mn(dpama)] 
show a single dispersion between 1 and 10 MHz, which rules out any scalar contribution to 
1
H 
0
2
4
6
8
10
re
la
xi
vi
ty
 /
 m
M
-1
s-
1
q = 1
q = 2
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relaxivity.
[20,24]
 Since the inner-sphere contribution to relaxivity depends upon a relatively 
large number of parameters, we have also measured reduced transverse 
17
O NMR relaxation 
rates and chemical shifts of an aqueous solution of [Mn(dpama)] (3.89 mM, pH = 7.2). These 
data provide independent information about some important parameters that control 
1
H 
relaxivity, especially the exchange rate of the coordinated water molecule(s) ( 298
exk ). The 1/T2r 
values increase with decreasing temperature, which is typical of systems in the fast-exchange 
regime. Despite, the changeover between the fast and slow exchange regimes can be observed 
in the temperature dependence of the chemical shifts (Figure 14), as also observed for the 
[Mn(edta)]
2-
 complex.
[21] 
 
 
Figure 13. 
1
H NMRD profiles recorded at different temperatures for [Mn(bcpe)] and 
[Mn(dpama)]. The lines represent the fit of the data as explained in the text. 
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Table 4. Parameters obtained from the simultaneous analysis of 
17
O NMR and 
1
H NMRD 
data. 
 bcpe
2- 
dpama
2-
 mX(dpama)2
4- 
mX(dpama)3
6-
 edta
4-
 
b 
r1p at 25/37 ºC / mM
-1
 s
-1 b
 1.4/1.2 5.3/4.2 8.6/6.1 11.4/8.3 3.3/2.8 
298
exk /10
6
 s
-1
  306 + 16 306
a 
306
a 
471 
H‡ kJ mol-1  28.1 + 2.2 28.1
a 
28.1
a 
33.5 
298
R /ps  47.8 + 0.9 95.8 + 1.8 136 + 3.0 57 
Er/kJ mol
-1
  25.3 + 0.6 27.3 + 0.7 31.6 + 1.0 21.8 
298
v /ps 19.9 + 0.9 39.2 + 5.6 57.6 + 7.0 27.7 + 3.4 27.9 
v/kJ mol
-1
 3.7 + 0.7 1.0
a
 1.0
a
 1.0
a
 1.0
a 
298
MnHD /10
-10
 m
2
 s
-1
 
21.8 + 0.2 22.4
a 
22.4
a 
22.4
a 
23.1 
DMnHE /kJ mol
-1
 
21.6 + 0.2 17.3
a 
17.3
a 
17.3
a 
18.9 
2/1019 s-2 9.0 + 0.5 2.38 + 0.39 1.48 + 0.25 3.26 + 0.50 6.9 
AO//10
6
 rad s
-1
 
 
-45.8 + 0.8 
 
 -40.5 
rMnH/Å 
 
2.74
a 
2.74
a 
2.74
a 
2.83
a 
aMnH/Å 3.6
a 
3.6
a 
3.6
a 
3.6
a 
3.6
a
 
q
298 
0 2
a 
2
a 
2
a 
1
a 
a
 Parameters fixed during the fitting procedure. 
b 
Ref. 21. 
 
 
Figure 14. Reduced transverse (blue ) 17O NMR relaxation rates and 17O NMR chemical 
shifts (red ) measured for [Mn(dpama)] at 11.74 T. The lines represent the fit of the data as 
explained in the text. 
 
The 
1
H NMRD profiles of [Mn(bcpe)] were analyzed by using the Freed model,
[25]
 which 
accounts for the outer-sphere contribution to relaxivity. The distance of closest approach for 
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the outer-sphere contribution aMnH was fixed at 3.6 Å, while the remaining parameters were 
allowed to refine freely during the fitting procedure. The parameters characterizing the 
electron spin relaxation, the electronic correlation time for the modulation of the zero-field-
splitting interaction (V), its activation energy (EV) and the mean square zero-field-splitting 
energy (2), take values that are similar to those reported for [Mn(edta)]2- and other Mn2+ 
complexes.
[7,21,26,27]
 Furthermore, the values obtained for the diffusion coefficient, 298
MnHD , and 
its activation energy, 
DMnHE
, are close to those reported for the self-diffusion of water 
molecules in pure water (2.3·10-9 m2·s-1 and 17.3 kJ mol-1).[74] Thus, we conclude that the 
value of 3.6 Å assumed for aMnH is reasonable. 
A simultaneous fitting of the 
1
H NMRD and 
17
O NMR data of [Mn(dpama)] was carried out 
by taking into account both the outer- and inner-sphere contributions to relaxivity.  
From the measured 
17
O NMR transversal relaxation rates and angular frequencies of the 
paramagnetic solutions, 1/T1, 1/T2 and , and of the acidified water reference, 1/T1A, 1/T2A and 
A, one can calculate the reduced relaxation rates, 1/T1r, 1/T2r and reduced chemical shifts 
(Eq. (3) – (4)), where 1/T2m is the relaxation rate of the bound water and m is the chemical 
shift difference between bound and bulk water, m is the mean residence time or the inverse of 
the water exchange rate kex and Pm is the mole fraction of the bound water.
[28,29] 
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The outer sphere contributions to the 
17
O relaxation rates and chemical shifts have been 
considered to be negligible in the present study. m is determined by the hyperfine or scalar 
coupling constant, A/, according to Equation (5), where B represents the magnetic field, S is 
the electron spin (S = 5/2 for high-spin Mn(II) complexes) and gL is the isotropic Landé g 
factor.
[75] 
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B
B3

g S S B
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
                                          (5) 
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The exchange rate is supposed to assume the Eyring equation. In Eq. (6) S‡ and H‡ are the 
entropy and enthalpy of activation for the water exchange process, and kex
298
 is the exchange 
rate at 298.15 K. 
 
         
2981 1 1
exp exp
R 298.15 298.15
B ex
ex
m
k T S H k T H
k
h RT R T
       
        
    
‡ ‡ ‡
              (6) 
 
In the transverse relaxation the scalar contribution, 1/T2sc, is the most important, Eq. (7). 1/s1 
is the sum of the exchange rate constant and the electron spin relaxation rate. 
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The measured longitudinal proton relaxation rate, R1
obs 
is the sum of a paramagnetic and a 
diamagnetic contribution as expressed in Eq. (9), where r1p is the proton relaxivity: 
 
    )]([11111 IIMnrRRRR p
dpdobs                                     (9) 
 
The relaxivity can be divided into an inner and an outer sphere term as follows: 
 
 1 1 1is osr r r                                                        (10) 
 
The inner sphere term is given in Eq. (11), where q is the number of inner sphere water 
molecules.
[30] 
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The longitudinal relaxation rate of inner sphere protons, 1/T1m
H
 is expressed by Eq. (12): 
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where rMnH is the effective distance between the electron charge and the 
1
H nucleus, I  is the 
proton resonance frequency and S is the Larmor frequency of the Mn(II) electron spin. 
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The longitudinal and transverse electronic relaxation rates, 1/T1e and 1/T2e are expressed 
by Eqs. (14)-(16), where V is the electronic correlation time for the modulation of the zero-
field-splitting interaction, EV the corresponding activation energy and 
2
 is the mean square 
zero-field-splitting energy. We assumed a simple exponential dependence of V versus 1/T as 
written in Eq. (16). 
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The outer-sphere contribution can be described by Eq. (17) where NA is the Avogadro 
constant, and Jos is its associated spectral density function.
[25,31] 
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where 1,2j  , 
MnH
MnH
MnH
D
a
2
 . 
 
The diffusion coefficient for the diffusion of a water proton away from a Gd(III) complex, 
DGdH, is assumed to obey an exponential law versus the inverse of the temperature, with an 
activation energy EGdH, as given in Eq. (19). DGdH
298
 is the diffusion coefficient at 298.15 K. 
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In line with the results obtained for [Mn(bcpe)], the distance of closest approach for the 
outer-sphere contribution aMnH was fixed at 3.6 Å during the fitting procedure, while 
298
MnHD  
and DMnHE  were set to the values obtained for the self-diffusion of water molecules in pure 
water. Furthermore, the distance between the proton nuclei of the coordinated water 
molecules and the Mn
2+
 ion (rMnH) was fixed at 2.74 Å, which corresponds to the average 
Mn···H distance obtained from our DFT calculations. Number of water molecules in the inner 
coordination sphere of Mn
2+
 was fixed to q=2. The parameters obtained from the fittings are 
listed in Table 4, while the curve fits are shown in Figures 13 and 14. 
The measured water exchange rate for [Mn(dpama)] (kex
298
=3.1 10
8
 s
-1
) is close to that 
reported for [Mn(edta)(H2O)]
2-
 (kex
298
=4.7 10
8
 s
-1
),
[21]
 and one order of magnitude faster than 
that determined for the aquated ion [Mn(H2O)6]
2+
 (kex
298
=2.8 10
7
 s
-1
).
[20]
 The value obtained 
for the 
17
O hyperfine coupling constant (AO/ħ=-45.810
6
 rads
-1
) is similar to those typically 
observed for Mn
2+
 complexes (-31106 to -43106 rad·s-1).[32] Theoretical DFT calculations 
carried out following previously reported methodology
[33,20]
 provide Aiso values of -48.110
6
 
rad·s-1 and -52.5106 rad·s-1 for the two coordinated water molecules, which present nearly 
identical Mn-O distances (2.206 and 2.205 Å). The excellent agreement between the 
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experimental and calculated AO/ħ values clearly confirms that the [Mn(dpama)] presents two 
coordinated water molecules. 
 
 
Figure 15. 
1
H NMRD profiles recorded at different temperatures for 
[mX(Mn(dpama)(H2O)2)2] and [mX(Mn(dpama)(H2O)2)3]. The lines represent the fit of the 
data as explained in the text. 
 
The 
1
H NMRD profiles of the [mX(Mn(dpama)(H2O)2)2] and [mX(Mn(dpama)(H2O)2)3] 
complexes were also recorded at different temperatures (Figure 15). The relaxivities measured 
at high fields (>20 MHz) for the mono-, bi- and tri-nuclear complexes follow a linear 
correlation (R
2
 > 0.9999) with their molecular weight (Figure 16.). At high fields the 
rotational dynamics (R) plays a major role in determining the relaxivity because both the 
exchange lifetime (M) and the electronic relaxation times are much longer than R. The 
1
H 
NMRD profiles recorded at three different temperatures could be fitted by fixing the structural 
parameters and those related to diffusion and water exchange to the values obtained for 
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[Mn(dpama)] (Table 4). Thus, only four parameters were allowed to vary during the fitting 
procedure: R, v, Er, and 
2
. Reasonably good fits of the relaxivity data were obtained using 
this procedure, which suggests that the water exchange of coordinated water molecules does 
not vary significantly in this series of complexes. The results of the fits are clearly showing 
that increasingly long R values are the main responsible for the increase of relaxivity with 
molecular weight. 
 
 
Figure 16. Plot of the relaxivity (20 MHz; 25 ºC) of the [Mn(dpama)], [mX(Mndpama)2] and 
[mX(Mndpama)3] complexes as a function of the molecular mass. The line represents the 
linear fit of the data. 
 
Human Serum Albumin (HSA) binding studies: 
 
The stability of the [Mn(dpama)] complex was first assessed by measuring its proton 
relaxivity (25 ºC, 20 MHz) as a function of pH. The relaxivity remains constant within a 
rather wide pH range from 10.3 to 5.5, while below pH~5.5 r1p increases due to the stepwise 
dissociation of the complex and gradual Mn
2+
 release (Figure 17.). The stability with time of 
[Mn(dpama)] was assessed by relaxometric measurement (0.47 T, 37 ºC) of a 0.98 mM 
solution of the complex in a lyophilized serum of human origin (Seronorm
TM
), which is 
normal human serum without added preservatives and therefore contains endogenous levels of 
the different serum components. The complex proved to be stable for more than 120 h (Figure 
18.), as only very small and negligible fluctuations in the relaxation rate data were detected, 
well within the experimental error (±3-4%). 
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Figure 17. Proton relaxivity of [Mn(dpama)] (20 MHz, 25 ºC) recorded as a function of pH. 
 
 
Figure 18. Proton relaxation rate at 0.47 T and 310 K of a 0.98 mM solution of [Mn(dpama)] 
in Seronorm
TM
 as a function of time. 
 
 
The proton relaxivity measured in Seronorm
TM
 at 0.47 T and 37 ºC (11.14 mM-1 s-1) was 
found to be significantly higher than that observed in pure water (4.17 mM
-1
 s
-1
). This 
prompted us investigate the interaction of the complex with HSA, which is the most common 
protein present in human blood plasma, through the well-established proton relaxation 
enhancement technique.
[34]
 Addition of HSA to an aqueous solution of [Mn(dpama)] (0.285 
mM, pH 7.2, 310 K) induces a significant increase of the observed longitudinal relaxation rate 
of water proton nuclei of the solution (Figure 19). The least-squares fit of the relaxometric 
titration data provide an association constant of 3372 + 138 M
-1
, with a calculated relaxivity 
for the fully bound form of 12.2 + 0.8 mM
-1
 s
-1
. The 
1
H nuclear magnetic relaxation 
dispersion (NMRD) obtained for the fully bound form presents a peak in the region 8-60 
 
56 
MHz, which is characteristic of slowly tumbling systems with long rotational correlation 
times (Figure 20). This confirms that [Mn(dpama)] binds to HSA, which slows down the 
rotation of the complex in solution. However, the overall relaxivity determined for the fully 
bound form is relatively low when compared to other Mn
2+
 complexes that bind HSA,
[35]
 with 
a rather small relaxivity gain with respect to that of the complex in pure water. Moreover, the 
peak in the NMRD profile is rather broad and significantly lower than that typical of 
paramagnetic adducts with HSA.  
 
 
Figure 19. Changes in the observed longitudinal relaxation rates of water protons observed 
upon addition of HSA to solutions [Mn(dpama)] (0.285 mM) and [(mX(Mndpama)2] (0.151 
mM) complexes. The solid lines represent the least-squares fits of the data according to a 1:1 
binding isotherm. 
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Figure 20. NMRD profiles recorded at 37 ºC for the [Mn(dpama)] and [(mX(Mndpama)2] 
complexes and their fully bound forms to HSA. Note the break in the ordinate axis introduced 
for better visualization. 
 
Rather, the shape of the profile and the value of r1p corresponding to the maximum of the 
peak are more similar to those of q=0 Gd
3+
- and Mn
2+
 chelates bound to HSA.
[1,36]
 This 
suggests that protein binding results in the replacement of the two water molecules 
coordinated to Mn
2+
 by donor groups contained in residues of the protein.
[37] 
In light of the 
results obtained for [Mn(dpama)], we hypothesized that a dimeric analogue of this complex 
could bind HSA while leaving a complex unit exposed to the solvent, which should result in a 
sizeable inner-sphere contribution to 
1
H relaxivity.  
The 
1
H NMRD profile of [(mX(Mndpama)2] is characteristic of a Mn
2+
 complex with a low 
molecular weight, with a single dispersion at 1-10 MHz. Titration of 0.151 mM solution of 
[(mX(Mndpama)2] with HSA (pH = 7.2, 37 ºC) indeed confirmed the binding of the complex 
to the protein with an association constant of 1125 ± 35 M-1 (Figure 19). This association 
constant is somewhat lower than that obtained for [Mn(dpama)], which indicates that the 
association with the protein is hindered by the presence of the mX(Mndpama) unit. However, 
the relaxivity of the fully bound form at 20 MHz and 37 ºC (39.0 ± 1.3 mM-1 s-1) is very high, 
confirming that one of the (Mndpama) moieties is exposed to the solvent providing a 
significant response in terms of relaxivity. Furthermore, the NMRD profile obtained for the 
fully bound form (Figure 20) is characteristic of a slowly tumbling species with sizeable 
inner-sphere contribution to relaxivity. It should be noted that this value of r1p represents an 
average between that of a Mn
2+
 ion with q=0, which contributes to the relaxivity with only the 
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outer- and second-sphere mechanisms, and that of a q=2 Mn
2+
 ion whose contribution (inner-
sphere) is largely dominant. Assuming in first approximation that the contribution of the q=0 
Mn
2+
 is similar to that of [Mn(dpama)]-HSA (12.2 mM
-1
 s
-1
), then we can estimate a 
relaxivity for the second Mn
2+
 of ca. 66 mM
-1
 s
-1
. 
The binding interaction of [mX(Mn(dpama)(H2O)2)3] has been also investigated through the 
same proton relaxation enhancement (PRE) technique. Similarly, to several previous cases, 
the data were fitted to a 1:1 binding isotherm even though the presence of multiple affinity 
sites on HSA cannot be excluded. Titration of a 0.055 mM solution of 
[mX(Mn(dpama)(H2O)2)3] with HSA (pH = 7.2, 20 MHz and 310 K) confirmed the binding 
of the complex to the protein with an association constant of 1286 ± 55 M-1 (Figure 21; Table 
5), a value very similar to that assessed for the dimeric derivative. As for 
[mX(Mn(dpama)(H2O)2)2], also the relaxivity of the adduct (45.2 ± 0.6 mM
-1
 s
-1
) is 
remarkably high, in line with the reasonable assumption that also in this case a single 
chelating unit is involved in the binding, while the other two are freely accessible to solvent 
and responsible for the relaxivity increase. The value of r1
b
 is the average relaxivity per Mn
2+
 
ion, while the molecular relaxivity (per complex) is 135.6 mM
-1
 s
-1
. If we assume for the unit 
with q = 0 (that embedded in the hydrophobic pocket of HSA) the same value of r1
b
 found per 
[Mn(dpama)], then each q = 2 unit is characterized by a relaxivity of about 62 mM
-1
 s
-1
. This 
value is quite comparable to that calculated previously for [mX(Mn(dpama)(H2O)2)2]. 
 
 
 
Figure 21. Plot of the water proton longitudinal relaxation rate of a solution of 
[mX(Mn(dpama)(H2O)2)3] (0.055 mM) as a function of HSA concentration at 20 MHz, 310 K 
and pH = 7.2. The line through the data has been calculated with the parameters of Table 5.  
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Figure 22. 
1
H NMRD profiles for [mX(Mn(dpama)(H2O)2)3] free (bottom) and fully bound to 
HSA (top) at 310 K and pH = 7.2. 
 
The NMRD profile of the trinuclear complex has been measured for 0.055 mM complex 
solution in the presence of 1.7 mM HSA at 310 K. Under these conditions, ca. 68% of the 
complex is bound to the protein. The calculated profile corresponding to the fully bound form 
is reported in Figure 22 (the r1
b
 values are expressed per Mn). The profile is characteristic of a 
slowly tumbling system with a pronounced peak around 30 MHz and a large relaxivity 
enhancement over the free complex due to the slow rotation and fast exchange conditions 
(long R and short M values).  
Table 5. Best-fit parameters obtained from the analysis of the 
1
H relaxometric titrations (20 
MHz; 310 K) of the Mn
2+
 complexes with HSA. 
 
 dpama
2-
 mX(dpama)2
4-
 mX(dpama)3
6-
 
n·KA (M
-1
) 3372 ± 138 1125 ± 35 1286 ± 85 
r1p
b
 (mM
-1
 s
-1
) 12.2 ± 0.8 39.0 ± 1.3 45.2 ± 0.6 
r1p
f
 (mM
-1
 s
-1
)
a 
4.2 6.1 8.3 
a
r1p
f
 is the relaxivity of the free complex 
 
Conclusions: 
We have investigated a series of ligands containing pentadentate-coordinating units designed 
for pentagonal bipyramidal coordination around Mn
2+
, thanks to the presence of two 
coordinated water molecules. This imparts remarkably high relaxivities to the solutions of the 
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corresponding Mn
2+
 complexes. Furthermore, these relaxivities are further improved by 
interaction with HSA, particularly in the case of the trinuclear Mn
2+
 complex. This property is 
very interesting for MRI visualization of blood vessels, as well as to improve the residence 
time of the agent in the blood pool. The Mn
2+
 complexes formed with this family of ligands 
present moderate thermodynamic stabilities. Although this may not be a very serious 
limitation due to the far better safety profile of Mn
2+
 compared to Gd
3+
, it is important to 
design and develop Mn
2+
 complexes that, while maintaining these favorable relaxometric 
properties, exhibit improved characteristics of kinetic inertia. 
 
Experimental: 
General. Chemicals were purchased from commercial sources and used without further 
purification. SiO2 (Fluka, pore size 60 Å, 70-230 mesh) was used for preparative column 
chromatography. 
1
H and 
13C NMR spectra were recorded at 25 ºC on a Bruker Avance 500 
MHz spectrometer. High resolution ESI-TOF mass spectra were recorded using a LC-Q-q-
TOF Applied Biosystems QSTAR Elite spectrometer in the positive mode. Elemental 
analyses were carried out on a ThermoQuest Flash EA 1112 elemental analyzer. IR spectra 
were recorded using a Bruker Vector 22 spectrophotometer equipped with a Golden Gate 
Attenuated Total Reflectance (ATR) accessory (Specac). 
Equilibrium measurements. All the equilibrium measurements were conducted at a constant 
ionic strength maintained by 0.15 M NaCl at 298 K. For determining the protonation 
constants of the bcpe
2-
, dpama
2-
, mX(dpama)2
4-
 and mX(dpama)3
6-
 ligands pH-potentiometric 
titrations were performed with 0.2 M NaOH using 0.002 M ligand solutions. The stability and 
protonation constants of Mn
2+
 and Zn
2+
 complexes were determined by pH-potentiometric 
titrations. The metal to ligand concentration ratios were 1:1 for bcpe
2-
 and dpama
2-
, 1:1 and 
2:1 for mX(dpama)2
4-
 and 1:1, 2:1 and 3:1 for mX(dpama)3
6-
 (the concentration of the ligand 
was generally 0.002 M). For the calculation of the equilibrium constants the mL base – pH 
data were used, obtained in the pH range 1.7–12.0. The pH-potentiometric titrations were 
carried out using a 785 DMP Titrino titration workstation with the use of a Metrohm- 
6.0233.100 combined electrode. The titrated solution (8 mL) was thermostated at 25 °C. The 
samples were stirred and to avoid the effect of CO2, N2 gas was bubbled through the 
solutions. The titrations were performed in the pH range 1.7–12.0. For the calibration of the 
pH meter, KH-phthalate (pH = 4.002) and borax (pH = 8.970) buffers were used. For the 
calculation of the H
+
 concentration from the measured pH values, the method proposed by 
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Irving et al. was used.
[38]
 A 0.01 M HCl (0.15 M NaCl) solution was titrated with the 0.2 M 
NaOH and the difference between the measured and calculated pH values was used to 
calculate [H
+
] from the pH values determined in the titration experiments. 
The stability constants of the [Cu(bcpe)] and [Cu(dpama)] complexes have been determined 
by spectrophotometry, with the use of the competition reactions taking place between the 
concerned ligand (bcpe
2-
 or dpama
2-
) and egta
4-
 for Cu
2+
 complexation in the pH range 6.8 – 
7.2. The concentration of Cu
2+
 and bcpe
2-
 (or dpama
2-
) in the 8 samples was 3 mM, while the 
concentration of egta was varied between 0 mM and 8 mM. The molar absorptivity of CuCl2 
and the complexes [Cu(dpama)], [Cu(bcpe)] and [Cu(EGTA)]
2-
 were determined in 1.5 mM, 
3.0 mM and 4.5 mM solutions. The absorbance and pH values were determined in the 
samples after the equilibrium was reached (the time needed to reach the equilibria was 
determined by spectrophotometry). Spectrophotometric measurements were made between 
700 and 800 nm at 11 wavelength values. The spectrophotometric measurements were 
recorded with the use of 1.0 cm cells using a Cary 1E spectrophotometer at 298 K. For the 
calculation of the equilibrium constants, the PSEQUAD program was used.
[84] 
  
1
H NMRD and 
17
O NMR measurements. The water proton longitudinal relaxation rates as a 
function of pH (20 MHz) were measured with a Stelar Spinmaster Spectrometer FFC2000 
(Mede, PV, Italy) on about 0.6-2.0 mM aqueous solutions. The exact concentrations of Mn
2+
 
ions were determined by measurement of bulk magnetic susceptibility shifts of a tBuOH 
signal on a Bruker Avance III spectrometer (11.7 T). The 
1
H T1 relaxation times were 
acquired by the standard inversion recovery method with typical 90° pulse width of 3.5 μs, 16 
experiments of 4 scans. The temperature was controlled with a Stelar VTC-91 airflow heater 
equipped with a calibrated copper–constantan thermocouple (uncertainty of ±0.1 °C). The 
proton 1/T1 NMRD profiles were measured on a fast field-cycling Stelar SmartTracer 
relaxometer over a continuum of magnetic field strengths from 0.00024–0.25 T 
(corresponding to 0.01–10 MHz proton Larmor frequencies). Additional data points in the 
range 15–70 MHz were obtained on a Stelar Relaxometer equipped with a Bruker WP80 
NMR electromagnet adapted to variable-field measurements (15–80 MHz proton Larmor 
frequency). Variable-temperature 
17
O NMR measurements were recorded on a Bruker Avance 
III spectrometer (11.7 T) equipped with a 5 mm probe and standard temperature control unit. 
An aqueous solution of the complex (4 mM) containing 2.0% of the 
17
O isotope (Cambridge 
Isotope) was used. The observed transverse relaxation rates were calculated from the signal 
width at half-height.  
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Chapter 5  
 
Developing the Family of 
Picolinate Ligands for Mn
2+
 
Complexation 
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Introduction: 
 
In general, the design of Mn
2+
-based MRI contrast agents represents a challenge for 
coordination chemistry. Indeed, a Mn
2+
 complex should fulfil a number of requisites to 
become a potential candidate as a contrast agent:  
i) a high thermodynamic and kinetic stability to avoid the release of the toxic Mn
2+
 ion. The 
lack of a crystal field stabilization energy associated with the high-spin d
5
 configuration 
results in rather low thermodynamic stabilities of Mn
2+
 complexes, which are also generally 
rather labile with respect to complex dissociation;
[1]
  
ii) the presence of at least one water molecule coordinated to the metal ion that exchanges 
rapidly with the bulk water, thereby imparting an efficient pathway to accelerate the 
relaxation rates of water proton nuclei. It is worth noting that Mn
2+
 chelates with high 
thermodynamic stability such as [Mn(DOTA)]
2-
 and [Mn(DO3A)]
-
 do not contain coordinated 
water molecules;
[2]
  
iii) a good redox stability to avoid the oxidation of Mn
2+
 to Mn
3+
, which generally provides 
lower relaxivities. However, redox Mn
2+
/Mn
3+
 potentials accessible to biologically relevant 
reducing agents can be potentially exploited to design redox-activated MRI probes.
[3,4] 
Based on the previous results, we decided to expand the family of ligands containing 
picolinate groups by investigating the pentadentate ligand H2DPAPhA and the hexadentate 
derivative H3DPAA. The latter ligand was reported previously by M. Mazzanti and studied in 
the context of Gd
3+
 MRI CAs.
[5]
 Furthermore, we also examined two lipophilic derivatives of 
H2DPAMA and H2PhDPAMA, which contain a dodecyl side chain attached to the amine 
nitrogen atom of H2DPAMA or a hexyl chain at the aniline function of H2DPAPhA, 
respectively. These lipophilic derivatives were designed to form micelles in solution and to 
bind HSA in a non-covalent fashion. Both effects are expected to increase the observed 
relaxivity by slowing down the rotation of the complex in solution. We report the synthesis 
and acid-base properties of the ligands, the stability constants of the Mn
2+
 complexes in 
solution, and a full physicochemical characterization of the chelates using 
1
H and 
17
O 
relaxometric techniques and theoretical (DFT) calculations. 
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Scheme 1. Structures of the ligands presented in this chapter.
 
 
 
Synthesis of the Ligands: 
Prof. Carlos Platas Iglesias provided the ligands discussed in this chapter, which were 
synthesized following the two-step procedure shown in Scheme 2. The first step consisted in 
the reaction of 6-chloromethylpyridine-2-carboxylic acid ethyl ester with the appropriate 
amine in the presence of K2CO3 as a base. It is worth mentioning that the reactions with 
anilines required rather harsh conditions involving heating for prolonged periods and addition 
of catalytic KI. The ester intermediates were isolated in rather good yields (65-72%) after 
purification with column chromatography. Hydrolysis of the methyl ester groups (and the 
amide group of the precursor of H3DPAA) provided the target ligands as the hydrochloride 
salts with good overall yields (52-61%). 
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Scheme 2. Synthesis of the ligands.
 
 
 
Ligand protonation constants and stability constants of the Mn
2+
 complexes: 
 
The protonation constants of the DPAPhA
2-
 and DPAA
3-
 were determined by potentiometry, 
in 0.15 NaCl. The ligand protonation constants are defined as in Eq 1. 
 
 Hi-1L  +   H
+
     HiL 
]L][Η[Η
L][Η
Κ
1i
iΗ
i 

           i=1, 2,…, 8.                                         (1) 
 
The protonation constants, with their corresponding standard deviations are listed in Table 1. 
For the DPAA
3-
 four protonation constants could be determined, indicating the stepwise 
protonation of the amine nitrogen atom and all the three carboxylate groups of the ligand. The 
first two protonation constants of DPAA
3-
 are very similar to DPAMA
2- 
ligand. These 
protonation processes are assigned to the protonation of the amine nitrogen atom (K1
H
) and 
one of the carboxylate groups of the picolinate arms (K2
H
). The first protonation constant of 
DPAPhA
2-
 (logK1
H
 = 5.48(4)) is ca. two orders of magnitude lower than those determined for 
DPAA
3-
 and DPAMA
2-
, in line with the lower basicity of anilines compared to aliphatic 
amines.
[7]
 In the case of DPAPhA
2-
 four protonation constants could be determined, indicating 
the protonation of the aniline nitrogen atom, two carboxylate groups and likely a nitrogen 
atom of a pyridine moiety. 
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Table 1. Ligand protonation constants and stability and protonation constants of the 
corresponding Mn
2+
 complexes determined using potentiometric titrations (25 ºC, 0.15 M 
NaCl).
b 
 
 DPAA
3-
 DPAPhA
2-
 DPAMA
2- 
 EDTA
4- a
 
logK1
H
 7.26(2) 5.48(4) 7.82 10.17 
logK2
H
 3.90(3) 4.51(4) 3.71 6.11 
logK3
H
 3.29(2) 4.28(4) 2.61 2.68 
logK4
H
 1.77(2) 2.70(4)   
∑logKi
H
 16.22 16.97 14.14  
     
logKMnL 13.19(5) 9.55(1) 10.13 13.88 
logKMnLH 2.90(6) 4.84(1) 2.57  
logKMnLH2  2.51(1)   
logKMLOH 11.97(6)  11.09  
pMn
c 
8.98 7.27 7.28 7.95 
a 
Data from reference 6. 
b
 Defined as –log[Mn]free with pH = 7.4, [Mn
2+
] = [L] = 10
-5
 M. 
 
As a result, the DPAA
3-
 and DPAPhA
2-
 ligands present very similar overall basicities, as 
estimated by the ∑logKi
H
 values (i = 1-4). The protonation constants determined for 
DPAA
3-
 in 0.15 M NaCl are in general good agreement with those reported by Mazzanti in 
0.1 M KCl (logK1
H
 = 7.33, logK2
H
 = 3.8 and logK3
H
 = 2.9).
[5] 
The stability and protonation constants of the Mn
2+
 complexes of DPAA
3-
 and 
DPAPhA
2-
 were determined by using direct potentiometric pH-titrations. The stability 
constants and protonation constants of the complexes are defined in Eqs 2 and 3: 
 
]][[
][
LM
ML
KML                                                                   (2) 
 
                         
]][[
][
1



HLMH
LMH
K
i
i
LH i
            with i = 1, 2                          (3) 
The titration curve of the Mn
2+
/DPAA
3-
 system evidenced the formation of a hydroxo 
complex characterized by protonation constant KMLOH defined as: 
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])][([
][


HOHML
ML
KMLOH                                           (4) 
The stability constant of the [Mn(DPAMA)] complex is higher than [Mn(DPAPhA)]  which is 
likely related to the weaker coordination of the aniline nitrogen atom of DPAPhA
2-
 compared 
to the amine nitrogen atom of DPAMA
2-
. The presence of an additional carboxylate group in 
DPAA
3-
 increases the stability of the Mn
2+
 complex by three orders of magnitude with respect 
to DPAMA
2-
. As a result, the stability constant of the [Mn(DPAA)]
-
 complex (logKML = 
13.19(5)) is close to the EDTA analogue (logKML = 13.88).
[8] 
 
 
 
 
Figure 1. Species distribution diagrams calculated for the H3DPAA:Mn
2+
 (top) and 
H2DPAPhA:Mn
2+
 (bottom) systems. [L] = [Mn
2+
] = 10
-3
 M. 
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Figure 1 presents the species distribution diagrams calculated using the equilibrium 
constants reported in Table 1. The [Mn(DPAA)]
-
 species is the most abundant in a wide range 
of pH from ca. 2.8 to 11.4. The formation of the hydroxo [Mn(DPAA)(OH)]
2-
 species occurs 
above pH ~ 10, while below pH ~ 5.0 the protonation of the complex is observed. 
Dissociation of the complex takes place at a rather low pH, with only 5.6% of the manganese 
under the form of [Mn(H2O)6]
2+
 at pH 2.0. 
The dissociation of [Mn(DPAPhA)] starts at higher pH than for [Mn(DPAA)]
-
, as 27.8% of 
the complex is dissociated at pH 2.0. However, the degree of dissociation of the complex at 
pH 2.0 is even higher in the case of [Mn(DPAMA)] (77.7%). [Mn(DPAPhA)] forms 
protonated species at higher pH (< 7.0). 
A comparison of the thermodynamic stabilities of complexes with different ligands is more 
properly given by the pMn values (pMn = -log[Mn
2+
]free) defined using the conditions 
suggested by Drahos
[9]
 (pH = 7.4, [Mn
2+
] = [L] = 10
-5
 M). The pMn values calculated for 
[Mn(DPAMA)] and [Mn(DPAPhA)] are almost identical (7.3, Table 1) and somewhat lower 
than that of [Mn(EDTA)]
2-
. The latter complex serves as a reference for potential MRI 
applications, as [Mn(EDTA)]
2-
 derivatives have been successfully used for in vivo MRI 
studies.
[10]
 Interestingly, the [Mn(DPAA)]
-
 complex presents a pMn value one order of 
magnitude higher than [Mn(EDTA)]
2-
 and very close to that reported for [Mn(DOTA)]
2-
,
[11]
 
which highlights its remarkable thermodynamic stability at physiological pH. 
 
 
1
H NMRD and 
17
O NMR studies of the [Mn(DPAPhA)] and [Mn(DPAA)]
-
 complexes:  
The relaxivity determined for [Mn(DPAA)]
-
 at pH 7.4 (25 ºC, 20 MHz) is 3.6 mM-1 s-1, a 
value that is close to that reported to monohydrated complexes such as [Mn(EDTA)]
2-
 (3.3 
mM
-1
 s
-1
 at pH 7.4, 25 ºV and 20 MHz). The r1p value for [Mn(DPAPhA)] under the same 
conditions (6.7 mM
-1
 s
-1
) is remarkably higher, which indicates the presence of two 
coordinated water molecules (Fig 2). 
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Figure 2. Plot of the 
1H relaxivities (20 MHz, 25 ºC) of [Mn(DPAPhA)] and [Mn(DPAA)]- as 
a function of pH. 
 
The relaxivity of [Mn(DPAA)]
-
 remains fairly constant (r1p = 3.60 + 0.15 at 25 ºC, 20 MHz)) 
in a broad pH range from 2.5 to 11.5. Below pH 2.5 relaxivity increases due to the 
dissociation of the complex and formation of [Mn(H2O)6]
2+
, while the slight decrease in 
relaxivity observed at pH > 11.5 is attached to the formation of a hydroxo complex. Thus, the 
pH dependence of r1p is in perfect agreement with the speciation in solution obtained from 
potentiometric measurements (Fig 1). 
The relaxivity of [Mn(DPAPhA)] is constant in the pH range 5.9-10.2, dropping quickly at 
more basic pH due to the dissociation of the complex and precipitation of Mn(OH)2.
[12]
 
1
H 
relaxivity decreases from 6.7 at pH 5.9 to 6.1 at pH 3.3. This effect can be attributed to the 
formation of the protonated [Mn(HDPAPhA)]
+
 species (logKMnLH = 4.84(1), see above). 
Dissociation of the complex below pH ~ 2.7 is responsible for the slight increase in relaxivity 
under acidic conditions. 
Proton nuclear magnetic relaxation dispersion (
1
H NMRD) profiles were recorded in the 
proton Larmor frequency range 0.01−70 MHz (corresponding to magnetic field strengths 
varying between 2.34310-4 and 1.645 T) of aqueous solutions [Mn(DPAPhA)] and 
[Mn(DPAA)]
-
 (Fig 3). The relaxivities of both complexes decrease with increasing 
temperature, as expected for small chelates in which fast rotation in solution limits proton 
relaxivity. The NMRD profiles present a single dispersion in the range 1 - 10 MHz, which 
excludes rules out a sizeable scalar contribution to 
1
H relaxivity.
[13,14] 
Reduced transverse 
17
O NMR relaxation rates of aqueous solutions of the [Mn(DPAPhA)] 
and [Mn(DPAA)]
-
 complexes were recorded to gain more insight into the physicochemical 
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parameters that govern the relaxivities of these systems (Fig 4). The 1/T2r values increase with 
decreasing temperature, reach a maximum and then decrease at lower temperatures. This is 
typical of systems that present a changeover from a fast exchange regime at high temperatures 
to a slow exchange at low temperatures.
[15]
 The lower temperature at which the maximum 
1/T2r value is observed for [Mn(DPAA)]
-
 (ca. 15 ºC) compared with [Mn(DPAPhA)] (~23 ºC) 
is indicative of a somewhat faster water exchange rate in the former. 
A simultaneous fitting of the 
1
H NMRD and 
17
O NMR data of the two complexes was 
carried out by using the method previously detailed in Chapter 4. Since the NMRD and 
17
O 
NMR data depend upon a relatively large number of parameters some of them had to be fixed 
during the fitting procedure to achieve a reliable analysis. The distance of closest approach for 
the outer-sphere contribution aMnH was fixed at 3.6 Å during the fitting procedure, while the 
distances between the proton nuclei of the coordinated water molecules and the Mn
2+
 ion 
(rMnH) were fixed at values corresponding to the average Mn···H distances obtained from 
DFT calculations (2.756 and 2.782 Å for [Mn(DPAA)]- and [Mn(DPAPhA)], respectively). 
The number of water molecules in the inner coordination sphere of Mn
2+
 was fixed to q=2 for 
[Mn(DPAPhA)] and q=1 for [Mn(DPAA)]
-
. The diffusion coefficient, DMnH
298 , and its activation 
energy, EDMnH, were fixed to the values for the self-diffusion of water molecules in pure 
water.
[16]
 The parameters obtained from the fittings are provided in Table 9, while the curve 
fits are shown in Figures 3 and 4. 
The water exchange rate determined for [Mn(DPAA)]
-
 (kex
298
=12.6107 s-1) is about twice 
that measured for [Mn(DPAPhA)] (kex
298
=5.6107 s-1). Both complexes present lower water 
exchange rates than [Mn(EDTA)]
2-
,
[17]
 approaching that determined for the aquated ion 
[Mn(H2O)6]
2+
 (kex
298
=2.8107 s-1).[14] DFT calculations performed in aqueous solution at the 
TPSSh/TZVP level provide some insight into the different water exchange rates determined 
for [Mn(dpaPha)] and [Mn(dpaa)]
-
 (Fig 5). In these calculations, we included two second-
sphere water molecules involved in hydrogen bonding with each coordinated water molecule, 
while bulk solvent effects were considered using a polarized continuum model. This mixed 
cluster/continuum approach was shown to provide accurate Mn-Owater distances and 
1
H and 
17
O hyperfine coupling constants of the coordinated water molecules. The optimized 
geometries of the [Mn(DPAPhA)(H2O)2]·4H2O and [Mn(DPAA)(H2O)]
-·2H2O systems 
indicate pentagonal bipyramidal coordination environments around the Mn
2+
 ion. The 
equatorial plane of the bipyramid is delineated by the amine nitrogen atom and the donor 
atoms of the picolinate units. In the case of [Mn(DPAPhA)(H2O)2]·4H2O two coordinated 
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water molecules occupy the apical positions, while for [Mn(DPAA)(H2O)]
-·2H2O the apical 
positions contain a coordinated water molecule and an oxygen atom of the acetate group of 
the ligand.  
 
 
Table 2. Parameters obtained from the simultaneous analysis of 
17
O NMR and 
1
H NMRD 
data.
a
 
 [Mn(DPAA)]
- [Mn(DPAPhA)] [Mn(DPAMA)] [Mn(EDTA)]2-b [Mn(H2O)6]
2+ 
r1p at 25/37 ºC / 
mM-1 s-1 b 
3.5/2.7 6.6/5.1 5.3/4.2 3.3/2.8  
𝑘𝑒𝑥
298/ 107 s-1 12.6 + 0.5 5.6 + 0.6 30.6 47.1 2.82 
H‡ / kJ mol-1 42.7 + 1.0 27.2 + 2.3 28.1 33.5 45.6 
𝜏𝑅
298 / ps 47.6 + 0.2 81.0 + 0.5 47.8 57 30.0 
Er / kJ mol
-1 22.8 + 0.4 27.0 + 2.6 25.3 21.8 16.7 
𝜏𝑉
298/ ps 19.4 + 0.2 15.6 + 0.1 39.2 27.9 10.0 
Ev / kJ mol
-1 1.0
a 1.0a 1.0a 1.0a 14.6 
𝐷MnH
298  / 10-10 m2 s-1 22.4
a 22.4a 22.4a 23.1 23.0a 
EDMnH / kJ mol
-1 17.3
a 17.3a 17.3a 18.9 29.7 
2 / 1019 s-2 5.5 + 0.2 11.5 + 0.4 2.38 6.9 0.6 
AO/ħ/ 10
6 rad s-1 -31.5 + 0.6 -25.0 + 0.6 -45.8 -40.5 -34.6 
rMnH/Å 2.756
a 2.782a 2.74a 2.83a 2.83 
aMnH/Å 3.6
a 3.6a 3.6a 3.6a 3.6 
q298 1
a 2a 2a 1a 6 
a
 Parameters fixed during the fitting procedure.
 b 
Data from Ref 17 
 
 
 
(A) (B) 
 
Figure 3. 
1
H NMRD profiles recorded at different temperatures for [Mn(DPAA)]
-
 and 
[Mn(DPAPhA)]. The lines represent the fit of the data as explained in the text. 
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 (A)  (B) 
 
Figure 4. Reduced transverse 
17
O NMR relaxation rates versus reciprocal temperature 
measured for [Mn(DPAA)]
-
 and [Mn(DPAPhA)] at 11.74 T. The lines represent the fit of the 
data as explained in the text.  
 
 (A)  (B) 
 
Figure 5. Structures of the [Mn(DPAA)(H2O)]
-·2H2O and [Mn(DPAPhA)(H2O)2]·4H2O 
systems obtained with DFT calculations (TPSSh/TZVP). Calculated bond distances (Å): 
[Mn(DPAA)(H2O)]
-·2H2O, Mn-N(1), 2.314; Mn-N(2), 2.521; Mn-N(3), 2.316 ; Mn-O(1), 
2.289; Mn-O(2), 2.291; Mn-O(1w), 2.288; Mn-O(3), 2.131; Mn-O(4w). 
[Mn(DPAPhA)(H2O)2]·4H2O, Mn-N(1), 2.285; Mn-N(2), 2.885; Mn-N(3), 2.268; Mn-
O(1), 2.225; Mn-O(2), 2.289; Mn-O(1w), 2.250; Mn-O(3); Mn-O(4w), 2.237. 
 
Prof. Carlos-Platas Iglesias performed the DFT calculations briefly described here. The 
calculated Mn-Owater distances involving the coordinated water molecule(s) are 2.288 Å for 
[Mn(DPAA)(H2O)]
-·2H2O and 2.237 and 2.250 Å for [Mn(DPAPhA)(H2O)2]·4H2O. Thus, 
the Mn-Owater distance in [Mn(DPAA)(H2O)]
-
 is significantly longer than those of the 
complex with dpaPha
2-
, revealing a weaker binding of the coordinated water molecule in the 
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former. Water exchange in these seven-coordinated complexes is expected to follow a 
dissociatively activated mechanism, the rate determining step being the rupture of the 
Mn-Owater bond to give a six-coordinated transition state. Thus, the strongest is the Mn-Owater 
bond the slowest is expected to be the water exchange process. Similar trends correlation the 
strength of the Gd-Owater bonds and the corresponding water exchange rates were observed for 
nine-coordinate Gd
3+
 complexes undergoing dissociatively activated water exchange 
processes.
[18] 
The values obtained for the 
17
O hyperfine coupling constants are in the low part of the range 
typically observed for Mn
2+
 complexes (AO/ = 25 10
6
 to 47  106 rad s-1), being very similar 
to the value reported for [Mn(H2O)6]
2+
 and other small complexes.
[19]
 Concerning the 
parameters related to the electron spin relaxation of the metal ion (the electronic correlation 
time for the modulation of the zero-field-splitting interaction, v, and the mean square zero-
field-splitting energy, 2), the parameters obtained from the analysis of NMRD and 17O NMR 
data are similar to those obtained for other Mn
2+
 complexes (Table 2). 
 
Characterization of the lipophilic derivatives [Mn(DPAHPhA)] and [Mn(DPADA)]:  
The critical micelle concentration (cmc) of [Mn(DPAHPhA)] and [Mn(DPADA)] was 
investigated by using relaxometric measurements at 20 MHz and 25 ºC.[20] The paramagnetic 
relaxation enhancement of water proton nuclei (R1
obs
) increased linearly with the 
concentration of [Mn(DPAHPhA)] complex in the range 0.07-0.61 mM (Figure 6.). The slope 
of the linear plot provides a relaxivity of the non-aggregated form of 4.1 mM
-1
 s
-1
. This value 
is consistent with that obtained from NMRD studies, which confirm the lack of self-
aggregation of the complex under these conditions (Figure 7.). Precipitation of the complex 
was observed at higher concentrations, thus preventing cmc determination. Surprisingly, the 
relaxivity determined for [Mn(DPAHPhA)] is considerably lower than that of the bis-hydrated 
[Mn(DPAPhA)] complex (6.6 mM
-1
 s
-1
), which suggests that the introduction of the hexyl 
chain in the ligand scaffold lowers the hydration number of the complex. 
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Figure 6. Determination of the CMC of the [Mn(DPAHPhA)] at 20 MHz and 298 K. 
 
 
Figure 7. 
1
H NMRD profile recorded at 298K for [Mn(DPAHPhA)] The line represent the fit 
of the data as explained in the text. 
 
The R1
obs
 values measured from solutions of [Mn(DPADA)] present two linear ranges with 
an inflection point at a complex concentration of ~0.1 mM (Figure 8.). The analysis of the 
data provides a cmc of 96(9) M with relaxivity values of r1p = 5.3 mM
-1
 s
-1
 and r1p = 8.5 
mM
-1
 s
-1
 for the non-aggregated and aggregated forms, respectively. The cmc determined for 
[Mn(DPADA)] is similar to that reported for a charge neutral Eu
3+
 complex having a C12 alkyl 
chain (67 M),[21] but considerably lower than the one determined for a similar system having 
negatively charged hydrophilic head units (4.5 mM).
[22]
 These results suggest that repulsive 
electrostatic interactions among the negatively charged head units are detrimental for the 
formation of micelles. 
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The relaxivity of [Mn(DPADA)] below the cmc (r1p = 5.3 mM
-1
 s
-1
) is lower than that of 
[Mn(DPAMA)], which suggests that the incorporation of the C12 alkyl chains to the ligand 
skeleton lowers the hydration number of the complex. As expected, the NMRD profile 
recorded below the cmc is typical of a small Mn
2+
 complex (Figure 9.). The best-fit analysis 
confirms these qualitative observations. The NMRD profile below cmc is well reproduced by 
fixing to one the number of inner sphere water molecules, at a distance of 2.782 Å and with a 
residence lifetime of 10 ns (298 K). The relaxivity is limited by the rotational dynamics even 
though the parameter τR assumes a value of 123 ps, more than twice that of [Mn(EDTA)]
-
 and 
[Mn(DPAA)]
-
. The longer τR reflects the presence of the pendant aliphatic chain and its effect 
is apparent from the nearly vanished field-dependence of relaxivity at high frequencies. The 
electronic relaxation parameters assume typical values: V = 21.4 ps and 
2
 = 8.1×1019 s-2. 
Conversely, above the cmc the NMRD profile presents a pronounced peak around 30 MHz 
that is characteristic of slowly tumbling systems. The NMRD at high field (> 3 MHz) was 
fitted using the Lipari-Szabo approach, which separates the global and local motions of the 
system.
[23]
 The analysis was performed by using as adjustable parameters those describing 
electron spin relaxation (v and 
2
), the correlation times describing global (RG) and local 
(RL) motions and the generalized order parameter S
2
, which takes a value of 0 if the internal 
motion is isotropic and a value of S
2
 = 1 if the motion is completely restricted. The hydration 
number was fixed to q = 1, the Mn···H distance (2.74 Å), the distance of closest approach of a 
second-sphere water molecule (aMnH = 3.6 Å) and diffusion coefficient (𝐷MnH
298
 = 2.24 10
-10
 m
2
 
s
-1
) were fixed to reasonable values (Table 2). The results of the fit provided RG = 5 ns and 
RL = 95 ps, with S
2
 = 0.27, indicating that relaxivity is limited by local rotational flexibility 
(Table 3).
[24]
 Analysis of the NMRD profile recorded at 37 ºC provides very similar results 
(Figure 10.). 
1
H relaxivity decreases upon increasing temperature, which indicates that the 
exchange rate of the coordinated water molecule is not limiting r1p. 
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Figure 8. Determination of the CMC of the [Mn(DPADA)] at 20 MHz and 298 K. 
 
 
 
Figure 9. 
1H NMRD profiles recorded at 25 ºC for [Mn(dpada)] above and below the cmc. 
The red line represents the fit of the data above cmc using the Lipari-Szabo approach. 
 
Table 3. Selected parameters obtained from the analysis of the NMRD profiles using the 
Lipari-Szabo approach (25 ºC).a 
 Mn(DPADA)
a 
Mn(DPADA)+HSA
b 
Mn(DPAHPhA)+HSA
c 
r1p (20 MHz) 8.5 ± 0.1 15.5 + 0.3 45.5 + 1.4 
RG (ns) 5.5 ± 0.7 50 (fixed) 50 (fixed) 
RL (ps) 91 ± 3 306 ± 10 1235 + 52 
S
2 
0.27 ± 0.01 0.26 ± 0.01 0.43 + 0.2 
KA / M
-1 
- 1.3 + 0.4  105 7.1 + 0.1  103 
av = 49 + 8 ps; 
2
 = 5.4 + 0.6 s
-2
. 
b v = 22 + 9 ps; 
2
 = 1.0 + 0.6 s
-2
.
c
 v = 18 + 8 ps; 
2
 = 0.84 
+ 0.04 s
-2
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Figure 10. 
1
H NMRD profiles recorded at 37 ºC for [Mn(dpada)] 
 
 
Interaction of the lipophilic derivatives [Mn(DPAHPhA)] and [Mn(DPADA)] with HSA: 
We measured the interaction of [Mn(DPAHPhA)] and [Mn(DPADA)] with by measuring the 
R1
obs
 values of a diluted solution of the complex as a function of protein concentration at a 
constant frequency and temperature. R1
obs
 increases with the concentration of the protein, 
because of the increase in the fraction of bound complex that is characterized by a slower 
reorientational motion. The analysis of the titration data (fitted to a 1:1 binding isotherm) 
affords the association constant KA, the number of equivalent and independent binding sites n 
(assumed to be 1) and the relaxivity of the bound form. The titration profile obtained for 
[Mn(DPAHPhA)] shows a rather sharp inflection point, which is indicative of a rather high 
stability constant (Figure 11). On the contrary [Mn(DPADA)] provides a smooth titration 
profile characteristic of a smaller association constant. Inspection of the titration profiles also 
shows that the relaxivity of the bound form is considerably higher in the case of 
[Mn(DPAHPhA)]. The fit of the data confirms these qualitative observations (Table 3). The 
association constant determined for [Mn(DPADA)] (7.1 x 10
5
 M
-1
) is 1-2 orders of magnitude 
higher than those determined for Mn
2+
 complexes containing benzyloxymethyl groups, and 
ca. 550 times higher than that obtained for [Mn(DPAHPhA)]. These results suggest that a 
lipophilic C12 alkyl chain provides a stronger interaction with the protein than 
benzyloxymethyl and 4-hexylphenyl moieties. This could be related to a better ability to 
penetrate inside the hydrophobic binding cavity of HSA.
[25]
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Figure 11. Changes in the observed longitudinal relaxation rates of water protons observed 
upon addition of HSA to solutions of the lipophilic [Mn(DPAHPhA)] (0.096 mM) and 
[Mn(DPADA)] (0.095 mM) complexes (25 ºC). The red lines represent the fit of the data to a 
1:1 binding isotherm. 
 
The analysis of the NMRD profiles recorded for the [Mn(DPAHPhA)] and [Mn(DPADA)] 
complexes fully bound to HSA (Figure 12) are characteristic of slowly tumbling species. The 
relaxivity of [Mn(DPADA)] at ca. 20 MHz and 25 ºC (45.5 mM-1 s-1) is close to those 
observed for HSA adducts of Mn
2+
 complexes containing benzyloxymethyl groups, while the 
relaxivity of [Mn(DPADA)] under the same conditions is much lower (15.5 mM
-1
 s
-1
). The 
analysis of the NMRD profiles using the Lipari-Szabo model (Table 3) clearly indicate that an 
increased local flexibility is responsible for the lower relaxivity of the adduct formed between 
[Mn(DPADA)] and HSA, as demonstrated by the lower values of τRL and S
2
. Thus, the alkyl 
C12 chain provides strong interactions with the protein, but its flexibility prevents attaining 
high relaxivities. 
 
 
81 
 
Figure 12. 
1
H NMRD profiles obtained at 25 ºC for the adducts formed by [Mn(DPADA)] 
and [Mn(DPAHPhA)] with HSA. The red lines represent the fit of the data above cmc using 
the Lipari-Szabo approach. 
 
Conclusions: 
We have characterized a new series of pentadentate ligands that contain a pentadentate 6,6'-
(azanediylbis(methylene))dipicolinic acid binding motif that can be easily functionalized with 
groups containing additional donor atoms or lipophilic chains. The hexadentate ligand 
DPAA
3-
 forms a Mn
2+
 complex with stability comparable to that of EDTA
4-
, although this 
decreases the hydration number of the complex from 2 to 1, which results in lower proton 
relaxivities. On the other hand, the pentadentate DPAPhA
2-
 and DPAMA
2-
 form bis-aquated 
Mn
2+
 complexes in solution. An interesting and unexpected result obtained in this study is the 
likely reduction of the hydration number upon incorporating aliphatic chains into the ligand 
scaffold. The lipophilic derivatives form rather stable adducts with HSA, particularly when 
incorporating a flexible dodecyl chain. However, the relaxivity of the bound form is partially 
quenched due to the contribution of relatively rapid local motions. 
These experimental results allow extending the number of Mn
2+
 systems that have been 
characterized in the search for alternative systems to the classical Gd
3+
-based MRI contrast 
agents. We have shown that the relaxivities of Mn
2+
 complexes can be modulated by changing 
the hydration number or introducing lipophilic units in the ligand scaffold, very much like in 
the case of Gd
3+
 complexes. The relaxivities of the adducts formed with HSA are also 
comparable to those attained with lipophilic Gd
3+
 agents 
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Experimental Section: 
 
Materials and Methods. All reagents and solvents were commercial and used without further 
purification. SiO2 (Fluka, pore size 60 Å, 70–230 mesh) was used for preparative column 
chromatography. 
1
H and 
13
C NMR spectra were recorded at 25ºC on Bruker Avance 300 MHz 
and Bruker Avance 500 MHz spectrometers. High resolution ESI-TOF mass spectra were 
recorded using a LC-Q-q-TOF Applied Biosystems QSTAR Elite spectrometer in the positive 
mode. Elemental analyses were carried out on a ThermoQuest Flash EA 1112 elemental 
analyser. IR spectra were recorded using a Bruker Vector 22 spectrophotometer equipped 
with a Golden Gate attenuated total reflectance (ATR) accessory (Specac). 
 
Equilibrium measurements. All the equilibrium measurements were conducted at a constant 
ionic strength maintained by 0.15 M NaCl at 298 K. For determining, the protonation 
constants of the ligands pH-potentiometric titrations were performed with 0.2 M NaOH using 
0.002 M ligand solutions. The stability and protonation constants of Mn
2+
 complexes were 
determined by pH-potentiometric titrations. The metals to ligand concentration ratios were 
1:1. For the calculation of the equilibrium constants the mL base – pH data were used, 
obtained in the pH range 1.7–12.0. The pH-potentiometric titrations were carried out using a 
785 DMP Titrino titration workstation with the use of a Metrohm- 6.0233.100 combined 
electrode. The titrated solution (8 mL) was thermostated at 25 °C. The samples were stirred 
and to avoid the effect of CO2, N2 gas was bubbled through the solutions. For the calibration 
of the pH meter, KH-phthalate (pH = 4.002) and borax (pH = 8.970) buffers were used. For 
the calculation of the H
+
 concentration from the measured pH values, the method proposed by 
Irving et al. was used. 
[26]
 A 0.01 M HCl (0.15 M NaCl) solution was titrated with the 0.2 M 
NaOH and the difference between the measured and calculated pH values were used to 
calculate [H
+
] from the pH values determined in the titration experiments. For the calculation 
of the equilibrium constants the PSEQUAD program was used.
[27]
 
 
1
H NMRD and 
17
O NMR Measurements. The proton 1/T1 NMRD profiles were measured 
on a fast field-cycling Stelar SmartTracer relaxometer (Mede, Pv, Italy) over a continuum of 
magnetic field strengths from 0.00024 to 0.25 T (corresponding to 0.01-10 MHz proton 
Larmor frequencies). The relaxometer operates under computer control with an absolute 
uncertainty in 1/T1 of ± 1%. The temperature control was carried out using a Stelar VTC-91 
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airflow heater equipped with a calibrated copper–constantan thermocouple (uncertainty of 
±0.1 K). Additional data points in the range 20-70 MHz were obtained on a Stelar 
Relaxometer equipped with a Bruker WP80 NMR electromagnet adapted to variable-field 
measurements (15-80 MHz proton Larmor frequency). The exact complex concentration was 
determined by the BMS shift method at 11.7 T. Relaxometric HSA titrations were performed 
on the Stelar Relaxometer at 0.47 T (20 MHz) and 25 °C on dilute aqueous solutions at 
neutral pH. 
17
O NMR measurements were recorded on a Bruker Avance III spectrometer 
(11.7 T) equipped with a 5 mm probe and standard temperature control unit. Aqueous solution 
of the complexes (ca. 6-10 mM) containing 2.0% of the 
17
O isotope (Cambridge Isotope) were 
used. The observed transverse relaxation rates were calculated from the signal width at half-
height. 
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Chapter 6  
 
Bisamide Derivative of 
[Mn(1,4-DO2A)] 
 
 
 
 
 
 
 
 
 
86 
Introduction: 
The number of publications on Mn
II
-based Magnetic Resonance Imaging (MRI) contrast 
agents (CAs) as an alternative to those based on Gd
III
 has dramatically increased in recent 
years.
[1,2]
 Several new chelators, open-chain or macrocyclic, with a variable number and 
typology of donor atoms have been proposed for the complexation of Mn
2+
 ions.
[3,4,5,6]
 Unlike 
Gd
III
-based contrast agents for which a large set of dissociation kinetic data is available,
[7] 
in 
the case of Mn
II
 complexes this important information is often lacking and studies are less 
systematic. It was recently shown that macrocyclic MnNOTA and MnDOTA chelates possess 
considerable kinetic inertia but, in both cases, the central metal ion lacks a water molecule in 
its inner coordination sphere (q = 0).
[8] 
For a water molecule to have access to the 
paramagnetic centre, the chelator should not have more than six donor atoms and this makes it 
more difficult the probe design. Studying the relationship between relaxometric properties of 
Mn
II
-chelates and their thermodynamic stabilities, M. Botta and co-workers have recently 
reported a detailed 
1
H and 
17
O NMR relaxometric and computational study on a series of Mn
II
 
complexes with cyclen-based (cyclen = 1,4,7,10-tetraazacyclododecane) ligands bearing one, 
two and three acetate pendant arms (DO1A, 1,4- and 1,7-DO2A, DO3A, respectively, Scheme 
1).
[9]
 While in aqueous solution Mn(DO3A) reproduces the behaviour of Mn(DOTA) and is a 
q = 0 complex, the Mn
II
 complex with the pentadentate DO1A contains one bound water 
molecule (q = 1). However, the most interesting result was that Mn(1,7-DO2A) is 
predominantly six-coordinate (q = 0) whereas Mn(1,4-DO2A) is present as a mixture of a 
seven- (ca. 87%) and six-coordinate species (ca. 13%) with one or no coordinated water 
molecule, respectively. Accordingly, the relaxivity of Mn(1,4-DO2A) is about 40% greater 
than that of Mn(1,7-DO2A). In order to obtain useful information about the coordination 
ability of different donor groups linked to the same macrocyclic scaffold, we decided to carry 
out the 1,4-substitution on cyclen with N,N-dimethylacetamide groups to obtain the 
hexadentate ligand 1,4-DO2AM (Scheme 1). The aim is the investigation of the differences in 
thermodynamic stability, kinetic inertness and 
1
H and 
17
O NMR relaxometric behaviour of the 
Mn
II
 complex as compared to the related carboxylate derivative Mn(1,4-DO2A). The main 
reason behind the choice of the N,N-dimethylacetamide pendant arms is the improved kinetic 
stability typically exhibited by Gd
III 
complexes with amide donor groups. In fact, it is well 
recognized that the replacement of acetate for amide donor groups slows down the rate of the 
dissociation reactions of the Ln-DOTA-like complexes.
[10,11]
 This property has been attributed 
to both the decreased negative charge of the complex which hinders the protonation and then 
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the acid-catalysed dissociation and to the low basicity of the amide oxygen atom which makes 
proton transfer to the ring nitrogen very unlikely.
[11]
 Moreover, the presence of neutral amide 
coordinating groups and the formation of a cationic Mn
II
 complex should impact its 
relaxometric properties.
[12]
 We are particularly interested in evaluating the water exchange 
rate (kex = 1/τM) of Mn(1,4-DO2AM) by 
17
O NMR techniques in order to ascertain the 
influence on this key parameter of the chemical nature of the donor group. Since the 
298
kex 
value of Mn(1,4-DO2A) is particularly high (1.1 × 109 s-1),[9] 2.4 times faster than that found 
for [Mn(EDTA)]
2-
, it is important to evaluate the effect of the amide coordination on kex. We 
report the synthesis of the bis-amide derivative of 1,4-DO2A and the equilibrium, kinetics and 
relaxometric properties of [Mn(1,4-DO2AM)]
2+
 in close comparison with those of the parent 
Mn(1,4-DO2A). 
 
 
Scheme 1. The structure of 1,4-DO2AM, 1,4-DO2A, 1,7-DO2A, DO3A and DOTA ligands 
discussed in this chapter. 
 
Synthesis: 
1,4-DO2AM was synthesised in one step starting from 1,4,7,10-tetraazacyclododecane 
(cyclen) following the same protocol used for the synthesis of 1,4-DO2A (Scheme 2).
[13]
 1.5 
equivalents of 2-chloro-N,N-dimethylacetamide were reacted with cyclen in CHCl3 in the 
presence of excess triethylamine. The final product was obtained in about 20% yield after 
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semi-preparative HPLC-MS purification and was characterized by ESI-MS spectrometry and 
1
H and 
13
C NMR spectroscopy. 
 
Scheme 2. Synthesis of 1,4-DO2AM 
Solution equilibrium studies: 
Protonation equilibria. The protonation constants of 1,4-DO2AM, defined by Eq. (1), were 
measured by pH-potentiometric titration and 
1
H-NMR spectroscopy in 0.1 M KCl aqueous 
solution.  
 
 Hi-1L  +   H
+
     HiL 
]L][Η[Η
L][Η
Κ
1i
iΗ
i 

           i=1, 2,…, 8.                                         (1) 
 
The protonation sequence of 1,4-DO2AM was determined by 
1
H-NMR spectroscopy, 
recording the chemical shift variations of the non-labile protons as a function of pH. The 
1
H-
NMR titration curves (Figure 1) display pronounced chemical shift changes over well-defined 
pH ranges. These are associated with the various protonation steps of the ligand. Because the 
protonation/deprotonation processes are fast on the NMR time scale, the chemical shifts of the 
observed signals represent a weighted average of the shifts of the different species involved in 
a specific protonation step (Eq. (2)):
[14]
  
 
          
LH
HiobsH
ix  )(                                                      (2) 
 
where H(obs) is the observed chemical shift of a given signal, xi and H(obs)
HiL
 are the molar 
fractions and the chemical shift of the involved species, respectively. The fitting of the data of 
Figure 1 according to Eq. (2) gave the results reported in Table 1, where the molar fractions xi 
and the concentration of the different protonated species are expressed in terms of the 
protonation constants Ki
H
.  
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In the 
1
H-NMR spectrum of 1,4-DO2AM at pH=9.6 (Figure 1), the protons of the acetamide 
arms give rise to three singlets (e, f, g), whereas relatively broad multiplets are associated with 
the methylene protons of the macrocyclic ring (a, b, c, d). The addition of one equivalent of 
acid to the deprotonated 1,4-DO2AM results in a downfield shift of the NMR signals 
corresponding to a, b, c, d and e, whereas the chemical shift of the N-methyl protons f and g 
slightly decreases in higher  pH range. The second protonation process causes the downfield 
shift of the peaks of e and ring protons (a-d), while the chemical shift values of f and g remain 
unchanged in the pH range 7.5 – 10. By considering the effects of the first and second 
protonation steps on the chemical shifts, we can safely assume that the first protonation occurs 
on the N1/N2 atoms of the macrocycle (the protonation involves partially both N-atoms). The 
second protonation takes place on the unsubstituted N3 (or N4) atom along with a shift of the 
former proton to afford a bis-protonated species on N1–N4 or N2–N3. This shift allows a better 
charge separation and is quite typical of DOTA- and DTPA-like ligands. The logKi
H
 values of 
1,4-DO2AM, 1,4-DO2A, 1,7-DO2A, DO3A and DOTA, are listed in Table 1. Standard 
deviations (3) are shown in parentheses. 
 
 
 
 
 
 
 
 
 
 
Figure 1. 
1
H-NMR spectra of 1,4-DO2AM (A) at 400 MHz and the chemical shifts of the 
different protons as a function of pH (B). (A: pH=9.6; B: a (●), b (), c (□), d (), e (),f 
(▲) and g (■), [1,4-DO2AM]=0.01 M, 0.1 M KCl, 25C).  
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Table 1. Protonation constants of 1,4-DO2AM, 1,4-DO2A, 1,7-DO2A, DO3A and DOTA at 
25C in 0.1 M KCl. 
 1,4-DO2AM 1,4-DO2A
[a]
 1,7-DO2A
[a]
 DO3A
[b]
 DOTA
[b]
 
I 0.1 M KCl 
Method pH-pot. 
1
H-NMR pH-pot. pH-pot. pH-pot. pH-pot. 
logK1 10.14(2) 10.34(9) 11.40 11.66 11.99 11.41 
logK2 8.38 (4) 8.64 (4) 9.58 9.75 9.51 9.83 
logK3 - - 3.74 4.06 4.30 4.38 
logK4 - - 1.65 1.78 3.63 4.63 
logK5 - - - - 1.84 1.92 
logK6 - - - - - 1.58 
logKi
H
 18.52 18.98 26.37 27.25 31.26 33.75 
          [a]Ref15. [b]Ref16 
Comparison of the protonation constants of 1,4-DO2AM with those of the related ligands 1,4-
DO2A, 1,7-DO2A, DO3A and DOTA indicates that the logK1
H
 and logK2
H
 values of 1,4-
DO2AM are lower by 1.5 logK unit. In general, the presence of an amide group in open-chain 
or macrocyclic amino-polycarboxylate ligands decreases the basicity of the amine N-
atoms.
[17,18]
 The lower protonation constants of 1,4-DO2AM can be explained by the 
replacement of the carboxylate pendant arms with the amide groups which form weaker H-
bond with the protonated ring nitrogens. The logKi
H
 value of 1,4-DO2AM is significantly 
lower than that of 1,4-DO2A, 1,7-DO2A, DO3A and DOTA due to the absence of protonable 
carboxylate groups. By taking into account the lower value of logKi
H
 for 1,4-DO2AM, a 
lower stability for the 1,4-DO2AM complexes compared to the related 1,4-DO2A, 1,7-DO2A, 
DO3A and DOTA complexes is to be expected. 
 
Complexation properties.  
The stability and protonation constants (KML and KMHiL, defined by Eqs. (3) and (4) with i=1, 
2, 3) characterizing the formation of 1,4-DO2AM, 1,4-DO2A and 1,7-DO2A complexes with 
Ca
2+
, Mn
2+
 and Zn
2+
 were calculated from the pH-potentiometric titration data obtained at 1:1 
metal to ligand concentration ratios (25 ºC, 0.1M KCl).  
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]][[
][
LM
ML
KML                                                                   (3) 
  
]][[
][
1



HLMH
LMH
K
i
i
LH i
    with i = 1, 2             (4) 
Moreover, the corresponding values of KML and KMHiL for the Cu
2+
 complexes were 
determined by UV-VIS spectrophotometry (Table 2). 
Table 2. The stability (logKML) and protonation (logKMHiL) constants of metal complexes 
formed with 1,4-DO2AM, 1,4-DO2A, 1,7-DO2A, DO3A and DOTA (0.1 M KCl, 25C). 
 1,4-DO2AM 1,4-DO2A
 
1,7-DO2A DO3A
[a] 
DOTA
[a] 
CaL  8.62 (3) 8.86 (5) 12.57 16.11 
CaHL - - - 4.60 3.67 
MnL 12.64 (5) 15.22 
[b] 
15.07 
[b] 
19.34 19.33 
MnHL - 4.15 (2) 4.48 (2) 3.69 4.09 
MnH2L - - - 3.02 3.70 
ZnL 15.59 (4) 18.03 (3) 18.86 (4) 21.57 20.21 
ZnHL  3.58 (4) 4.23 (2) 3.47 4.12 
ZnH2L  1.65 1.78 2.07 3.49 
CuL 21.38 (3) 24.43 (1) 24.24 (5) 25.75 24.83 
CuHL - 2.95 (3) 3.06 (6) 3.65 4.12 
CuH2L - - - 1.69 3.57 
CuH3L - - - - 0.87 
                          [a]Ref16. [b]Ref15 
We calculated of the equilibrium constants. The best fitting of the experimental data (volume 
of KOH added vs. pH) was obtained by assuming the formation of ML complexes with 1,4-
DO2AM and ML and MHL species with 1,4-DO2A and 1,7-DO2A. In the case of the Cu-
complexes, the equilibrium reaction (5) was investigated over the [H
+
] range 0.01 – 1.0 M 
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([H
+
]0.1 M; [H+]+[K+]=0.1 M), assuming the formation of Cu2+, CuL, CuHyL and HxL 
species (1,4-DO2AM: x=2, y=0; 1,4-DO2A, 1,7-DO2A: x=3, 4; y=0, 1).  
 
                 Cu
2+
 + HxL [Cu(HyL)] + (x-y)H
+
                      (5) 
 
Some characteristic absorption spectra and the species distribution of the Cu
2+
-1,4-DO2AM, 
Cu
2+
-1,4-DO2A and Cu
2+
-1,7-DO2A systems with the maxima of the absorption spectra (max 
values) are shown in Figures 2 and 3. Noteworthy, the metal complexes of 1,4-DO2AM show 
a significantly lower stability as compared to the corresponding complexes with 1,4-DO2A 
and 1,7-DO2A (logKML = 2.5 – 3.0). The difference with DO3A or DOTA complexes is 
even larger. A similar effect was reported for DOTA-tetramide complexes which are 
characterized by stability constants approxametly 6-7 logK units lower than those of the 
corresponding DOTA complexes.
[19]
 The lower stability constants of the 1,4-DO2AM metal 
complexes can be accounted for by the significantly lower basicity (logKi
H
) of the ring N-
atoms. 
 
Figure 2. Absorbtion spectra of Cu
2+–1,4-DO2AM (A), Cu2+–1,4-DO2A (B) and Cu2+–1,7-
DO2A systems ([Cu
2+
]=[1,4-DO2AM]=[1,4-DO2A]=[1,7-DO2A]=1.5 mM, [H
+
] = 1.0 M, 
0.60 M, 0.31 M, 0.10 M, 0.050 M, 0.025 M and 0.01 M, [H
+
]+[K
+
]=0.1 M in the last 4 
samples,  l=1 cm, 25 C). 
We determined the protonation constants of [Cu(1,4-DO2A)] and [Cu(1,7-DO2A)] by 
spectrophotometric titrations of the complexes in the pH range 1.7 – 6.0, in this pH range 
mono-protonated and deprotonated complexes are present. The species distribution diagram 
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and the maxima of the absorption spectra (max values) of Cu
2+
-1,4-DO2AM, Cu
2+
 - 1,4-
DO2A and Cu
2+
 - 1,7-DO2A systems are shown as functions of pH in Figure 3. 
 
Figure 3. Species distribution and the max values (♦) of Cu
2+
- 1,4-DO2AM (A), Cu
2+
- 1,4-
DO2A (B) and Cu
2+
 - 1,7-DO2A (C) system as a function of pH. ([Cu
2+
]=[1,4-DO2A]=[1,7-
DO2A]=1.0 mM, 0,1 M KCl, 25 C). 
 
Transmetallation kinetics: 
 
Because of the toxicity of free metal ions and ligands, the study of the dissociation kinetics of 
the metal complexes used in medical diagnosis and/or therapy has a great relevance since the 
products of the dissociation.
[7]
 Typically, the dissociation of MnDOTA-like complexes is very 
slow and occurs via proton-assisted pathways whereas the presence of endogenous metal ions 
like Zn
2+
 and Cu
2+
 has a minor influence on the dissociation rates.
[8,15]
 While the rates of the 
metal exchange reactions occurring between [Mn(1,4-DO2A)] and [Mn(1,7-DO2A)] and Zn
2+
 
and Cu
2+
 ions were previously investigated,
[3,4,5,6]
 in this work we studied the kinetic inertness 
of [Mn(1,4-DO2AM)] by focusing on the metal exchange reactions with high Zn
2+
 
concentrations (10 – 40 fold excess) in order to form pseudo-first order conditions (Eq. (6)). 
These reactions were followed by relaxometry at 20 MHz and 25C in the pH range 4.5 – 6.5.  
 
MnL  +   Zn
2+
    ZnL   +   Mn
2+
                                            (6) 
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As a pseudo-first-order process, the reaction rate is expressed by the Eq. (7) where kd is a 
pseudo-first-order rate constant, [MnL]t and [MnL]tot are the concentrations of the MnL 
species at time t and the total concentration of the complex, respectively. 
 
to td
t ]LnM[
dt
]LnM[d
k
                                       (7) 
 
The calculated pseudo-first order rate constants for the transmetallation reaction of [Mn(1,4-
DO2AM)]
2+
 and Zn
2+
 as a function of [H
+
] are shown in Figure 4. 
 
 
Figure 4. kd values of the transmetallation reactions between [Mn(1,4-DO2AM)]
2+
 and Zn
2+
 
([MnL]=1.0 mM, [Zn
2+
]=10 mM (), 20 mM (), 30 mM () and 40 mM (), 0.1 M KCl, 
25C) 
The dissociation rates of [Mn(1,4-DO2AM)]
2+
 are shown in Figure 4. The dissociatin rates are 
directly proportional to the H
+
 concentration and independent of the concentration of the 
exchanging Zn
2+
 ions. The increase in the kd values with increasing [H
+
] can be interpreted in 
terms of a rate determining step consisting of the proton assisted dissociation of [Mn(1,4-
DO2AM)]
2+
 followed by a fast reaction between the free ligand and the Zn
2+
 ion. The 
dependence of kd on [H
+
] can be expressed as a first-order function of [H
+
] which indicates 
that the exchange can take place by proton-independent (Eq. (8)) and proton assisted (Eq. (9)) 
pathways. 
MnL   Mn
2+
    +   H2L                                              (8) 
 
k0 
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MnL  +   H
+
     Mn
2+
    +   HxL                                   (9) 
 
k0 and k1 are the rate constants characterizing the dissociation of [Mn(1,4-DO2AM)]
2+
 
through spontaneous and proton-assisted reaction pathways, respectively. By considering all 
the possible pathways and the rate of transmetallation of [Mn(1,4-DO2AM)]
2+
 (Eq. (7)), the 
pseudo-first-order rate constant (kd) can be expressed by Eq. (10). 
 
      ]][[][
][
10
 HMnLkMnLk
dt
tMnLd
                                        (10) 
By taking into account the total concentration of the complex ([MnL]tot = [MnL]), the pseudo-
first-order rate constant (kd) can be expressed as follows:  
][10
 Hkkkd                                                    (11) 
The parameters k0 and k1 were calculated by fitting the experimental data in Figure 4 to Eq. 
(11). The rate constants characterizing the transmetallation reaction of [Mn(1,4-DO2AM)]
2+
 
with Zn
2+
 and the half-life of dissociation (t1/2 = ln2/kd) of the complex calculated at pH=7.4 
are listed in Table 3 and compared with the corresponding values reported for Mn(1,4-
DO2A), Mn(1,7-DO2A) and Mn(DOTA). 
 
Table 3. Rate constants and half-lives for the dissociation reactions of [Mn(1,4-DO2AM)]
2+
, 
[Mn(1,4-DO2A)],  [Mn(1,7-DO2A)] and [Mn(DOTA)]
2-
 (pH=7.4; 0.1 M KCl; 25C). 
 1,4-DO2AM 1,4-DO2A
[a] 
1,7-DO2A
[a] 
DOTA
[b] 
k0 (s
-1
) - - - 1.8x10
-7 
k1 (M
-1
s
-1
) 8.7±0.5 99 84 0.04 
k2 (M
-2
s
-1
) - 1.5x10
6 
2.5x10
6
 1.6x10
3
 
logKMnLH - 4.15 4.48 4.26 
kd (s
-1
) pH=7.4 3.5x10
-7 
3.9x10
-6 
3.3x10
-6 
2.6x10
-6 
t1/2 (h) pH=7.4 556 49.4 58.3 1070 
                  [a] Ref 15. [b] Ref 8 
The rate constant k0 is very small and the associated error is relatively large, to suggest that 
the spontaneous dissociation of [Mn(1,4-DO2AM)] does not give a sizeable contribution to 
the transmetallation reaction. The data presented in Table 3 also show that the k1 value, i.e. 
k1 
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the rate of proton-assisted dissociation of [Mn(1,4-DO2AM)], is one order of magnitude 
lower than that of [Mn(1,4-DO2A)] or [Mn(1,7-DO2A)]. In the latter complexes, most likely 
the dissociation occurs by protonation at one of the carboxylate groups. After that the proton 
is transferred to the ring nitrogen forcing the release of Mn
2+
 from the coordination cavity. 
The replacement of the protonable carboxylate groups with non-protonable amide groups does 
not allow the formation of the protonated MnHL intermediate. Thus, it can be assumed that 
the proton assisted dissociation of [Mn(1,4DO2AM)]
2+
 takes place by protonation of the ring 
N-atom followed by dissociation of the Mn
2+
 ion. Finally, the half-life (t1/2) of dissociation of 
[Mn(1,4-DO2AM)]
2+
 is ca. 50% lower than that measured for [Mn(DOTA)]
2-
 and 
significantly higher than those reported for of [Mn(1,4-DO2A)] or [Mn(1,7-DO2A)]. Notably, 
in acidic condition the dissociation reaction of [Gd(DOTA)]
-
 takes place more than 5 times 
faster than for [Gd(DOTTA)]
3+
 (DOTTA = 1,4,7,10-tetrakis[(N,N-
dimethylcarbamoyl)methyl]-1,4,7,10-tetraazacyclododecane] ([Gd(DOTA)]
-
: t1/2 = 68 h; 
[Gd(DOTTA)]
3+
: t1/2 = 384 h;  [HNO3] = 2.5 M, 25°C), which clearly confirms that the 
replacement of acetate with bismethyl-amide groups improves the kinetic inertness of the 
metal-complexes with DOTA-like ligands.
[10]
 
 
1
H and 
17
O NMR relaxometric studies: 
 
We performed the measurmnet of the proton relaxivity of [Mn(1,4-DO2AM)]
2+
 as a function 
of pH, temperature and magnetic field strength. Together, this information allows to obtain a 
comprehensive picture of the relaxometric properties the complex and to understand the 
changes in the molecular parameters following the transformation of the carboxyl groups into 
amide groups. At neutral pH and 25°C, the measurement of r1p at 60 MHz provides the value 
of 2.2 mM
-1
 s
-1
, which compares well with the corresponding value for [Mn(1,4-DO2A)], 
namely 2.0 mM
-1
 s
-1
.
[9]
 These values are roughly intermediates between that associated with a 
q = 1 complex ([Mn(EDTA)]
2-
) and that of a complex without water molecules in the first 
coordination sphere (q = 0; [Mn(1,7-DO2A)]) (Figure 5). The small difference between the 
values of r1p of [Mn(1,4-DO2A)] and [Mn(1,4-DO2AM)]
2+
 can be attributed to the small 
difference in their molecular masses that dictates the value of the rotational correlation time. 
Therefore, these findings suggest that [Mn(1,4-DO2AM)]
2+
 in aqueous solution shows a 
behaviour very similar to [Mn(1,4-DO2A)], which is characterized by the presence of a 
hydration equilibrium involving q = 1 and q = 0 complex species. In our previous study we 
estimated an "effective" q value of 0.87 (± 0.01) for [Mn(1,4-DO2A)].[9] In the absence of 
further experimental evidence, we attribute the same value also to [Mn(1,4-DO2AM)]
2+
. 
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Figure 5. Plot of the 
1
H relaxivity, r1p, for selected Mn(II) complexes at 20 and 60 MHz and 298 K. 
The behaviour of r1p with pH reproduces quite closely the main features found for [Mn(1,4-
DO2A)] and [Mn(1,7-DO2A)].
[9] 
The relaxivity is constant over the pH range 12 to 6, where 
complete formation of the metal complex occurs, then it increases rather sharply to reach a 
new plateau at pH lower than ca. 3. Such an increase is clearly associated with the progressive 
release of the Mn(II) ion as a result of the protonation of the basic sites of the chelator. The 
lower stability of [Mn(1,4-DO2AM)]
2+ 
is reflected in the slightly higher pH value in which 
the increase of r1p begins. The pH dependence of the relaxivity is reported in Figure 6, 
together with the species distribution diagram for the Mn
2+
/1,4-DO2AM system. 
 
 
Figure 6. Plot of 
1
H relaxivity r1p at 20 MHz and 298 K for [Mn(1,4-DO2AM)]
2+
 and the 
species distribution diagram of the Mn
2+
/1,4-DO2AM system as a function of pH ([Mn
2+
] = 
[1,4-DO2AM] = 1 × 10−3 M, [KCl] = 0.1 M, 20 MHz, 25 °C). 
The (NMRD) profile, has been measured at 283, 298 and 310 K over the proton Larmor 
frequency range 0.01-70 MHz, corresponding to magnetic field strengths varying between 
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2.34310-4 T and 1.645 T (Figure 7A). The profiles have the typical shape of rapidly 
tumbling, low molecular weight complexes, featuring a region of constant relaxivity at low 
fields, a single dispersion around 6-8 MHz and another plateau, not well defined, in the region 
at high fields (> 20 MHz).
[20] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. (A) 1/T1 
1
H NMRD profiles for [Mn(1,4-DO2A)]
2+
 at pH = 7.2 and 283 K (blue 
squares); 298 K (black circles); 310 K (red triangles). The solid lines represent the results of 
the best fitting to the experimental data (Table 3). Temperature dependence of the reduced 
water 
17
O NMR transverse relaxation rates (B) and chemical shifts (C) at 11.75 T and pH = 
7.2 for a 4.8 mM solution. 
The relaxivity decreases by increasing temperature over the entire frequency range, which 
indicates that water exchange (kex = 1/M) in and out of the coordination site does not 
represent a limiting factor. Rather, the fast rotation of the complex in solution determines and 
controls the value of the relaxivity. This is clearly shown by the temperature dependence of 
A B 
C 
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r1p at 20 MHz over the range 280 - 341 K. At neutral pH, the relaxivity of the complex 
increases exponentially with lowering temperature (Figure 8), following the behaviour of 
systems in the fast-exchange regime (the exchange lifetime, M, is much shorter than the 
longitudinal relaxation time of the bound water protons, T1M), such as the Mn(II) complexes 
of AAZTA-like ligands.
[21]
  
Detailed information on the water exchange kinetics is obtained by measuring and analysing 
the temperature dependence of the 
17
O NMR transverse relaxation rate (R2) and paramagnetic 
shift (Δω) (Figure 7B and C).[20] The data were collected at 14.1 T on a 4.8 mM solution of 
the complex at neutral pH and analysed according to the well-established set of Swift-
Connick equations.
[22]
 The reduced R2 (1/T2r) and Δω values are reported in Figure7B and 
%C, respectively. The increase of 1/T2r with decreasing temperature over a wide range of 
values indicates the occurrence of a relatively fast rate of water exchange, as for 
[Mn(EDTA)]
2-
.
[9]
  
The relaxometric data, 
1
H NMRD and 
17
O NMR, were fitted simultaneously according to the 
established theory of paramagnetic relaxation expressed in terms of the well known Solomon-
Bloembergen-Morgan
[23] and Freed’s[24] equations for the inner- (IS) and outer sphere (OS) 
proton relaxation mechanisms, respectively, and of the Swift-Connick theory for 
17
O 
relaxation. The IS contribution to r1p is determined by the number q of bound water molecules 
and their rate of exchange (kex), the molecular rotational correlation time (R), and the 
electronic relaxation times (T1,2e) of Mn
II
.
[17]
 The OS term depends on T1,2e, the relative 
diffusion coefficient between the complex and the water molecules (D) and their distance of 
closest approach, a. The Swift-Connick equations depend on a number of parameters, among 
which the most relevant are:
[22]
 i) those associated with T1,2e, i.e. the trace of the square of the 
zero-field splitting tensor, 2; the correlation time describing the modulation of the zero-field 
splitting, V, and its activation energy, EV; ii) the enthalpy, H
#
, of activation for the water 
exchange process; iii) the hyperfine Mn-
17
Owater coupling constant, A/ħ. Given the large 
number of parameters, we need to fix the value of some of them according to reasonable 
estimates: q was fixed to 0.87; the distance between the metal ion and the protons of the 
bound water molecule, r, was fixed to 2.83 Å; a and D were set to 3.6 Å and 2.3×10-5 cm2 s-1 
(at 25°C), respectively; EV was fixed to 1.0 kJ mol
-1
. To ER (activation energy for the 
rotational motion of the complex) and ED (activation energy of D) were assigned the same 
values found for [Mn(1,4-DO2A)]: 19.1 and 17.3 kJ mol
-1
, respectively. The relevant best-fit 
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parameters are listed in Table 4 and compared with those of related Mn(II) complexes of 
similar size. 
270 280 290 300 310 320 330 340 350
0
1
2
3
4
5
r 1
 /
 m
M
 -
1
 s
 -
1
T / K
 
Figure 8. Temperature dependence of the longitudinal water proton relaxivity at 20 MHz and 
pH = 7 
 
Table 4. Parameters obtained from the simultaneous analysis of 
1
H NMRD profiles and 
17
O 
NMR data (14.1 T) for the Mn
2+
 complexes of 1,4-DO2AM and related ligands 
Parameters 1,4-DO2AM
 1,4-DO2A
[9] 
DO1A
[9] 
EDTA
[9] 
r1/mM
-1
s
-1
 2.5 2.1 2.4 3.3 
298
kex /×10
6
 s
-1
 111 ± 6 1134 5957 471 
2 /×1019 s-2 51 ± 8 48.1 12.8 6.9 
298V / ps 5.5 ± 0.2 4.4 13.9 27.9 
298R / ps 53 ± 3 46 22 57 
ΔH#/kJ mol-1 39.8 ± 0.7 29.4 17.6 33.5 
A/ħ/106 rad s-1 39.0 ± 0.4 43.0 39.4 40.5 
q 0.87 0.87 1 1 
rMn–H / Å 2.83 2.83 2.83 2.83 
 
 
The electron relaxation parameters, 2 and V, are nearly identical for the both hexadentate 
macrocyclic complexes and this is indicative of quite similar solution structures, as expected. 
The rotational correlation time is slightly longer, about 15%, for [Mn(1,4-DO2AM)]
2+ 
and in 
perfect agreement with its larger molecular weight. This result confirms the dominant role of 
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the rotational dynamics in determining the relaxivity of the small metal chelates at high 
magnetic field strengths. Then, the difference in the r1p values between the two chelates is 
fully accounted for by their different R values. In the case of [Mn(EDTA)]
2- 
the higher values 
of both R and q are responsible of the higher r1p.
[9] 
The rate of water exchange is markedly lower, about one order of magnitude, thus 
representing the parameter most influenced by the nature of the donor groups. Accordingly, 
the enthalpy of activation is sensibly higher. For Gd(III) chelates the replacement of 
carboxylates with amides results in slower rates of water exchange due to a combination of 
lower steric encumbrance, decreased electron density at the metal centre and reduced overall 
negative charge of the complexes.
[7,10,25]
 Likewise, these factors seem to play a significant role 
also for the Mn(II) chelates, being the magnitude of the resulting effect quite comparable.  
 
Dynamic NMR study: 
Some insights into the structural and dynamic properties of [Zn(1,4-DO2AM)]
2+
, as a 
diamagnetic analogue of [Mn(1,4-DO2AM)]
2+
, have been investigated by 
1
H-NMR 
spectroscopy in aqueous solution. The solution structure of [Zn(1,4-DO2AM)]
2+
 is expected 
to be similar to that of the corresponding [Mn(1,4-DO2A)], investigated at the solid state by 
X-ray diffraction method and in solution by density functional theory (DFT) calculations.
[9,26]
 
Crystallographic data reveal the formation of a dimeric [Mn(1,4-DO2A)]2 complex in which 
the coordination geometry around each Mn(II) ion can be described as a distorted 
monocapped trigonal prism where the two triangular faces, formed by two ring N- and the 
carboxylate O-atoms, are nearly parallel (distortion angle is 1.8) and the capping positions 
are occupied by two bridging carboxylate O donor atoms.
[26]
 The optimized geometries of the 
complexes [Mn(1,4-DO2A)] and [Mn(1,4-DO2A)(H2O)] obtained from DFT calculations 
highly resemble that found in the solid state: a trigonal prism and a monocapped trigonal 
prism, respectively, comprised of two parallel (distortion angle is 5.4) triangular faces 
defined by two ring N- and the carboxylate O-atoms.
[9]
  
We assume that the predominant species in solution of [Zn(1,4-DO2AM)]
2+
 corresponds 
closely to that of [Mn(1,4-DO2A)]. In the 
1
H-NMR spectra of [Zn(1,4-DO2AM)]
2+
 obtained 
at 273 K, the signals associated with the protons of the cyclen ring give rise to unresolved 
multiplets, whereas an AB multiplet (-CH2-) and two singlets (-CH3) are attributed to the 
protons of the acetamide pendant arms. By increasing temperature, the bands of the AB 
multiplet broaden, coalesce (T = 288 K) and then merge into a single resonance (Figure 9). 
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This fluxional behaviour is likely to be associated with the processes of de-coordination and 
rotation of the acetamide arms (Scheme 3).  
 
 
 
 
 
 
 
 
 
Figure 9. Experimental (left) and calculated (right) 
1
H-NMR spectra (400 MHz) of the e 
protons in [Zn(1,4-DO2AM)]
2+
 as a function of temperature. 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Arms rotation process in [Zn(1,4-DO2AM)]
2+ 
 
A complete line-shape analysis allows extracting the kinetic parameters of the dynamic 
process. The proton NMR spectral data were collected at eighteen different values of 
temperature, in the range 273-343 K (Figure 9). The limiting value of the transverse 
relaxation time (T2) has been calculated from the line width of the g and f proton signals at 
 
103 
273 K (T2 = 0.07 s), because of its temperature independence below 283 K. In the simulation a 
chemical shift difference, n°, between the e protons signals of 61.8 Hz was considered. 
From the temperature dependence of the calculated rate constants (kex=1/) characterizing the 
dynamic process the activation parameters were assessed using the Eyring equation (Figure 
10). The activation parameters for [Zn(1,4-DO2AM)]
2+
 are listed in Table 5. 
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Figure 10. Eyring plots for determining the activation parameters of the de-coordination and 
the arm rotation processes in [Zn(1,4-DO2AM)]
2+ 
 
Table 5. Rate constant and activation parameters for the de-coordination and arm rotation 
processes of [Zn(1,4-DO2AM)]
2+
 obtained from the line-shape analysis of the 1H-NMR 
spectra. 
 [Zn(1,4-DO2AM)]
2+ 
H / kJ·mol-1 54.4 (8) 
S / J·mol-1K-1 -14 (2) 
G298 / kJ·mol-1 50.2 (8) 
k
298
 / s
-1
 328 (5) 
 
 
The value of G298 is markedly lower than that found (G298 = 68.2 kJ mol-1) for the 
racemisation processes of the terminal N atoms in [Lu(DTPA-bis-propylamide)], in spite of a 
higher H value.[17] This suggests that the dynamic process occurring in [Zn(1,4-DO2AM)]2+ 
might require the concerted inversion of the macrocyclic ring, which is typically characterized 
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by high activation enthalpies. For example, in LnDOTA-like complexes H  values are ca. 
59 – 69 kJ·mol-1.[25] 
 
Conclusions: 
The replacement of two negatively charged acetate groups with neutral acetamide arms has a 
marked influence on the solution properties of the corresponding Mn
II
 chelates. The 
thermodynamic stability decreases by about 2.5 logKML units because of the lower basicity of 
the nitrogen atoms of the macrocyclic ring. On the other hand, the kinetic inertness of the 
cationic complex [Mn(1,4-DO2AM)]
2+
 is significantly greater than that of the related 
carboxylates analogues. The half-life for dissociation is ca. one order of magnitude longer 
than that measured for [Mn(1,4-DO2A)] and [Mn(1,7-DO2A)]. 
The relaxometric properties are only marginally influenced by the chemical modification of 
the ligand, with the exception of the rate of water exchange which decreases by more than one 
order of magnitude with respect to the value found for [Mn(1,4-DO2A)]. This effect is well 
known and documented in the case of Gd
III
 chelates. The relevant difference is that in the case 
of the Mn
II
 complexes examined in the present work the kex values never assume values as 
short as to limit the relaxivity. So, improved kinetic inertness of Mn
II
 chelates can be attained 
without a negative impact on the relaxivity. Clearly, a further effort is necessary to combine 
elevated kinetic inertness and relaxivity with high thermodynamic stability. 
Experimental Section: 
General: All chemicals were purchased from Sigma-Aldrich Co. and were used without 
further purification. The concentration of the MnCl2, ZnCl2, CaCl2 and CuCl2 solutions were 
determined by complexometric titration with standardized Na2H2EDTA and xylenol orange 
(ZnCl2), murexid (CuCl2), Patton-Reader (CaCl2) and Eriochrome Black T (MnCl2) as 
indicators.  The concentration of the 1,4-DO2AM, 1,4-H2DO2A
[10]
 and 1,7-H2DO2A
[24]
 was 
determined by pH-potentiometric titration in the presence and absence of a 50 fold excess of 
CaCl2. The pH-potentiometric titrations were made with standardized 0.2 M KOH solution. 
1
H and 
13
C NMR spectra were recorded on a Bruker DRX 400 (9.39 T) and Bruker Avance III 
(11.74 T) spectrometers. Chemical shifts are reported relative to TMS and were referenced 
using the residual proton solvent resonances. Electrospray ionization mass spectra (ESI MS) 
were recorded on an SQD 3100 Mass Detector (Waters), operating in positive or negative ion 
mode, with 1% v/v HCOOH in methanol as the carrier solvent. HPLC analyses were carried 
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out on a 1525EF Waters liquid chromatograph equipped with Waters 2489 UV/vis and Waters 
SQD 3100 MS detectors and using a Waters Atlantis® T3 RPC18 column (150 mm × 4.6 
mm, 5 μm). Preparative HPLC separations were carried out using a Waters Atlantis® T3 OBD 
RPC18 column (100 mm × 19 mm, 5 μm) and a Waters FCIII fraction collector.  
Synthesis of DO2AM: Cyclen (0.3 g, 1.7 mmol) was dissolved in CHCl3 (15 mL) and 
triethylamine (10 eq., 2.42 mL, 17.5 mmol) was added. Then, 2-chloro-N,N-
dimethylacetamide (1.5 eq., 0.488 g, 2.6 mmol) dissolved in CHCl3 (5 mL) was added 
dropwise to the solution over a period of 4 hours. After stirring overnight at room 
temperature, the solvent was removed using a rotary evaporator. The solid product was 
dissolved in CH2Cl2 (20 mL) and washed with water (3 x 15 mL). Finally, the aqueous phase 
was washed with CH2Cl2 (3 x 15 mL). The resulting aqueous solution was dried and the crude 
product was then purified by semi-preparative HPLC-MS (Solvent A: H2O TFA 0.1%; 
Solvent B: MeOH; 0-2 min 5% B then gradient 5-40% B in 7 min; Flow 20 mL/min; retention 
time: 4.6 min) to obtain 90 mg of a pale yellow oil (0.26 mmol, 20.2% yield). Analytical 
HPLC: (Solvent A: H2O TFA 0.1%; Solvent B: MeOH; 0-1 min 5% B then gradient 5-100% 
B in 19 min; flow 1 mL/min; retention time: 6.35 min). ESI-MS (m/z): found 343.3 [M + H
+
] 
(calc. for C16H35N6O2: 343.5). 
1
H-NMR  (D2O, 500 MHz): δ 3.81 (s, CH2CO, 4H), 3.18-3.05 
(m, NCH2 ring, 16H), 2.88 and 2.86 (s, NCH3, 12H); 
13
C-NMR (D2O, 125 MHz): δ 169.8 
(C=O), 55.9 (CH2), 55.5 (CH2), 53.3 (CH2), 44.5 (CH2), 43.3 (CH2), 37.4 (CH3), 37.0 (CH3). 
Equilibrium measurements: The protonation constants of 1,4-DO2AM, the stability and 
protonation constants of the Mn
2+
-, Ca
2+
-, Zn
2+
- and Cu
2+
-complexes formed with the 1,4-
DO2AM, 1,4-DO2A and 1,4-DO2A ligands have been determined by pH-potentiometry and 
UV-VIS-spectrophotometry. The pH-potentiometic titrations were performed at 1:1 metal-to-
ligand concentration ratio (the concentration of the ligand was generally 0.002 M). In 
calculating the equilibrium constants, the best fitting of the 80-150 mL NaOH – pH and mL 
KOH - pH data pairs have been obtained by assuming the formation of ML and MHL 
complexes in the pH range of 1.7-12.0. The equilibrium constants were calculated with the 
program PSEQUAD.
[27]
 For the pH measurements and titrations, a Methrohm 888 Titrando 
titration workstation and a Metrohm 6.0233.100 combined electrode were used. Equilibrium 
measurements were carried out at a constant ionic strength (0.1 M KCl) in 6 mL samples at 25 
C. The solutions were stirred, and N2 was bubbled through them. The titrations were made in 
the pH range of 1.7-12.0. KH-phthalate (pH=4.005) and borax (pH=9.177) buffers were used 
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to calibrate the pH meter. For the calculation of [H
+
] from the measured pH values, the 
method proposed by Irving et al. was used.
[28]
 A 0.01M HCl solution was titrated with the 
standardized KOH solution in the presence of 0.1 M KCl ionic strength, respectively. The 
differences between the measured (pHread) and calculated pH (-log[H
+
]) values were used to 
obtain the equilibrium H
+
 concentration from the pH values, measured in the titration 
experiments. The ion product of water was determined from the same titrations (HCl/KOH) in 
the pH range of 11.5-12.0.The stability constants of [Cu(1,4-DO2AM)]
2+
, [Cu(1,4-DO2A)] 
and [Cu(1,7-DO2A)] have been determined by VIS-spectrophotomtry studying the Cu
2+
 - 1,4-
DO2AM, Cu
2+
 - 1,4-DO2A and Cu
2+
 - 1,7-DO2A systems at the absorption band of Cu
2+
 
complexes in the [H
+
] range 0.01 – 1.0 M. For these experiments 7 samples were prepared 
(73 mL) in which the concentration of Cu2+ and ligands was identical ([Cu2+]=[L]=2.0 mM). 
The total H
+
 concentration was adjusted by addition of calculated amount of 2.0M HCl 
([H
+
]0.1 M, [H+]+[K+]=0.1 M). The samples were kept at 25C for a week. The absorbance 
values of the samples were determined at 11 wavelengths (575, 595, 615, 635, 655, 675, 695, 
715, 735, 755 and 775 nm). For the calculations of the stability and protonation constants of 
the [Cu(1,4-DO2AM)]
2+
, [Cu(1,4-DO2A)] and [Cu(1,7-DO2A)], the molar absorptivities of 
Cu
2+
, CuL and CuHL species were determined by recording the spectra of 1.5 mM, 3.0 mM 
and 5.0 mM solutions of CuCl2, [Cu(1,4-DO2AM)]
2+
, [Cu(1,4-DO2A)] and [Cu(1,7-DO2A)] 
in the pH range 1.5 – 6.5 (0.1M KCl, 25°C). The protonation constants of [Cu(1,4-DO2A)] 
and [Cu(1,7-DO2A)] complexes were also determined by pH-potentiometric titrations at 1:1 
metal-to-ligand concentration ratio. The spectrophotometric experiments were performed with 
a Cary 1E spectrophotometer in a 1 cm quartz cuvette at 25C. 
Kinetic studies: The rates of the metal exchange reactions of [Mn(1,4-DO2AM)]
2+
 with Zn
2+
 
was followed by measuring the water proton relaxation rates (1/T1) of the samples with a 
Bruker MQ20 Minispec spectrometer owing to the large differences in the relaxivities of 
[Mn(1,4-DO2AM)]
2+
 (r1p=2.51 mM
-1
s
-1
) and that of free Mn
2+
 (r1p=8.0 mM
-1
s
-1
) at 20 MHz 
and 25 C. The longitudinal relaxation times were measured by the ‘inversion recovery’ 
method (180 - - 90) by using 8 different  values. The measurements were made with 2.0 
mM [Mn(1,4-DO2AM)]
2+
 solution in the presence of 10 to 40 fold excess of Zn
2+
. The 
temperature was maintained at 25 C and the ionic strength of the solutions was kept constant 
(0.15 M NaCl and 0.1 M KCl). For keeping the pH values constant, N-methylpiperazine (pH 
range of 4.1 – 5.2) and piperazine (pH range of 4.7 – 6.6) buffers (0.01 M) were used. The 
pseudo-first-order rate constants (kd) were calculated with the use of the Eq. (12) 
 
107 
 
                                                   
e
1
e
1
0
1
t
1
RRRR   tde k)(                                                   (12) 
 
where R1
0
, R1
t
, and R1
e
 are the relaxation rate (1/T1) values at the start, at time t, and at 
equilibrium of the reactions, respectively. The calculations were performed using the 
computer program Micromath Scientist, version 2.0 (Salt Lake City, UT, USA). 
NMR measurements: 
1
H-NMR measurements were performed by a Bruker DRX 400 
spectrometer (9.4 T) equipped with Bruker VT-1000 thermocontroller and a BB inverse z 
gradient probe (5mm). The protonation processes of the 1,4-DO2AM ligand were followed by 
1
H- NMR spectroscopy. A 0.01 M solution of the ligand in H2O was prepared for these 
experiments (D2O was added to the samples in capillary). The pH was adjusted by stepwise 
addition of KOH and/or HCl solutions (both prepared in H2O). The structural behaviour and 
the dynamic processes of the [Zn(1,4-DO2AM)]
2+
 complexes were followed by 1D (
1
H and 
13
C) and 2D (COSY, NOESY and HSQC) NMR spectroscopy. In 
13
C-NMR spectroscopy 
proton decoupling was used with an inverse gated decoupling pulse program. The [Zn(1,4-
DO2AM)]
2+
 complexes were prepared in D2O ([ZnL]=0.01 M, pD=7.4). The COSY, 
NOESY, HSQC and HMBC spectra were collected by using gradient pulses in the z direction 
with the standard Bruker pulse programs. For NOESY spectra the mixing time (D8) was 300 
ms. Spectra were analysed with Bruker WinNMR software package. 
1
H and 
17
O NMR relaxometric measurements: The proton 1/T1 NMRD profiles of [Mn(1,4-
DO2AM)]
2+
 aqueous solutions ([MnL] ~ 1.0 mM) were measured on a fast field-cycling 
Stelar SmartTracer relaxometer over a continuum of magnetic field strengths from 0.00024 to 
0.25 T (corresponding to 0.01-10 MHz proton Larmor frequencies). Additional data points in 
the range 15-70 MHz were obtained on a Bruker WP80 NMR electromagnet adapted to 
variable-field measurements (15-80 MHz proton Larmor frequency) Stelar Relaxometer. 
Variable-temperature 
17
O NMR measurements were recorded on a Bruker Avance III (11.7 T) 
spectrometer equipped with a 5 mm probe and standard temperature control units. Aqueous 
solution of the [Mn(1,4-DO2AM)]
2+
 complex (~5 mM) containing 2.0% of the 
17
O isotope 
(Cambridge Isotope) were used. The observed transverse relaxation rates were calculated 
from the signal width at half-height. 
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Chapter 7 
 
Hexadentate Macrocyclic 
Ligands for Mn(II) 
Complexation 
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Introduction: 
Many ligands based upon 1,4,7,10-tetraazacyclododecane (cyclen) and containing different 
types and numbers of pendant coordinating functionalities were investigated in the last 
decades, due to several successful applications of their metal complexes.
[1]
 For example, 
lanthanide complexes of such ligands have proved useful as magnetic resonance imaging 
(MRI) contrast agents, 
[2]
 NMR shift reagents,
[3]
 in vivo temperature reporters,
[4]
 and catalysts 
in RNA cleavage.
[5]
 The properties of these complexes are mainly connected with the 
chemical properties and number of pendant groups. The acetic acid group (-CH2CO2H) is 
probably the most common functionality, since cyclen-based ligands containing similar 
groups form metal complexes characterized by high thermodynamic stability and marked 
kinetic inertness towards dissociation, hence favouring their use for in vivo applications.
[6]
 
The formation of manganese(II) complexes with polyaminopolycarboxylic ligands based 
upon 1,4,7,10-tetraazacyclododecane (cyclen) has been studied in aqueous solution by means 
of potentiometric and microcalorimetric techniques affording logK, ∆H° and T∆S° values for 
the complexation reactions. The ML complexes present high stability constants, due to both 
favourable enthalpic and entropic contributions; with the unique exception of DOTA 
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), the entropic term is prevalent. The 
1,4-DO2A (1,4,7,10-tetraazacyclododecane-1,4-diacetic acid) forms a more stable complex 
than the 1,7-DO2A isomer.
[7] 
In this chapter we discuss two newly synthesized ligands and we investigate in detail their 
Mn(II) complexes. We performed thermodynamic, kinetic studies and we report their ability 
to enhance water (
1
H and 
17
O) relaxation times. Our plan was to synthesize two new ligands 
maintaining the thermodynamic and kinetic stability properties of the [Mn(1,4-DO2AM)]
2+
 
(Chapter 6), while increasing its relaxivity by suitable modification of the molecular structure. 
We have introduced two benzyl groups either on the amino groups of cyclen (1,4-BzDO2AM) 
or on the two acetamide pendant arms (1,4-DO2AMBz). The presence of two hydrophobic 
moieties favors the formation of adducts with Human Serum Albumin (HSA)
[8]
 through non-
covalent interactions. We know that such macromolecular adducts are characterized by large 
enhancement in the relaxivity thanks to the reduced rotational tumbling in solution.
[1a]
 Of 
course we need to make sure the chemical modification does not change the hydration state of 
the complexes (q). 
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Scheme 1. The structure of the ligands 1,4-DO2AMBz, 1,4-DO2AM, 1,4-BzDO2AM, 1,4-
DO2A, DOTA and 1,7-DO2A, discussed in this chapter. 
 
Synthesis: 
The 1,4-DO2AMBz was synthesized in a two-step reaction. First, the sidearm was 
synthesized from 2-bromoacetyl bromide and benzyl amine 
[9]
, after that, the sidearm was 
added to cyclen. The final product was obtained in about 20% yield after semi preparative 
HPLC-MS purification and was characterized by ESI-MS spectrometry and 
1
H and 
13
C NMR 
spectroscopy. The 1,4-BzDO2AM was synthesized starting from 1,4,7,10- 
tetraazacyclododecane (cyclen) following the same protocol used for the synthesis of 1,4-
dibenzyl-1,4,8,11-tetraazacyclotetradecane 
[10]
, after that the intermediates and N,N-dimethyl 
2-chloroacetamides reaction led to the final product in about 20% yield. 
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Scheme 2. Synthesis of 1,4-DO2AMBz 
 
 
Scheme 3. Synthesis of 1,4-BzDO2AM 
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Solution equilibrium studies: 
Protonation equilibria. The protonation constants of 1,4-DO2AMBz and 1,4-BzDO2AM 
ligands, defined by Eq. (1), were determined by pH-potentiometry in 0.1 M KCl aqueous 
solution. The logKi
H
 values of 1,4-DO2AMBz and 1,4-BzDO2AM ligands are listed and 
compared with those of 1,4-DO2AM, 1,4-DO2A, 1,7-DO2A, DO3A and DOTA in Table 1. 
Standard deviations (3) are shown in parentheses. 
 
 Hi-1L  +   H
+
     HiL 
]L][Η[Η
L][Η
Κ
1i
iΗ
i 

           i=1, 2,…, 8.                                         (1) 
 
 
The protonation scheme of DO2AM ligand is well known and it has been fully characterized 
with both 
1
H-NMR
 
spectroscopy and pH-potentiometry methods.
 
Because of the similarities 
of 1,4-BzDO2AM, 1,4-DO2AMBz and 1,4-DO2AM, we may assume that the first 
protonation occurs on the N1/N2 atoms of the macrocycle (the protonation involves partially 
both N-atoms). The second protonation takes place on the un-substituted (1,4-DO2AMBz) or 
benzyl-substituted (1,4-BzDO2AM) N3 (or N4) atom along with a shift of the former proton to 
Table 1. Protonation constants of 1,4-BzDO2AM, 1,4-DO2AMBz, 1,4-DO2AM, 1,4-DO2A, 
1,7-DO2A, and DOTA at 25C in 0.1 M KCl 
 1,4-
BzDO2AM 
1,4-
DO2AMBz 
1,4-
DO2AM
[a] 
1,4-
DO2A
[b] 
1,7-
DO2A
[b]
 
DOTA
[c]
 
 0.1 M KCl 
logK1 11.11(1) 9.62(3) 10.14 11.40 11.66 11.41 
logK2 8.22(4) 6.90(5) 8.38 9.58 9.75 9.83 
logK3   - 3.74 4.06 4.38 
logK4   - 1.65 1.78 4.63 
logK5   - - - 1.92 
logK6   - - - 1.58 
logKi
H
 19.33 16.52 18.52 26.37 27.25 33.75 
[a] Ref 11 [b] Ref 12 [c]Ref 13 
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afford a bis-protonated species on N1–N4 or N2–N3. This shift of protons allows a larger 
charge separation, which is well known to occur during the protonation of tetraaza 
macrocyclic ligands.  
Comparison of the protonation constants of 1,4-BzDO2AM and 1,4-DO2AMBz with those of 
the 1,4-DO2AM indicates that the logK1
H
 value of 1,4-BzDO2AM is slightly higher, whereas 
the logK1
H
 and logK2
H
 values of 1,4-DO2AMBz are significantly lower than those of the 1,4-
DO2AM. In general, the nature of the substituents on the amide group of macrocyclic amino-
polycarboxylate ligands can influence the basicity of the ring N-atoms.
[14]
 The lower 
protonation constants of 1,4-DO2AMBz can be explained by the electron withdrawal effect of 
the benzyl group on the amide pendant arm results in the lower basicity of the ring nitrogens. 
The total basicity (logKi
H
) of 1,4-BzDO2AMBz is comparable whereas the logKi
H
 value of 
1,4-DO2AMBz is significantly lower than that of 1,4-DO2AM ligand. By taking into account 
the logKi
H
 values, a lower stability for the 1,4-DO2AMBz complexes can be expected in the 
comparison with the related complexes of 1,4-DO2AM ligand. 
 
Complexation properties: 
The stability constants of the Mn
II
-complexes formed with 1,4-BzDO2AM and 1,4-
DO2AMBz ligands are defined by Eq. (2).  
]][[
][
LM
ML
KML                                                             (2) 
 
The stability constants of the 1,4-BzDO2AM and 1,4-DO2AMBz complexes have been 
calculated from the titration curves obtained at 1:1 metal to ligand concentration ratios. The 
best fitting of the experimental data (volume of KOH added vs. pH) was obtained by using the 
model which includes the formation of ML species in equilibrium. However, the titration data 
of the Mn
2+
 - 1,4-BzDO2AM and Mn
2+
 - 1,4-DO2AMBz systems indicate base consuming 
process at pH>8.5. This process characterized by KMLH-1 equilibrium constants, can be 
interpreted by assuming the hydrolysis of the metal ion (the coordination of OH
-
 ion to Mn
II
 
center) according to Eq. (3). 
]H][MLH[
]ML[
1
MLH 1 



K
                                                                 (3) 
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The logKMnL and logKMnLH-1 values of Mn(1,4-BzDO2AM), Mn(1,4-DO2AMBz) complexes 
obtained by pH-potentiometry are listed and compared with those of Mn(1,4-DO2AM), 
Mn(1,4-DO2A), Mn(1,7-DO2A), Mn(DO3A) and Mn(DOTA) in Table 2. 
Table 2. The stability (logKML) and protonation (logKMLH-1) constants Mn
II
-complexes 
formed with 1,4-BzDO2AM, 1,4-DO2AMBz, 1,4-DO2AM, 1,4-DO2A, 1,7-DO2A, DO3A 
and DOTA (0.1 M KCl, 25C). 
 1,4-
BzDO2AM 
1,4-
DO2AMBz 
1,4-
DO2AM
[a] 
1,4-
DO2A
[b] 
1,7-
DO2A
[b] 
DOTA
[c] 
MnL 11.54 (4) 10.72(3) 12.64 15.22[b] 15.07[b] 19.33 
MnHL - - - 4.15[b] 4.48[b] 4.09 
MnH2L - - - - - 3.70 
MnLH-1 10.44(5) 9.44(7) - - - - 
[a] Ref 11 [b] Ref 12 [c]Ref 13 
 
The stability constants of the Mn
II
-complexes formed with the 1,4-BzDO2AM and 1,4-
DO2AMBz are about 1 and 2 orders of magnitude lower than that of Mn(1,4-DO2AM), 
respectively. The lower logKML value determined for Mn(1,4-DO2AMBz) complex is not 
surprising, since the total basicity of 1,4-DO2AMBz is lower by 2 logK unit than that of 1,4-
DO2AM ligand. However, the stability constant of Mn(1,4-BzDO2AM) complex is 
significantly lower than it can be expected by taking into account the logKi
H
 values 
presented in Table 1. Because of the similar basicity of the N donor atoms in 1,4-BzDO2AM 
and 1,4-DO2AM ligands, it can be assumed that the presence of the bulky benzyl substituents 
on the N2 and N3  sterically hinder the optimal arrangement of two amide oxygen and four 
ring nitrogen donor atoms around the relatively small Mn
II
-ion (82 pm). Because of the lower 
stability of Mn(1,4-BzDO2AM) and Mn(1,4-DO2AMBz) complexes, the hydrolysis of Mn
II
-
ion takes place by the formation of MnLH-1 species (Eq. (3)) at basic pH range.  
It should be noted that MnL complexes formed with 1,4-BzDO2AM, 1,4-DO2AMBz and 1,4-
DO2AM ligands are characterized with significantly lower stability than Mn(1,4-DO2A), 
Mn(1,7-DO2A), Mn(DO3A) and Mn(DOTA) complexes. The lower logKML values of the 
Mn
II
-complexes formed with 1,4-DO2A-bisamide ligands can be explained by the 
significantly lower basicity (logKi
H
) of the ring N-atoms due to the replacement of the 
charged carboxylate groups with the non-charged amide pendant arms.  
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Transmetallation kinetics 
The metal-complexes used in vivo, must have high kinetic inertness, because the products of 
their dissociation, both the free metal ion and the ligand are toxic.
[15] 
 Nowadays it has been 
realized that, in the in vivo applications of metal-complexes, the kinetic stability is more 
important that the stability constant.
[16]
 Body fluids are very complex systems and the in vivo 
study of the rate of dissociation reactions of metal-complexes would be difficult. However, 
the results of in vitro studies may provide important information concerning the kinetic 
behavior of the complexes under in vivo conditions. The kinetic stabilities of complexes are 
characterized either by the rates of their dissociation measured in 0.1 M HCl or by the rates of 
transmetallation reaction, occurring in solutions with Zn
2+
 or Cu
2+
.
[11,12,17]
 Generally, the 
dissociation of MnDOTA-like complexes take place slowly via the proton-assisted 
dissociation of Mn
II
-complexes whereas the presence of endogenous metal ions like Zn
2+
 and 
Cu
2+
 has essentially no effect on the dissociation rates.
[11,12,18] 
The rates of the metal exchange 
reactions of [Mn(1,4-DO2AM)], [Mn(1,4-DO2A)] and [Mn(1,7-DO2A)] with Zn
2+
 and Cu
2+
 
ions were previously investigated.
[11,12]
 For the direct comparison of the kinetic properties of 
[Mn(1,4-BzDO2AM] and [Mn(1,4-DO2AMBz)] with those of [Mn(1,4-DO2AM)], [Mn(1,4-
DO2A)] and [Mn(1,7-DO2A)],  the same method and identical conditions were used as in the 
study of [Mn(1,4-DO2AM)], [Mn(1,4-DO2A)] and [Mn(1,7-DO2A)].
[11,12]
 The rates of the 
transmetallation reactions of [Mn(1,4-BzDO2AM] and [Mn(1,4-DO2AMBz)] with the use of 
Zn
2+
 as exchanging metal ion  (Eq. (4)) were studied by relaxometry at 20 MHz and 25C in 
the pH range 4.5 – 6.5.  
 
 MnL  +   Zn
2+
    ZnL   +   H2L
2+
                                   (4) 
 
In the presence of 10 and 20 fold excess of the Zn
2+
-ion the transmetallation can be treated as 
a pseudo-first-order process and the rate of reactions can be expressed with the Eq. (5).  
 
                                                 (5) 
 
where kd is a pseudo-first-order rate constant and [MnL]t and [MnL]tot are the concentrations 
of the MnL species at time t and the total concentration of the complex, respectively.  The 
calculated pseudo-first order rate constants for the transmetallation reaction of [Mn(1,4-
BzDO2AM)]
2+
, [Mn(1,4-DO2AMBz)]
2+ 
and Zn
2+
 as a function of [H
+
] are shown in Figure 1. 
totd
t ]LnM[
dt
]LnM[d
k
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Figure 1. kd values of the transmetallation reactions of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
 with Zn
2+
 ([MnL]=0.5 mM, [Zn
2+
]=10 mM () and 20 mM (); 0.1 M KCl, 
25C) 
 
As it can be seen in Figure 1, the transmetallation rates of [Mn(1,4-BzDO2AM)]
2+
 and 
[Mn(1,4-DO2AMBz)]
2+
 are directly proportional to the H
+
 concentration and independent of 
the [Zn
2+
]. The increase in the kd values with increasing [H
+
] can be interpreted in terms of the 
relatively slow proton assisted dissociation of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
, followed by a fast reaction between the free ligand and the exchanging Zn
2+
 
ions. The dependence of kd on the [H
+
] can be expressed as a first-order function of [H
+
] by 
taking into account the proton-independent (Eq. (6)) and proton assisted (Eq. (7)) pathways. 
 
MnL    Mn
2+
    +   H2L                                             (6) 
 
MnL  +   H
+
    Mn
2+
    +   HxL                                        (7) 
 
k0 and k1 are the rate constants characterizing the spontaneous and proto-assisted dissociation 
of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
, respectively. By considering all the 
possible pathways and the rate of transmetallation of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
 (Eq. (5)), the pseudo-first-order rate constant (kd) can be expressed by Eq. (8). 
 
                                       (8) 
 
0.0E+00
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s
-1
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]H][MnL[]MnL[
dt
]LMn[d
1
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k0 
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By taking into account the total concentration of the complex ([MnL]tot = [MnL]), the pseudo-
first-order rate constant (kd) can be expressed as follows:  
 
 kd = k0   +   k1[H
+
]                                                         (9) 
 
The k0 and k1 rate constants were calculated by fitting the experimental data presented in 
Figure 1 to Eq. (9). The rate constants and the dissociation half-lives at pH=7.4 (t1/2 = ln2/kd) 
characterizing the transmetallation reaction of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
 with Zn
2+
 are listed and compared with the corresponding values reported for 
[Mn(1,4-DO2AM)]
2+
, [Mn(1,4-DO2A)], [Mn(1,7-DO2A)] and [Mn(DOTA)] in Table 3.  
 
 
Table 3. Rate constants and half-lives at pH=7.4 for the dissociation reactions of [Mn(1,4-
BzDO2AM)]
2+
, [Mn(1,4-DO2AMBz)]
2+
, [Mn(1,4-DO2AM)]
2+
, [Mn(1,4-DO2A)],  [Mn(1,7-
DO2A)] and [Mn(DOTA)]
2-
 complexes (0.1 M KCl, 25C). 
 Mn(1,4-
BzDO2AM) 
Mn(1,4-
DO2AMBz) 
Mn(1,4-
DO2AM)
[a] 
Mn(1,4-
DO2A)
 [b]
 
Mn(1,7-
DO2A)
 [b]
 
Mn(DOT
A) 
[c] 
k0 (M
-1
s
-1
) (-9±8)10–6 (-1±5)10–7 -6  10–7   1.8  10
–7
 
k1 (M
-1
s
-1
) 36 ± 2 38 ± 2 8.7 99 84 0.04 
k2 (M
-2
s
-1
)    1.5  10
6
 2.5  106 1.6  103 
logKMnLH    4.15 4.48 4.26 
kd (s
-1
) 
pH=7.4 
1.410-6 1.510-6 3.510-7 3.9 10-6 3.3  10-6 2.6 10-6 
t1/2 (h) 
pH=7.4 
136 126 556 49.4 58.3 1070
 
[a] Ref 11 [b] Ref 12 [c]Ref 18 
 
 
The data presented in Table 3 also show that the obtained k0 values are very low and the error 
in them is very high, indicating the unimportance of the spontaneous dissociation of the 
[Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
. The k1 rate constants characterizing the 
proton-assisted dissociation of the Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
  
complexes are about 4 times higher than that of the [Mn(1,4-DO2AM)]
2+
 and about three 
times smaller than those of [Mn(1,4-DO2A)] and [Mn(1,7-DO2A)] complexes. It is generally 
accepted that the proton assisted dissociation of Mn
II
-complexes of DOTA-like ligands 
possessed by carboxylate pendant arms takes place by the protonation at one of the 
carboxylate group, which is more likely followed by the transfer of proton to the ring nitrogen 
with the release of Mn
2+
 from the coordination cavity.
[12,18] 
Since the replacement of the 
protonable carboxylate groups with non-protonable amide groups does not allow the 
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formation of the protonated MnHL intermediate, it can be assumed that the proton assisted 
dissociation of Mn
II
-complexes formed with DO2A-bisamides takes place by protonation of 
the ring N-atom followed by dissociation of the Mn
2+
 ion. By taking into account the k1 values 
of Mn(1,4-BzDO2AM)]
2+
, [Mn(1,4-DO2AMBz)]
2+
 and [Mn(1,4-DO2AM)]
2+
, it can be 
assumed that the protonation of the ring N-atom in [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
 occur more easily, which might be explained by the weak interactions 
between the donor atoms of 1,4-BzDO2AM and 1,4-DO2AMBz ligands and Mn
II
-ion. This 
hypothesis has been confirmed by the lower stability constants of [Mn(1,4-BzDO2AM)]
2+
 and 
[Mn(1,4-DO2AMBz)]
2+
 complexes (Table 2). The half-life (t1/2) of dissociation of [Mn(1,4-
BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 calculated for pH=7.4 is about four times lower 
than that measured for [Mn(1,4-DO2AM)]
2+
 but remain significantly higher than those 
reported for of [Mn(1,4-DO2A)] or [Mn(1,7-DO2A)]. 
 
1
H and 
17
O NMR relaxometric studies. 
 
The relaxometric characterization of the two complexes begins with the measure of the pH 
dependency of the relaxivity. The overall behaviour follows quite closely that observed for 
[Mn(1,4-DO2AM)]
2+
. The relaxivity is constant over the pH range 12 to 5, where complete 
formation of the metal complex occurs, and then it shows a sharp increase up to pH ca. 3-4, 
where another range of constant r1p is formed. These results confirm that the introduction of 
the benzyl groups either on the macrocycle or on the pendant arms does not alter significantly 
the stability of the complexes. The pH dependence of the relaxivity for both complexes is 
reported in Figure 2. 
 
Figure 2. Plot of the relaxivity (20 MHz; 25 ºC) of the [Mn(1,4-BzDO2AM)]2+ (left) and 
[Mn(1,4-DO2AMBz)]
2+
 (right) complexes as a function of pH.  
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The r1p values of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 as measured at 25°C, 
20 MHz and neutral pH are 3.8 and 3.5 mM
-1
 s
-1
, respectively. These values are considerably 
higher than that of [Mn(1,4-DO2A)] and [Mn(1,4-DO2AM)]
2+
, suggesting that both 
complexes feature one coordinated water molecule and an enhanced inner sphere relaxivity 
associated with their larger size (longer R). 
The NMRD profiles have been measured at 298 and 310 K over the proton Larmor frequency 
range 0.01-70 MHz, corresponding to magnetic field strengths varying between 2.34310-4 T 
and 1.645 T (Figure 3). As typical for low molecular weight complexes, the profiles have a 
rather simple functional form consisting of a region of constant relaxivity at low fields, a 
simple dispersion around 6-8 MHz, and another region at high fields (> 20 MHz) where the 
relaxivity tends to flatten out.  
 
 
Figure 3.
 1
H NMRD profiles recorded at different temperatures for [Mn(1,4-BzDO2AM)]
2+
 
(left) and [Mn(1,4-DO2AMBz)]
2+
 (right). The lines represent the fit of the data as explained 
in the text. 
 
As for the parent complex, also in this case the relaxivity decreases by increasing temperature 
over the entire frequency range, clearly indicating that both Mn(II) chelates are in the fast-
exchange regime and that r1p is only limited by the rotational correlation time.  
Also in this case a quantitative assessment of the water exchange kinetics has been gained 
through the measurements and analyses of the temperature dependence of the 
17
O NMR 
transverse relaxation rate (R2) and paramagnetic shift (Δω) (Figure 4 A and B). The 
experimental data were measured on a high-resolution NMR spectrometer, operating at 14.1 
T, on aqueous solutions of the complexes (2-7 mM) at neutral pH. The data were then 
analysed according to the well-established set of Swift-Connick equations. The reduced R2 
(1/T2r) and Δω values are reported in Figure 4A and 4B, respectively. As for the parent 
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complex (see Chapter 6), the increase of 1/T2r with decreasing temperature over a wide range 
of values represents a clear indication of a fast rate of exchange for the coordinated water 
molecule, in agreement with the qualitative conclusions obtained from the analysis of the T-
dependent NMRD profiles. 
 
 
 
 
Figure 4. Reduced transverse (A) 
17
O NMR relaxation rates and 
17
O NMR chemical shifts (B) 
measured for[Mn(1,4-DO2AMBz)]
2+
 (left) and [Mn(1,4-BzDO2AM)]
2+ 
(right) at 11.74 T. 
The lines represent the fit of the data as explained in the text 
 
The 
1
H NMRD and 
17
O NMR data were fitted simultaneously according to the established 
theory of paramagnetic relaxation expressed in terms of the Solomon-Bloembergen-
Morgan
[19] and Freed’s[20] equations for the inner- (IS) and outer sphere (OS) proton 
relaxation mechanisms, respectively, and of the Swift-Connick theory for the 
17
O relaxation. 
Following a well-established practice, due to the large number of relaxation parameters some 
of them were fixed to reasonable values: q was fixed to 1; the distance between the metal ion 
and the protons of the bound water molecule, r, was fixed to 2.83 Å; a and D were set to 3.6 
Å and 2.3×10-5 cm2 s-1 (at 25°C), respectively; EV was fixed to 1.0 kJ mol
-1
. To ER (activation 
energy for the rotational motion of the complex) and ED (activation energy of D) were 
A
B 
A 
B 
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assigned the same values found for [Mn(1,4-DO2A)]: 19.1 and 17.3 kJ mol
-1
, respectively. 
The relevant best-fit parameters are listed in Table 4 and compared with those of related 
macrocyclic Mn(II) complexes. 
 
Table 4. Parameters obtained from the simultaneous analysis of 
17
O NMR and 
1
H NMRD 
data. 
Parameters 
1,4-
BzDO2AM 
1,4-
DO2AMBz 
1,4-
DO2AM 
1,4-
DO2A[21] 
r1 / mM
-1 s-1 3.8 3.5 2.5 2.1 
298kex /×10
6 s-1 253 ± 9 175 ± 5 111 ± 6 1134 
2 /×1019 s-2 20 ± 2 20 ± 1 51 ± 8 48.1 
298V / ps 13 ± 1 11 ± 1 5.5 ± 0.2 4.4 
298R / ps 96 ± 2 85 ± 3 53 ± 3 46 
ΔH# / kJ mol-1 14.4 ± 1.1 24.6 ± 0.8 39.8 ± 0.7 29.4 
A/ħ / 106 rad s-1 31.0 ± 0.4 33.0 ± 0.3 39.0 ± 0.4 43.0 
q 1* 1* 0.87 0.87 
rMn–H / Å* 2.83 2.83 2.83 2.83 
a / Å* 3.6 3.6 3.6 3.6 
* fixed during the fit 
 
 
The electron relaxation parameters, 2 and V, are very similar for the both macrocyclic 
complexes and similar to the values for the parent complex. This represents a strong 
indication of the occurrence of strictly analogous solution structures for the three complexes. 
The rotational correlation time R assumes the value of 96 and 85 ps for [Mn(1,4-
BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
, respectively. This nicely reflects the increased 
molecular mass of the benzylic derivatives over the parent complex and confirms the limiting 
role of the rotational dynamics to the relaxivity of the complexes. In addition, the difference 
in the r1p and R values between the two chelates is well accounted for by their slightly 
different molecular masses.
 
The rates of water exchange are about are about two times higher than for [Mn(1,4-
DO2AM)]
2+ 
and approximately half that of [Mn(EDTA)]
2-
. So, the introduction of 
hydrophobic substituents impacts not only the rotational dynamics but also the water 
exchange dynamics of the complexes, likely by influencing the relative energy values of their 
six- and seven-coordinate states. 
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Human Serum Albumin (HSA) binding studies. 
The presence of hydrophobic groups allows the complexes to bind HSA. The binding 
interaction has been investigated through the well-established proton relaxation enhancement 
(PRE) technique that consists in measuring the increase of the water proton longitudinal 
relaxation rate (R1) as a function of increasing concentration of the protein at 20 MHz and 298 
K (Figure 5). R1 is enhanced by the increase of the fraction of bound complex, characterized 
by a decreased reorientational motion. The fitting of the experimental data to the theoretical 
values calculated based on the established theory provides the values of the thermodynamic 
association constant, KA, the number of the equivalent and independent binding sites, n, and 
the relaxivity of the resulting paramagnetic metallo-protein, r1
bound
. All the data were fitted to 
a 1:1 binding isotherm even though the presence of multiple affinity sites on HSA cannot be 
excluded for these complexes. The affinity of the complexes for the protein is influenced by 
the position of the pendant hydrophobic moieties: KA is ca. 3.9×10
3
 M
-1
 for [Mn(1,4-
BzDO2AM)]
2+
 and 1.9×103 M-1 for [Mn(1,4-DO2AMBz)]2+. 
 
 
Figure 5. Changes in the observed longitudinal relaxation rates of water protons observed 
upon addition of HSA to solutions of the [Mn(BzDO2AM)]
2+
 (0.139 mM) and 
[Mn(DO2AMBz)]
2+
 (0.199 mM) complexes. The solid lines represent the least-squares fits of 
the data according to a 1:1 binding isotherm. 
Table 5. Best-fit parameters obtained from the analysis of the 
1
H relaxometric titrations (20 
MHz; 298 K) of the Mn
2+
 complexes with HSA.
 
 [Mn(1,4-DO2AMBz)]
2+
 [Mn(1,4-BzDO2AM)]
2+
 
n·KA (M
-1
) 1964 ± 342 3909 ± 583 
r1p
b
 (mM
-1
 s
-1
) 27.4 ± 1.4 18.5 ± 0.7 
r1p
f
 (mM
-1
 s
-1
)
 
3.5 3.8 
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These values are 2-3 times higher than similar data reported for Gd(III) complexes bearing 
analogous targeting groups.
[22] 
However, the Gd-chelates (anionic) and these Mn(II) 
complexes (cationic) differ for the overall charge. The r1p
bound
 (20 MHz and 298 K) values 
show a difference: 18.5 mM
-1
 s
-1
 for [Mn(1,4-BzDO2AM)]
2+
 and 27.4 mM
-1
 s
-1 
for [Mn(1,4-
DO2AMBz)]
2+ 
(Table 5). Clearly, the relative position of the benzylic groups in the two 
complexes influences the motional coupling between the paramagnetic unit and the protein. 
One hypothesis is that the presence of the two hydrophobic groups on the coordinating 
acetamide moieties limits the degree of local motions involving the coordination cage (longer 
effective rotational correlation time) and thus increases relaxivity. 
Conclusions: 
The chemical modification of the basic structure of DO2AM, with the introduction of two 
benzyl groups either on the macrocycle or on the pendant arms, has strong effect on various 
properties of the corresponding Mn(II) complexes.  
- Both complexes show higher r1p values. The increase of molecular mass seems to be 
translated entirely into a corresponding increase of relaxivity, thus suggesting a rather 
compact structure characterized by an isotropic tumbling motion. 
- The high relaxivity values suggest the presence of one bound water molecule, although we 
cannot exclude the presence of a small population of the q=0 isomer. In any case, the 
hydration state of the parent complex did not decrease upon the chemical modification. 
- The rate of water exchange has increased by a factor of ca. two as compared to the value of 
MnDO2AM. This is not easy to explain without additional information on the mechanism of 
exchange, because the overall charge of the complexes and their coordination geometries did 
not change. Probably, steric interactions between the hydrophobic substituents and the 
coordinated water molecule might be involved. 
- As for the corresponding Gd(III) chelates, the presence of the hydrophobic pendant groups 
enables the formation of non-covalent adducts with HSA. The affinity constants and the 
relaxivity values of the adducts are quite comparable to those typical of the analogous Gd(III) 
complexes. 
- The thermodynamic stability constants decreased by nearly one logK. Moreover, the kinetic 
inertness of the modified complexes sensibly reduced, as shown by the t1/2 values, ca. 5 times 
lower than for MnDO2AM.  
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This last point is quite disappointing because the lower stability of the complexes attenuates 
to some extent the advantages obtained in terms of relaxation efficiency. Clearly, more efforts 
are necessary to find a better compromise between safety and efficiency for the Mn-based 
MRI probes.  
Experimental Section: 
General: All chemicals were purchased from Sigma-Aldrich Co. and were used without 
further purification. The concentration of the MnCl2, and ZnCl2 solutions were determined by 
complexometric titration with standardized Na2H2EDTA and xylenol orange (ZnCl2), and 
Eriochrome Black T (MnCl2) as indicators. The concentration of the 1,4-BzDO2AM, and 1,4-
DO2AMBz was determined by pH-potentiometric titration in the presence and absence of a 
50 fold excess of CaCl2. The pH-potentiometric titrations were made with standardized 0.2 M 
KOH solution. 
1
H and 
13
C NMR spectra were recorded on a Bruker DRX 400 (9.39 T) and 
Bruker Avance III (11.74 T) spectrometers. Chemical shifts are reported relative to TMS and 
were referenced using the residual proton solvent resonances. Electrospray ionization mass 
spectra (ESI MS) were recorded on an SQD 3100 Mass Detector (Waters), operating in 
positive or negative ion mode, with 1% v/v HCOOH in methanol as the carrier solvent. HPLC 
analyses were carried out on a 1525EF Waters liquid chromatograph equipped with Waters 
2489 UV/vis and Waters SQD 3100 MS detectors and using a Waters Atlantis® T3 RPC18 
column (150 mm × 4.6 mm, 5 μm). Preparative HPLC separations were carried out using a 
Waters Atlantis
®
 T3 OBD RPC18 column (100 mm × 19 mm, 5 μm) and a Waters FCIII 
fraction collector.  
Synthesis of 1,4-DO2AMBz:2-bromoacetyl bromide (1 mL, 11.5 mmol) and benzyl amine 
(1.14mL, 10.4 mmol) were dissolved in CH2Cl2 (10 mL) and triethylamine (0.88 mL, 6.26 
mmol) was added at 0 °C. The reaction mixture was stirred at 0 oC for 1 h, and then allowed 
to warm to room temperature. 15 ml of water was added and the aqueous layer was extracted 
with 4x 15 ml CH2Cl2. The combined organic layer was washed with 50 ml 5% HCl, water, 
50 ml saturated NaHCO3, and brine. The organic layer was dried over MgSO4 and then 
filtered. The solvent was removed in vacuum and the product 3 was purified by flash 
chromatography Petroleum ether 7:3 Ethyl acetate on silica gel. ESI-MS (m/z): found 228.0 
[M + H
+
]. We used the sidearm without other characterization.
[23]
 After that cyclen (0.28 g 1.6 
mmol) and K2CO3 (0.33 g 2.4 mmol) was dissolved in ACN (15 ml) and the product 3 (0.74 g 
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3.3 mmol) was added dropwise. The mixture was heated to reflux for 24 h. The resulting 
aqueous solution was dried and the crude product was then purified by semi-preparative 
HPLC-MS (Solvent A: H2O TFA 0.1%; Solvent B: MeOH; 0-2 min 10% B then gradient 10-
100% B in 18 min; Flow 20 mL/min; retention time: 6.3 min) to obtain 140 mg of an orange 
oil 5 (0.26 mmol, 18.2% yield). ESI-MS (m/z): found 467.5 [M + H
+
] (calc. for C26H38N6O2: 
466.5). 
1
H-NMR (D2O, 500 MHz): δ 3.22 (σ CH2NH 4H) 3.05 (s, CH2CO, 4H), 2.85-2.65 (m, 
NCH2 ring, 16H), 7.51-7.41 (m, CHAr, 10H); 
13
C-NMR (D2O, 125 MHz): δ 171.4 (C=O), 
131.0 (CH), 129.1 (CH), 57.7 (CH2), 53.5 (CH2), 53.0 (CH2), 50.0 (CH2), 48.9 (CH2), 36.6 
(CH2) 
 
Synthesis of 1,4-BzDO2AM:Cyclen (0.5 g 2.9 mmol) was dissolved in ethanol (15 ml) and 
diethyl oxalate (585 μL 4.3 mmol) was added dropwise. The mixture was heated to reflux for 
24 h and then the solvent was removed in vacuum. We characterized the intermediate with 
mass chromatography: ESI-MS (m/z): found 227.2 [M + H
+
]. The product 3 (0.64 g 2.8 
mmol) was dissolved in ACN (15 ml) and benzyl bromide (840 μL 7.0 mmol) and K2CO3 
(2.35 g 17 mmol) were added to the mixture. The mixture was heated to reflux for 24 h and 
then the solvent was removed in vacuum. The crude product 5 was dissolved in CH2Cl2 (20 
ml) and washed with water (3x15 ml). The product was purified by flash chromatography 
(DCM 98:2 MeOH, silica gel). ESI-MS (m/z): found 407.5 [M + H
+
].  The product 5 was 
dissolved in 5 M NaOH (20 ml) and was stirred on 100 °C for 24 h.  The solvents volume was 
rotavaporated to smaller amount (10 ml) and washed with CH2Cl2 (3x20 ml); after that the 
organic phase was washed with water (3x20 ml). The organic layer was dried over MgSO4 
and then filtered. The organic solvent was then removed in vacuum. ESI-MS (m/z): found 
353.5 [M + H
+
]. The intermediate was used without any further characterization.
[24]
The 
product 6 (0.17 g 0.5 mmol) and K2CO3 (0.63 g, 4.5 mmol) were suspended in ACN (10 ml) 
and N,N-dimethyl 2-chloroacetamide (105 μL 1.01 mmol) was added dropwise. The mixture 
was stirred for 24 h and then the solvent was removed in vacuo. The crude product 8 was 
purified by flash chromatography (DCM:MeOH 99:1, silica gel) to obtain a pale yellow oil.  
(0.46 mmol, 15.9 % yield). ). ESI-MS (m/z): found 523.5 [M + H
+
] (calc. for C30H46N6O2: 
522.5). 
1
H-NMR (D2O, 500 MHz): δ 4.31 (σ CH2 4H) 3.18 (s, CH2CO, 4H), 3.51 (s CH3 12H) 
2.01-2.28 (m, NCH2 ring, 16H), 7.30-7.37 (m, CHAr, 10H); 
13
C-NMR (D2O, 125 MHz): δ 
172.5 (C=O), 137.8 (CH), 126.5.0 (CH), 127.0 (CH), 127.6 (CH) 49.5 (CH2), 50.1 (CH2), 
50.6 (CH2), 51.2 (CH2), 51.9 (CH2), 55.0 (CH2) 41.9 (CH3) 
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Equilibrium measurements: The protonation constants of 1,4-BzDO2AM and 1,4-
DO2AMBz the stability and protonation constants of the Mn
2+
-complexes formed with the 
1,4-BzDO2AM and 1,4-DO2AMBz ligands have been determined by pH-potentiometry. The 
pH-potentiometic titrations were performed at 1:1 metal-to-ligand concentration ratio (the 
concentration of the ligand was generally 0.002 M). For the calculation of the equilibrium 
constants the mL base – pH data were used, obtained in the pH range 1.7–12.0.. The 
equilibrium constants were calculated with the program PSEQUAD.
[25]
 For the pH 
measurements and titrations, a Methrohm 888 Titrando titration workstation and a Metrohm 
6.0233.100 combined electrode were used. Equilibrium measurements were carried out at a 
constant ionic strength (0.1 M KCl) in 8 mL samples at 25 C. The solutions were stirred, and 
N2 was bubbled through them. The titrations were made in the pH range of 1.7-12.0. KH-
phthalate (pH=4.005) and borax (pH=9.177) buffers were used to calibrate the pH meter. For 
the calculation of [H
+
] from the measured pH values, the method proposed by Irving et al. 
was used.
[26]
 A 0.01M HCl solution was titrated with the standardized KOH solution in the 
presence of 0.1 M KCl ionic strength, respectively. The differences between the measured 
(pHread) and calculated pH (-log[H
+
]) values were used to obtain the equilibrium H
+
 
concentration from the pH values, measured in the titration experiments. The ion product of 
water was determined from the same titrations (HCl/KOH) in the pH range of 11.5-12.0. 
Kinetic studies: The kinetic inertness of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
 were characterized by the rates of the exchange reactions taking place 
between the MnL complexes and Zn
2+
.  The rates of the metal exchange reactions of [Mn(1,4-
BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 with Zn
2+
 was followed by measuring the water 
proton relaxation rates (1/T1) of the samples with a Stelar Relaxometer equipped with a 
Bruker WP80 NMR electromagnet adapted to variable-field measurements (15-80 MHz 
proton Larmor frequency. The kinetic measurements were performed on the Stelar 
Relaxometer at 0.47 T (20 MHz) and 25 °C owing to the large differences in the relaxivities 
[Mn(1,4-BzDO2AM)]
2+
 (r1p=3.83 mM
-1
s
-1
) and [Mn(1,4-DO2AMBz)]
2+
 (r1p=3.47 mM
-1
s
-1
) 
and that of free Mn
2+
 (r1p=8.0 mM
-1
s
-1
). The longitudinal relaxation times were measured by 
the ‘inversion recovery’ method (180 - - 90) by using 8 different  values. The 
measurements were made with 1.0 mM of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
  solution in the presence of 10 to 20 fold excess of Zn
2+
. The temperature was 
maintained at 25 C and the ionic strength of the solutions was kept constant (0.15 M NaCl 
and 0.1 M KCl). For keeping the pH values constant, N-methylpiperazine (pH range of 4.1 – 
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5.2) and piperazine (pH range of 4.7 – 6.6) buffers (0.01 M) were used. The pseudo-first-
order rate constants (kd) were calculated with the use of the Eq. (10) 
                                                          
e
1
e
1
0
1
t
1
RRRR   tde k)(                                              (10) 
 
where R1
0
, R1
t
, and R1
e
 are the relaxation rate (1/T1) values at the start, at time t, and at 
equilibrium of the reactions, respectively. The calculations were performed using the 
computer program Micromath Scientist, version 2.0 (Salt Lake City, UT, USA). 
1
H NMRD and 
17
O NMR measurements. The water proton longitudinal relaxation rates as a 
function of pH (20 MHz) were measured with a Stelar Spinmaster Spectrometer FFC2000 
(Mede, PV, Italy) on about 0.6-2.0 mM aqueous solutions in non-deuterated water. The exact 
concentrations of Mn
2+
 ions were determined by measurement of bulk magnetic susceptibility 
shifts of a tBuOH signal on a Bruker Avance III spectrometer (11.7 T). The 
1
H T1 relaxation 
times were acquired by the standard inversion recovery method with typical 90° pulse width 
of 3.5 μs, 16 experiments of 4 scans. The reproducibility of the T1 data was ±5%. The 
temperature was controlled with a Stelar VTC-91 airflow heater equipped with a calibrated 
copper–constantan thermocouple (uncertainty of ±0.1 °C). The proton 1/T1 NMRD profiles 
were measured on a fast field-cycling Stelar SmartTracer relaxometer over a continuum of 
magnetic field strengths from 0.00024–0.25 T (corresponding to 0.01–10 MHz proton Larmor 
frequencies). The relaxometer operates under computer control with an absolute uncertainty 
in 1/T1 of ±1%. Additional data points in the range 15–70 MHz were obtained on a Stelar 
Relaxometer equipped with a Bruker WP80 NMR electromagnet adapted to variable-field 
measurements (15–80 MHz proton Larmor frequency). 
Variable-temperature 
17
O NMR measurements were recorded on a Bruker Avance III 
spectrometer (11.7 T) equipped with a 5 mm probe and standard temperature control unit. An 
aqueous solution of the complex (4 mM) containing 2.0% of the 
17
O isotope (Cambridge 
Isotope) was used. The observed transverse relaxation rates were calculated from the signal 
width at half-height. 
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Summary  
The main objective of this thesis was the detailed characterization of homogeneous series of 
Mn(II) complexes to assess the possibility of using Mn-based systems as an alternative to Gd 
(III)-based MRI probes. There is a need to expand the available limited library of compounds 
so far investigated to achieve better and more reliable information on the correlation between 
solution structure and molecular relaxation parameters. This is key to enhance the efficacy 
(relaxivity) of the probes. Moreover, it is very important to obtain accurate information 
relating to thermodynamic stability and kinetic inertia of the complexes. This is key to 
develop safe probes for in vivo use.  
A contrast agent for MRI must have the ability to catalyze efficiently the T1 and/or T2 
relaxation in tissues at low (μM to mM) concentrations and with acceptable tolerance. The 
following points summarize the most important features of paramagnetic MRI contrast agents. 
 high relaxivity 
 high kinetic and thermodynamic stability 
 rapid clearance 
 low toxicity 
 specific biodistribution/accumulation 
 low osmolality and viscosity 
Our studies focused on the first two points: thermodynamic and kinetic measurements 
combined with detailed 
1
H and 
17
O NMR relaxometric investigations.  
 
Two main classes of complexes were addressed in the thesis.  
1) The first is represented by the Mn(II) complexes containing the acyclic pentadentate 
coordinating unit 6,6-((methylazanediyl)bis(methylene))dipicolinic acid (H2dpama).  
 
 
H2dpama 
 
I investigated mono-, bi- and trinuclear bis-hydrated complexes. Furthermore, several other 
derivatives bearing different pendant moieties were considered and analyzed.  
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2) The second general class of complexes I dealt with are those based on the macrocyclic 
scaffold of cyclen (1,4,7,10-tetraazacyclododecane). In particular, I focused on the exadentate 
ligands containing two acetamide side arms (1,4-DO2AM) and their derivatives containing 
hydrophobic pendant groups.  
 
 
1,4-DO2AM 
Chapter 4 reports the characterization of the Mn(II)-complexes of dpama
2-
, mX(dpama)2
4-
, 
mX(dpama)3
6-
 and bcpe
2-
. The ligands contain the pentadentate coordinating unit designed for 
pentagonal bipyramidal coordination around Mn
2+
 thanks to the presence of two coordinated 
water molecules. The high hydration number (q=2) imparts remarkably high relaxivities to the 
Mn
2+
 complexes. Furthermore, these relaxivities are further improved by interaction with 
HSA, particularly in the case of the bi- and trinuclear complexes. These multimeric 
complexes show that it is possible to develop low molecular weight Mn
2+
 chelates that may 
represent viable alternatives to Gd-based MRI probes. Their relaxometric properties, in both 
the free form and bound to HSA, are fully comparable or better than those shown by the Gd
3+
 
complexes commonly used in the clinical practice.  
The Mn
2+
 complexes formed with this family of ligands present moderate thermodynamic 
stabilities. Although this may not be a very serious limitation due to the far better safety 
profile of Mn
2+
 compared to Gd
3+
, it is still relevant to continue the search for complexes that 
exhibit improved characteristics of kinetic inertness with respect to complex dissociation. 
 
In Chapter 5 we expanded the family of ligands containing the picolinate group by 
considering the pentadentate ligand H2DPAPhA and the hexadentate derivative H3DPAA. 
Furthermore, we also investigated two lipophilic derivatives of H2DPAMA and 
H2PhDPAMA, which contain a dodecyl side chain attached to the amine nitrogen atom of 
H2DPAMA or a hexyl chain at the aniline function of H2DPAPhA, respectively. These 
lipophilic can be incorporated into micelles or liposomes, for the preparation of lipid magnetic 
nanoprobes. These complexes are also able to bind HSA in a non-covalent manner. The 
hexadentate ligand DPAA
3-
 forms a complex with Mn
2+
 with stability and relaxivity 
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comparable to that of [Mn(EDTA)(H2O)]
2
. On the other hand, the pentadentate ligands 
DPAPhA
2-
 and DPAMA
2-
 form bis-aquated Mn
2+
 complexes in solution. The r1p value of 6.7 
mM
-1
 s
-1 measured for [Mn(DPAPhA)] at pH 7.4 (25 ºC, 20 MHz) is considerably high, which 
indicates the presence of two coordinated water molecules. The results obtained have shown 
that the relaxivities of Mn
2+
 complexes can be modulated by changing the hydration number 
or introducing lipophilic units in the ligand scaffold, very much like in the case of Gd
3+
 
complexes. The adducts formed with HSA have also relaxivities comparable to those attained 
with lipophilic Gd
3+
 agents. 
 
In Chapter 6 I discussed the synthesis and characterization of the hexadentate ligand 1,4-
DO2AM and its Mn(II) complex. The replacement of two negatively charged acetate groups 
with neutral acetamide arms has a marked influence on the solution properties of the 
corresponding Mn
II
 chelates. The thermodynamic stability decreases by about 2.5 logKML 
units because of the lower basicity of the nitrogen atoms of the macrocyclic ring. On the other 
hand, the kinetic inertness of the cationic complex [Mn(1,4-DO2AM)]
2+
 is significantly 
greater than that of the related carboxylates analogues. The half-life for dissociation is ca. one 
order of magnitude longer than that measured for [Mn(1,4-DO2A)] and [Mn(1,7-DO2A)]. 
The relaxometric properties are only marginally influenced by the chemical modification of 
the ligand, with the exception of the rate of water exchange which decreases by more than one 
order of magnitude with respect to the value found for [Mn(1,4-DO2A)].  
The main conclusion from this study is that the kinetic inertness of Mn
II
 chelates can be 
improved without a negative impact on the relaxivity. Clearly, further efforts are necessary to 
combine the elevated kinetic inertness and relaxivity with high thermodynamic stability. We 
hope that the results of this study can provide some clues to achieve this ambitious goal. 
 
Chapter 7 presents the results of the synthesis and complete characterization of two novel 
ligands bearing benzyl pendant groups: 1,4-BzDO2AM, and 1,4-DO2AMBz. We performed 
thermodynamic, kinetic and relaxometric (
1
H and 
17
O) studies. The chemical modification of 
the basic structure of 1,4-DO2AM did not changed significantly the thermodynamic stability 
and also the kinetic stability remains relatively high, with a the half-life (t1/2) of dissociation 
significantly higher than that reported for [Mn(1,4-DO2A)] and [Mn(1,7-DO2A)]. The r1p 
values of the two complexes are considerably higher than those of [Mn(1,4-DO2A)] and 
[Mn(1,4-DO2AM)]
2+
, arising from the presence of one coordinated water molecule associated 
with a larger molecular size (longer R). The presence of hydrophobic groups allows the 
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complexes to bind HSA. The affinity of the complexes for the protein is influenced by the 
position of the pendant hydrophobic moieties: KA is ca. 3.9×10
3
 M
-1
 for [Mn(1,4-
BzDO2AM)]
2+
 and 1.9×103 M-1 for [Mn(1,4-DO2AMBz)]2+. Both the affinity constants and 
the relaxivity values of the adducts are quite comparable to those typical of the analogous 
Gd(III) complexes. Unfortunately, the thermodynamic stability constants decreased by nearly 
one logK. Moreover, the kinetic inertness of the modified complexes sensibly reduced, as 
shown by the t1/2 values, ca. 5 times lower than for MnDO2AM. 
All the r1p and logKMnL values of the Mn(II)-complexes investigated in this thesis are plotted 
in Figure 1 and 2. In the logKMnL table we also show the stability values of the [Mn(1,4-
DO2A)], [Mn(1,7-DO2A)] and [Mn(EDTA)]
2-
 for comparison. 
 
Scheme 1. Structures of the ligands shown in Figure 1. 
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Figure 1. r1p values at 25 °C of the investigated Mn(II)-complexes as a function of their 
molecular weight. 
 
 
Figure 2. logKMnL values of the complexes investigated during the doctoral thesis. 
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